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Abstract	
The	conjunctiva	is	a	mucous	membrane	lining	the	ocular	surface	and	is	crucial	to	
ocular	surface	homeostasis.	Ocular	surface	diseases	lead	to	a	poor	tear	film,	
irreversible	conjunctival	scarring	and	continual	corneal	desiccation	that	may	result	in	
painful	loss	of	vision.	Conjunctival	integrity	and	a	tear	film	with	appropriate	
consituents	are	crucial	to	the	survival	of	corneal	and	limbal	stem	cell	transplants.	I	
hypothesised	that	two	novel	substrates	could	be	developed	for	the	ex	vivo	expansion	
of	conjunctival	epithelium	to	address	a	range	of	transplantation	requirements:	1)	a	
degradable	biological	substrate	from	the	decellularisation	of	human	conjunctiva	and	2)	
a	synthetic	non-degradable	substrate	from	expanded	polytetrafluoroethylene	(ePTFE).		
	
This	study	demonstrated	that	conjunctival	epithelial	cells	(HCjE-Gi	cell	line)	were	
supported	at	a	greater	cell	density	on	ePTFE	subjected	to	ammonia	gas	plasma	treatment.	
Flow	cytometry	determined	the	phenotype	of	conjunctival	epithelium	developed	on	
treated	ePTFE	was	similar	to	that	developed	on	an	established	cell	culture	product;	
Thincert,	a	chemically	modified	polyethylene	terephthalate	(PET)	membrane.	Primary	
conjunctival	epithelium	was	also	expanded	ex	vivo	on	ammonia	plasma	treated	ePTFE,	
however,	the	cell	density	declined	after	14	days	in	culture.	No	significant	differences	were	
found	in	terms	of	intracellular	marker	expression	between	primary	conjunctival	
epithelium	developed	on	ammonia	plasma	treated	ePTFE	and	the	positive	control	(PET	
membrane).		Human	conjunctiva	was	successfully	decellularised	(99%	DNA	removal).	
There	was	no	demonstrable	cytotoxicity,	evidence	of	collagen	denaturation,	change	in	
tensile	strength	or	change	in	the	qualitative	detection	of	extracellular	matrix	proteins	
collagen	IV,	laminin	and	fibronectin.	The	development	of	stratified	conjunctival	
epithelium	of	an	appropriate	phenotype	was	also	demonstrated	following	explant	
culture	on	a	freshly	decellularised	conjunctival	tissue	substrate.		
	
This	is	the	first	study	to	develop	decellularised	conjunctiva	and	plasma	modified	ePTFE	
as	substrates	for	the	ex	vivo	expansion	of	conjunctival	epithelium.	Novel	conjunctival	
constructs	developed	from	both	substrates	may	be	further	developed	to	address	a	
range	of	transplantation	requirements.		
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1.	 Introduction													
1.1	 The	ocular	surface	
The	ocular	surface	comprises	the	cornea,	conjunctiva	and	the	tear	film.		The	cornea	and	
conjunctiva	line	the	anterior	surface	of	the	globe.	The	cornea	is	a	transparent	convex	
structure	and	is	the	main	refractive	component	of	the	eye.		It	is	surrounded	by	and	is	
contiguous	with	the	conjunctiva,	which	covers	the	anterior	episcleral	tissue.	The	
conjunctiva	extends	from	the	corneal	limbus	and	covers	the	tarsal	(inner)	surface	of	the	
eyelids.		It	is	a	moist	translucent	membrane	with	redundant	folds	that	are	most	
prominent	in	the	fornices	which	are	anatomical	spaces	between	the	globe	and	eyelids	
that	enable	free	ocular	movement.(1)	The	tear	film	and	conjunctiva	are	essential	for	the	
homeostasis	of	the	cornea.	The	associated	tear	film	is	crucial	to	the	maintenance	of	
corneal	clarity,	and	to	the	prevention	of	infection.(1)	The	ocular	surface	is	also	protected	
from	drying,	desiccation	and	injury	by	the	upper	and	lower	eyelids	and	its	components	
including	the	eyelashes	and	sebaceous	secretions	from	meibomian	glands.	(1)	
	
	
	
Figure	1:	Schematic	drawing	illustrating	a	cross	section	of	the	globe	and	eyelids.	Taken	from	
Stewart	RMK.	(2013)	Identification	of	progenitor	rich	sites	in	the	conjunctiva.	PhD	Thesis.	
University	of	Liverpool;	adapted	in	part	from	Paulsen	and	Berry	(2006).(2)		
Caruncle	
Plica	Semilunaris	
Palpebral	
Conjunctiva	
Accessory	lacrimal	glands	
Forniceal	
conjunctiva	
Orbital	conjunctiva	
Tarsal	conjunctiva	
Corneal	epithelium	
Bulbar	conjunctiva	
Tarsal	plate	with	
meibomian	glands	
Corneal	
limbus	
	 2	
1.1.1	 The	cornea	and	limbus		
The	cornea	is	a	transparent	structure	that	enables	the	entry	of	light	and	is	the	main	
refractive	component	of	the	eye.	The	average	vertical	and	horizontal	diameters	in	an	
adult	are	10.6mm	and	11.77mm,	respectively.(1)	From	superficial	to	deep,	the	cornea	is	
composed	of	an	epithelial	layer	and	basement	membrane,	an	anterior	limiting	lamina	
(Bowman’s	layer),	the	substantia	propria	(stroma),	a	posterior	limiting	lamina	
(Descemet’s	membrane)	and	an	endothelial	layer,	which	is	contact	with	the	aqueous	
humour	of	the	anterior	chamber	of	the	eye.		
	
The	corneal	epithelium	is	a	stratified	squamous	non-keratinising	epithelium	that	is	5-6	
cell	layers	deep.	The	basal	epithelial	cells	are	associated	with	the	basal	lamina	via	type	
VII	and	VI	collagen.(3)	Continuous	turnover	of	corneal	epithelial	cells	occurs	in	which	
transiently	amplifying	cells	arise	from	the	corneal	stem	cell	niche	at	the	basal	limbus	
and	migrate	centripetally.(4)	The	corneal	epithelium	is	densely	innervated	by	sensory	
but	also	by	a	smaller	proportion	of	sympathetic	fibres.	The	sensory	nerves	can	respond	
to	temperature,	chemical	and	mechanical	stimuli.(5)	Epithelial	defects	heal	rapidly	
through	the	amoeboid	movement	of	corneal	epithelial	cells.(6)	The	apical	corneal	
epithelial	cells	possess	a	glycocalyx,	microplicae	and	microvilli	that	interact	with	and	
stabilise	the	tear	film.(7)	The	corneal	epithelium	meets	the	conjunctival	epithelium	at	
the	limbus,	a	transition	zone	at	the	edge	of	the	cornea.		
	
Corneal	and	conjunctival	epithelia	have	similar	features	in	terms	of	ABGC2	and	ΔNp63	
expression	in	progenitor	cell	populations	but	differ	in	cytokeratin	expression.(8-10)	
Differentiating	features	include	the	absence	of	goblet	cells	in	normal	corneal	
epithelium	and	differential	cytokeratin	expression.(11)	Corneal	stem	cells	are	found	in	
the	basal	crypts	of	limbal	epithelium.	Notable	features	of	the	limbus	are	radial	papillae	
(termed	palisades	of	Vogt),	dense	vascularisation	and	an	epithelial	layer	around	10	cells	
deep.(1)	In	this	transition	zone,	conjunctival	epithelial	cells	end	along	with	its	blood	
vessels.	The	vascular	supply	of	the	peripheral	cornea	originates	from	the	marginal	
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corneal	arcades	and	that	of	the	limbus	is	from	an	episcleral	plexus	derived	from	the	
anterior	ciliary	arteries	that	travel	anteriorly	from	the	rectus	muscles	deep	to	the	
conjunctiva.(1)	The	basement	membrane	composition	of	the	limbus	differs	from	the	
corneal	basement	membrane	such	that	laminins	α1,	β1	and	γ1	are	found	in	greater	
abundance	together	with	collagen	IVα2.(12)	In	limbal	stem	cell	disease	conjunctival	
epithelialisation	of	the	cornea	occurs,	resulting	in	a	loss	of	corneal	clarity.(1)	
	
Bowman’s	layer	is	a	modified	layer	of	the	corneal	stroma	containing	collagens	type	I,	III,	
V	and	VI	and	terminates	at	the	limbus.	The	corneal	basement	membrane	at	the	corneal	
limbus	is	composed	mainly	of	collagen	IV	and	VII,	but	also	extracellular	matrix	proteins	
laminin	(subtypes	332	and	γ2),	fibronectin	and	a	number	of	glycoproteins:	perlecan,	
nidogen,	fibrillin,	clusterin.(3)	The	corneal	stroma	consists	of	collagen	I,	III,	V	and	VI	in	
regularly	arranged	lamellae,	the	spacing	of	which,	is	determined	by	intervening	
glycosaminoglycans	and	proteoglycans.(1)	The	maintenance	of	corneal	clarity	is	
dependant	upon	the	regular	arrangement	and	diameter	of	collagen	fibrils	and	the	tight	
regulation	of	hydration.	In	the	healthy	cornea	no	blood	vessels	are	found	in	within	the	
corneal	stroma	apart	from	the	marginal	corneal	arcades.		Nerve	fibres	are	present	in	
the	anterior	stroma.	The	nerve	supply	of	the	cornea	is	via	the	long	ciliary	nerves	that	
originate	from	the	ophthalmic	division	of	the	trigeminal	nerve.	(1)	Descemet’s	
membrane	is	basement	membrane	of	the	corneal	endothelium	and	is	continuous	with	
the	trabecular	meshwork	peripherally.	The	corneal	endothelium	is	a	monolayer	of	
continuous	polygonal	squamous	epithelium	rich	in	mitochondria.(1)	These	cells	are	
responsible	for	active	transport	regulating	the	fluid	and	electrolyte	balance	of	the	
cornea	and	therefore	its	clarity.		
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Figure	2:	Photomicrograph	of	the	normal	human	cornea.	Paraffin	embedded	tissue	section	was	
subjected	to	staining	with	Haematoxylin	and	Eosin.	Scale	bar	50μm.	Taken	from	Taken	from	
Stewart	RMK.	(2013)	Identification	of	progenitor	rich	sites	in	the	conjunctiva.	PhD	Thesis.	
	
1.1.2	 The	human	conjunctiva	
The	conjunctival	is	a	thin,	translucent	vascularised	membrane	that	lines	the	sclera	and	
the	inner	aspect	of	the	upper	and	lower	eyelids.	It	is	a	stratified	epithelium	supported	
by	a	basement	membrane	that	overlies	a	thin	layer	of	vascularised	loose	connective	
stromal	tissue.(1)	Between	the	conjunctival	connective	tissue	and	the	sclera	lies	the	
tenon’s	capsule,	which	is	a	thin	layer	of	fibrous	tissue	that	forms	adhesions	with	the	
underlying	episclera	and	also	serves	a	protective	function.		
	
The	conjunctiva	is	a	stratified	non-keratinised	squamous	and	columnar	epithelium	and	
contains	goblet	cells,	which	bear	similarities	to	glandular	epithelia.	The	conjunctiva	
varies	between	3	and	9	cell	layers	deep	and	extends	from	the	edge	of	the	corneal	
limbus,	to	the	mucocutaneous	junction	of	the	eyelid	margin	where	the	transition	zone	
from	non-keratinising	to	keratinising	epithelium	occurs.(1)	The	conjunctiva	is	reflected	
Epithelium	
Bowman’s	membrane	
Stroma	
Descemet’s	membrane	
Endothelium	
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from	the	anterior	sclera	to	the	tarsal	(inner)	surface	of	the	eyelids	to	form	an	
anatomical	space	between	the	upper	and	lower	eyelids	and	the	globe	known	as	the	
conjunctival	fornices.		The	excess	conjunctival	tissue	seen	as	folds	in	these	areas,	allows	
a	full	range	of	ocular	movement.	The	volume	of	this	space	with	the	eyelids	closed	has	
been	estimated	at	approximately	7μl.	(1)	
	
The	conjunctiva	can	be	divided	anatomically	into	three	regions:	the	bulbar,	forniceal	
and	palpebral	conjunctiva.	The	bulbar	conjunctiva	covers	and	is	loosely	adherent	to	the	
globe.		In	contrast,	the	palpebral	or	tarsal	conjunctiva	is	tightly	adherent	to	the	tarsal	
plate	on	the	inner	aspect	of	the	eyelids.	The	forniceal	conjunctiva	forms	the	blind	
pouch	between	the	eyelids	and	globe	where	it	is	thrown	into	folds.	The	subepithelial	
connective	tissue	is	sparse	in	the	palpebral	conjunctiva.	The	lacrimal	puncti	open	into	
the	lid	margin	medially.	These	are	small	openings	of	the	narrow	passages	that	connect	
the	eyelids	to	the	nasal	cavity	allowing	the	drainage	of	tears.	The	conjunctival	
epithelium	is	continuous	with	that	lining	the	inferior	meatus	of	the	nasal	cavity.	The	
forniceal	conjunctiva	is	also	continuous	with	the	medial	and	lateral	canthi	and	contains	
accessory	lacrimal	glands	(Krause’s	glands).		
	
The	secretions	from	most	of	the	accessory	lacrimal	glands	in	addition	to	those	from	the	
main	duct	of	the	lacrimal	gland	open	into	the	superolateral	fornix.	The	facial	sheaths	of	
the	rectus	muscles	in	the	upper	and	lower	eyelids	and	levator	palpebrae	superioris	in	
the	upper	lid	are	associated	with	the	conjunctiva.	The	bulbar	conjunctiva	acts	a	coating	
for	the	sclera,	which	is	also	covered	with	episclera	and	Tenon’s	capsule	and	also	covers	
the	extraocular	muscles.	The	conjunctiva	is	loosely	adherent	to	episcleral	tissue	over	
the	bulbar	conjunctiva	but	is	tightly	adherent	at	the	limbus.	At	the	medial	fornix	the	
bulbar	conjunctiva	forms	a	semilunar	fold	(plica	semilunaris)	of	thickened	tissue	that	is	
highly	vascularised,	rich	in	immunocompetent	and	mucin	producing	goblet	cells.(1)	
Medial	to	this	is	a	nodular	tissue	known	as	the	caruncle	that	contains	densely	packed	
sebaceous	glands,	accessory	lacrimal	glands	and	lymphoid	cells.(1)		
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The	conjunctival	epithelial	cells	are	mostly	cuboidal	or	polyhedral	in	shape.	Goblet	cells	
can	be	found	interspersed	within	layers	of	stratified	conjunctival	epithelia	either	in	
isolation	or	in	clusters	lining	crypts.	They	are	found	within	apical	layers	of	epithelium	
and	can	be	easily	recognisable	as	they	are	often	more	rounded	in	appearance	than	the	
surrounding	epithelia.	(13)	Goblet	cells	tend	to	be	large	and	are	characterised	by	an	
apical	portion	that	is	broad	in	comparison	to	their	basal	proportions.	These	cells	are	
characteristically	rich	in	intracellular	organelles	owing	to	their	secretory	and	storage	
capacity	for	the	gel	forming	mucin	MUC5AC.	(11)	
	
Other	than	goblet	cell	secretions,	the	conjunctiva	also	contains	accessory	lacrimal	
glands	known	as	Krause’s	glands	in	the	conjunctival	fornices	and	glands	of	Wolfring	
located	in	the	upper	border	of	the	tarsus.	These	glands	contribute	to	the	baseline	tear	
production	and	are	innervated	by	sympathetic	nerves.(1)	The	conjunctiva	is	also	known	
to	have	lymphoid	tissue	known	as	conjunctiva	associated	lymphoid	tissue	(CALT)	where	
MHC	II	dendritic	cells	transport	internalised	antigens	and	signals	to	mount	an	adaptive	
immune	response.(1)	In	addition,	intraepithelial	CD3+ve	lymphocytes	are	a	recognised	
feature	of	conjunctiva	and	occasionally	B-lymphocytes	as	part	of	the	immune	defence	
system	of	the	conjunctiva.	Scattered	melanocytes	can	also	be	found.(1)			
	
The	sensory	supply	of	the	conjunctiva	is	derived	from	the	ophthalmic	branch	of	the	
trigeminal	nerve.	Parasympathetic	and	sympathetic	nerves	arise	from	the	
pterygopalatine	ganglion	and	sympathetic	plexus	respectively	and	course	along	
branches	of	the	ophthalmic	artery,	terminating	around	goblet	cells.	The	vascular	supply	
of	the	conjunctiva	is	in	the	substantia	propria,	delivered	by	the	anterior	conjunctival	
branches	of	the	anterior	ciliary	artery	and	the	palpebral	branches	of	the	ophthalmic	
and	lacrimal	arteries.		These	vessels	anastomose	with	the	marginal	corneal	arcades	and	
the	limbal	plexus.	Venous	drainage	occurs	into	a	venous	plexus	that	leads	to	the	
superior	and	inferior	ophthalmic	veins.	Lymphatic	vessels	are	also	found	within	a	
network	in	the	bulbar	and	palpebral	conjunctiva.	(14)	
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Biochemical	components	of	the	conjunctival	basement	membrane	zone	have	been	
characterised	and	include	collagens	I/IV/VII,	laminins	and	also	fibronectin.(15)	Collagen	
IV	and	VII,	however,	are	found	with	greatest	abundance	with	laminins	specifically	of	-
332,	α3,	γ1,	γ2	and	5:	integrin	β4,	fibronectin,	nidogen,	perlecan,	and	clusterin.(3)	
Although	these	components	are	identical	to	those	of	the	corneal	and	limbal	basement	
membranes,	the	proportions	of	some	of	these	components	vary	between	the	
aforementioned	tissues.(3)	
	
There	is	a	continual	turnover	of	conjunctival	epithelium,	which	has	a	great	regenerative	
capacity.	This	applies	to	cells	of	both	an	epithelial	and	goblet	phenotype.(11,	16,	17)	
Evidence	for	this	was	determined	from	cloning	studies	in	which	it	was	also	
demonstrated	that	goblet	cells	were	not	terminally	differentiated.(18)	Markers	
associated	with	progenitor	cells	were	mostly	found	in	basal	epithelium	and	were	found	
in	greatest	abundance	at	the	inferior	fornix	and	medial	canthus.(19)	
	
1.1.3	 Protection	of	the	ocular	surface	and	the	tear	film	
There	are	physical	barriers	to	chemical,	environmental	and	infectious	insults	such	as	
the	blink	reflex,	eyelids	and	eyelashes.	The	conjunctiva	covering	the	majority	of	the	
ocular	surface	provides	a	barrier	function	and	plays	a	role	in	mucosal	immunity.		The	
eyelids	contain	meibomian	glands	that	are	found	within	the	fibrous	tarsal	plates	and	
secrete	the	lipid	component	of	the	tear	film	(Figure	1).	Blinking	is	a	reflex	action	that	
redistributes	the	tear	film	and	together	eyelashes	prevent	trauma	and	the	entry	of	
foreign	bodies.	The	meibomian	gland	secretions	form	the	superficial	layer	of	the	tear	
film.	It	is	a	complex	lipid	layer	comprising	heterogeneous	species	of	polar	and	non-
polar	lipids,	13-100nm	in	depth	that	stabilises	the	tear	film	and	prevents	evaporation	
from	its	aqueous	phase.	(20)		
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The	tear	film	is	crucial	to	the	normal	function	of	the	ocular	surface	including	the	
maintenance	of	corneal	clarity.	Several	models	of	the	tear	film	have	been	suggested.	It	
is	generally	accepted	however,	that	tear	film	comprises	an	outer	meibomian	lipid	layer,	
a	gel	phase	comprising	aqueous	secretion	including	electrolytes,	antimicrobial	factors	
and	gel	forming	mucin,	and	an	inner	mucin	layer	directly	in	contact	with	the	apical	
epithelia	of	both	corneal	and	conjunctival	cells.(7)	The	structure	of	the	precorneal	tear	
film	has	more	recently	been	considered	as	mattress	structure	comprising	three	layers;	
an	epithelial	cell	surface	glycocalyx	layer,	an	aqueous/mucin	layer	and	a	superficial	lipid	
layer.(7)		
	
The	aqueous	component	of	the	tear	film	is	produced	primary	by	the	lacrimal	gland,	
which	is	located	in	the	lacrimal	fossa	in	the	superotemporal	orbit.		There	are	also	
contributions	from	the	accessory	lacrimal	glands.	The	aqueous	secretions	contain	
lactoferrin,	immunoglobulin	A,	defensin,	betalysin,	lysozyme,	lipocalin	and	the	
antibody-complement	system	of	proteins	that	serve	an	antimicrobial	function.	(7,	21)	
	
Mucins	are	a	critical	component	of	the	tear	film	and	are	produced	by	conjunctival	
epithelial	goblet	cells.	These	are	glycosylated	complex	high	molecular	weight	
glycoproteins	that	are	hydrophilic	in	nature	and	capable	of	forming	gels.	Mucins	serve	
to	create	a	mucin-aqueous	complex	that	lubricates	the	surface	of	ocular	surface	
epithelia	and	prevents	drying.	The	role	of	mucin	also	extends	to	a	role	in	the	primary	
defence	against	microorganisms	as	goblet	cells	also	interact	with	antimicrobial	
constituents	of	the	tear	film,	such	as	defensins	and	peroxidase.(17,	22)	Mucins	have	been	
recognised	not	only	to	bind	to	bacterial	cell	walls	but	also	to	participate	in	the	innate	
immune	response	through	interactions	with	neutrophils	and	leucocytes	via	
oligosaccharide	epitopes	found	on	mucins.(23)	In	addition	to	mucin,	goblet	cells	also	
secrete	the	trefoil	family	peptides	(TFF)	TFF1	and	3.(2)	These	peptides	together	with	
mucin	promote	epithelial	cell	migration	and	have	anti-apoptotic	properties.(24)	
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The	mucins	on	the	ocular	surface	comprise	membrane-associated	mucins	on	the	
microplicae	of	apical	conjunctival	and	corneal	epithelium	and	form	the	glycocalyx	that	
supports	interactions	at	the	cell-tear	interface.(1)	The	large	gel	forming	mucin	MUC5AC	
is	produced	exclusively	by	conjunctival	goblet	cells	by	exocytosis.	MUC5AC	and	a	
further	small	soluble	mucin	MUC7	produced	by	the	lacrimal	gland	are	the	major	mucin	
components	of	the	aqueous	layer	of	the	tear	film	and	are	responsible	for	its	lubricating	
and	visco-elastic	properties.(7)	Mucins	also	form	a	protective	layer	within	the	tear	film	
reducing	evaporation	of	the	aqueous	components	of	the	tear	film,	thereby	maintaining	
moisture	of	the	conjunctiva	and	cornea.		
	
Ocular	surface	disease	can	be	associated	with	both	the	overproduction	and	
underproduction	of	mucin.(17)	Of	these	conditions	however,	mucin	depletion	leads	to	
more	severe	disease	and	goblet	cell	depletion	is	associated	with	most	ocular	surface	
diseases	and	include	ocular	mucous	membrane	pemphigoid,	neurotropic	keratitis	and	
chemical	injury.(25,	26)	In	the	severe	dry	eye	state	the	continual	microtrauma	of	the	
cornea	occurs	leading	to	desiccation,	opacity,	ulceration	and	eventually	painful	
blindness.	In	such	conditions,	the	conjunctival	epithelium	also	undergoes	squamous	
metaplasia	with	loss	of	goblet	cells	and	propensity	to	infection.(27)		
	
The	regulation	of	mucin	production	is	complex	and	not	fully	understood.	Mucins	are	
produced	by	conjunctival	squamous	epithelial	cells	(MUC	1,	4,	16)	and	are	found	as	
transmembrane	glycoproteins	but	have	also	as	secreted	components	in	the	tear	film.(28)	
The	precise	pathways	and	mechanisms	by	which	the	shedding	of	these	mucins	occurs	
are	still	under	investigation.	In	contrast,	MUC5AC	secretion	from	goblet	cells	is	known	
to	occur	through	an	apocrine	mechanism	mediated	by	growth	factors,	in	addition	to	
parasympathetic	and	sympathetic	nervous	stimulation.	Purinergic	and	muscarinic	
agonists	together	with	acetylcholine,	carbachol	and	vasoactive	intestinal	peptide	have	
been	shown	to	stimulate	goblet	cell	mucin	secretion.(17)	In	addition,	epidermal	growth	
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factor	(EGF)	stimulates	goblet	cells	and	may	occur	following	release	from	bacteria,	
platelets	and	nerves.(17)	
	
	
1.2	 Conjunctival	disease	in	humans	
Homeostasis	of	the	ocular	surface	is	dependent	upon	normal	conjunctival	function	
including	mucin	production.	The	conjunctival	epithelium	may	become	irreversibly	
destroyed	by	infective,	inflammatory,	neoplastic	conditions	and	traumatic	injury.	This	
may	lead	to	keratinisation,	loss	of	goblet	cells,	cicatrisation,	forniceal	contraction	and	
corneal	ulceration	leading	to	painful	loss	of	vision.(29)	These	factors	may	result	in	limbal	
stem	cell	deficiency	and	visual	deterioration.	
	
A	number	of	acquired	and	autoimmune	diseases	may	cause	these	changes.	
Pathological	change	in	the	conjunctiva	includes	the	formation	of	neoplastic	lesions,	
both	malignant	and	benign	including	the	formation	of	pterygium,	proposed	to	occur	
from	ultraviolet	damage.	Inflammation	can	arise	through	autoimmune	disease,	
infectious	diseases	including	those	from	viral	and	bacterial	pathogens,	allergy	and	also	
induced	iatrogenically	from	topical	agents	such	medications	used	to	treat	glaucoma.		
	
Trachoma	is	an	eye	disease	caused	by	the	intracellular	bacteria	Chlamydia	trachomitis.	
It	is	an	important	infectious	cause	of	cicatrising	eye	disease	and	is	the	second	
commonest	cause	of	blindness	in	developing	nations.	An	estimated	1.3	million	people	
are	blind	worldwide	from	this	condition.(30)	The	highest	prevalence	of	trachoma	is	in	
sub-Saharan	Africa,	Middle	East	and	Southeast	Asia.	Although	easily	treatable	with	oral	
tetracyclines,	the	global	burden	of	this	disease	is	significant	as	many	do	not	have	access	
to	treatment	and	therefore	a	high	proportion	develop	end	stage	cicatrising	conjunctival	
disease	which	leads	to	chronic	pain	and	corneal	blindness.		
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Trauma	may	occur	from	a	variety	of	injuries	including	thermal	injury	and	chemical	
burns.	Ocular	burns	constitute	7-18%	of	ocular	injuries	seen	in	emergency	departments	
and	17.3%	of	battlefield	injuries	have	been	recorded	in	Iraq	and	Afghanistan.(31,	32)	
Visual	disability	occurred	in	33%	and	blindness	in	15%	of	patients	with	battlefield	
injury.	(31)	
	
Autoimmune	diseases	of	the	conjunctiva	include	mucous	membrane	pemphigoid,	
Stevens-Johnson	syndrome,	linear	IgA	disease	and	graft-versus-host	disease.	
Autoimmune	disease	in	particular,	mucous	membrane	pemphigoid,	can	be	one	of	the	
most	challenging	conditions	to	treat	given	the	chronicity	of	the	inflammation	that	leads	
to	irreversible	cicatricial	eye	disease.	The	incidence	of	mucous	membrane	pemphigoid	
has	been	reported	between	1.13	and	1.78	per	million	per	year	in	European	countries	
with	ocular	involvement	in	60-95%	of	patients.(33)	The	incidence	of	Stevens	Johnson	
syndrome	is	estimated	at	2-3	per	million	per	year	in	Europe	and	the	USA	of	which	43-
81%	have	ocular	involvement	and	35%	have	permanent	visual	disability.(34)	Developing	
countries	such	as	India	are	recognised	to	have	a	significant	number	of	Stevens-Johnson	
syndrome	cases,	thought	to	be	the	result	of	widespread	availability	and	unprescribed	
use	of	antimicrobial	drugs	including	sulphonamide	containing	drugs	and	
fluoroquinolones.(35)	The	incidence	of	cicatrising	conjunctivitis	overall	in	the	UK	has	
been	estimated	at	1.3	per	million	per	year,	however,	the	authors	of	this	surveillance	
study	stated	that	this	figure	was	likely	to	be	an	underestimation.(36)	In	contrast	to	
developing	nations,	the	burden	in	developed	countries	is	largely	due	to	autoimmune	
conjunctival	disease,	particularly	ocular	mucous	membrane	pemphigoid.		Diagnosis	of	
the	latter	may	at	times	be	considered	at	a	relatively	late	stage	in	the	disease	process,	
and	even	in	those	diagnosed,	under-recognised	exacerbations	between	follow	up	
periods	despite	treatment	have	been	noted.	(36)	
	
Ocular	surface	disorders	lead	to	squamous	metaplasia	and	cicatrisation	characterised	
by	progressive	fibrosis	and	scarring.	Cicatrisation	may	be	defined	by	the	presence	of	
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limbal	stem	cell	deficiency,	forniceal	shortening	and	symblepharon.(27)	The	histological	
changes	in	conjunctival	squamous	metaplasia	have	been	described	in	the	following	
three	stages	by	impression	cytology:	a)	loss	of	goblet	cells	b)	increase	in	cellular	
stratification	and/or	enlargement	of	the	superficial	cells	and	c)	keratinisation.(37)	Many	
ocular	surface	diseases	lead	to	squamous	metaplasia	and	cicatrising	eye	disease	both	in	
advanced	stages	of	chronic	inflammation	and	by	a	severe	insult	such	a	chemical	injury.	
Ocular	surface	disorders	are	an	important	clinical	problem	as	irreversible	scarring	and	
keratinisation	of	the	conjunctiva	leads	to	an	abnormal	epithelium	with	loss	of	secretory	
and	membrane	bound	mucin	and	therefore	compromised	defence	against	infection.(38)	
It	is	also	accompanied	by	depletion	of	goblet	cells	and	secondary	tear	film	deficiency.	
When	severe,	along	with	forniceal	shortening,	symblepharon	and	ankyloblepharon,	lid	
deformities	also	occur	such	as	entropion	and	ectropion.	This	results	in	trichiasis,	
exposure	keratopathy	and	recurrent	corneal	desiccation.	These	factors	in	combination	
may	lead	to	corneal	blindness	due	to	limbal	stem	cell	deficiency	resulting	in	ulceration	
or	progressive	conjunctivalisation	and	opacification.		
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Table	1:	Table	of	potential	causes	of	cicatrizing	conjunctivitis.	This	list	has	been	adapted	from	
Saw	et	al.	(2008)	and	illustrates	a	non-exhaustive	list	of	the	diseases	processes	that	may	lead	to	
conjunctival	cicatrisation.(39)	
	
1.2.1	 Medical	strategies	in	cicatrising	conjunctival	disease	
Crucial	to	the	management	of	cicatrising	conjunctival	disease	is	early	diagnosis	and	
treatment	to	remove	the	inciting	agent	if	present,	reduce	or	terminate	the	
inflammatory	process	and	encourage	epithelial	regeneration.	The	treatment	strategy	
depends	upon	the	nature	and	cause	of	the	inflammation.		For	example,	the	medical	
treatment	of	ocular	burns	comprises	acute	irrigation	to	remove	the	inciting	agent,	
tetracyclines	and	citrate	to	reduce	metalloproteinase	activity,	steroids	to	reduce	
inflammation,	tear	supplements,	antimicrobials	to	prevent	infection	and	ascorbate	to	
promote	healing.	In	trachoma,	the	inflammation	is	caused	by	Chlamydia	trachomitis	
and	therefore	responds	to	oral	tetracyclines.		
	
	
Causes	of	cicatrising	conjunctivitis	
	
Trauma:		 	 	 Chemical,	thermal,	radiation,	physical	
Infection:		 Trachoma,	membranous	conjunctivitis,	chronic	
mucocutaneous	candidiasis	
Allergic	eye	disease		 	 Atopic	keratoconjunctivits	
Drug	induced	cicatrisation		 Benzalkonium	chloride	containing	solutions	
Mucocutaneous	disorders:		 Stevens-Johnson	disease,	graft	versus	host	disease,	
lichen	planus	
Immunobullous	disease:		 Mucous	membrane	pemphigoid,	linear	IgA	disease,	
bullous	pemphigoid,	paraneoplastic	pemphigus		
Neoplasia:		 	 	 Sebaceous	cell	carcinoma,	squamous	cell	carcinoma	
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Stevens-Johnson	syndrome	may	be	diagnosed	through	skin	biopsy	rather	than	any	
specific	serological	test	together	with	clinical	findings.	The	treatment	of	Stevens-
Johnson	syndrome	involves	cessation	of	the	inciting	agent,	intravenous	
immunoglobulin,	systemic	corticosteroids	and	the	management	of	the	systemic	
sequelae	of	this	severe	illness.(40)	None	of	the	immunomodulatory	treatments	however	
have	been	found	to	influence	the	ocular	outcomes.(41,	42)		Similarly,	other	autoimmune	
conjunctival	diseases	including	ocular	mucous	membrane	pemphigoid	may	be	
diagnosed	through	their	clinical	features,	biochemical	features	of	autoimmune	disease	
and	the	direct	immunofluorescence	assay	of	a	mucous	membrane	biopsy	which	may	be	
taken	from	the	conjunctiva.(39)	A	negative	biopsy,	however,	is	not	conclusive.	
Immunosuppressive	therapy	is	only	required	when	the	autoimmune	disease	process	is	
active.	First	line	therapy	involves	the	use	of	dapsone,	sulfasalazine	or	methotrexate.(39)	
Second	line	agents	include	azathioprine,	mycophenolate	mofetil	and	
cyclophosphamide.(39)	Adjunctive	use	of	corticosteroids	including	pulsed	intravenous	
methylprednisolone	may	also	be	considered	for	the	short-term	control	of	severe	
inflammation.	The	use	of	biologics	including	anti-	tumour	necrosis	factor	agents	
etanercept	and	infliximab,	and	the	anti-CD20	antibody	rituximab	have	been	
successfully	used	to	treat	severe	refractory	disease.(43-45)	It	is	recognised,	however,	that	
symblepharon	formation	may	still	progress	despite	the	apparent	control	of	ocular	
inflammation	in	autoimmune	conjunctivitis,	particularly	in	ocular	mucous	membrane	
pemphigoid.(36)	In	many	cases	of	cicatrising	conjunctivitis,	irreversible	and	significant	
conjunctival	damage	occurs	such	that	medical	strategies	alone	may	be	insufficient	to	
enable	the	regeneration	of	healthy	ocular	surface	epithelia.		
	
In	all	forms	of	cicatrising	eye	disease,	supportive	therapy	includes	management	of	the	
factors	that	exacerbate	the	condition.	This	includes	management	of	inflammation	
associated	with	co-existent	ocular	surface	disease.	For	example,	meibomian	gland	
dysfunction	and	blepharitis	may	co-exist	with	the	cicatrising	disease	process.	Indeed,	
blepharitis	can	lead	to	colonisation	with	bacterial	pathogens	and	therefore	represents	
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a	risk	factor	for	microbial	keratitis.(39)	In	a	study	of	lid	pathogens,	85%	of	mucous	
membrane	pemphigoid	patients	were	demonstrated	as	carriers	for	such	pathogens	in	
contrast	to	49%	in	the	control	group.(46)	Dry	eye	due	to	mucin	and	tear	deficiency	can	
occur	in	a	many	cicatrising	eye	diseases	due	to	sparse	goblet	cells	and	also	other	
dysfunction	of	other	components	including	the	meibomian	glands.	In	turn,	this	
predisposes	to	poor	epithelial	integrity	and	compromised	immune	defence.	
Management	strategies	include	tear	supplements	including	autologous	serum,	punctal	
occlusion,	topical	cyclosporine	or	steroid	to	address	keratoconjunctivitis	sicca,	and	lid	
surgery	to	address	lid	malpositions	such	as	entropion	with	trichiasis	or	
lagophthalmos.(39)		
	
Diagnosis	
	
	
																																																															Disease	control																						Disease	treatment*	
	
	
Supportive	therapy			 	 	 Restoration	
	
-Treatment	of	associated	ocular	surface	disease	 					-	Correction	of	lid	malposition	
-Treatment	of	dry	eye		 	 	 	 					-	Fornix	reconstruction		
-Treatment	of	trichiasis	 	 	 																		-	Conjunctival	replacement		
-Treatment	of	persistent	epithelial	defects	 	 					-	Limbal	stem	cell	transplant	
-Avoidance	of	toxicity		 	 	 																		-	Corneal	transplant		
	
Figure	3:	Flow	diagram	to	illustrate	that	the	management	of	ocular	disease	involves	treatment	
of	the	disease	process	along	with	supportive	therapies	and	restorative	treatment.	*Disease	
treatment	may	involve	removal	of	the	inciting	agent,	antimicrobials,	immunosuppressants	or	
anti-inflammatory	agents	as	described	in	earlier	paragraphs	(section	1.2.1).		
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1.2.2	 Surgical	ocular	surface	reconstruction	strategies	and	the	clinical	need	for	
novel	conjunctival	equivalents	
Poor	conjunctival	integrity	and	adnexal	abnormalities	including	dry	eye,	entropion	and	
trichiasis	are	prognostic	factors	for	corneal	and	limbal	stem	cell	transplant	failure	
leading	to	poor	visual	outcomes	in	these	patients.(29)	It	is	paramount	therefore,	that	
strategies	for	ocular	surface	reconstruction	include	the	correction	of	lid	deformities	
including	entropion	and	also	trichiasis,	which	would	otherwise	result	in	continual	
abrasion	and	trauma	to	ocular	surface	epithelia.	Lid	deformities	together	with	
improvements	in	conjunctival	function	must	therefore	be	addressed	with	surgical	
interventions	to	enable	the	success	of	a	potential	corneal	or	limbal	stem	cell	transplant.		
	
Current	strategies	for	the	replacement	of	conjunctival	loss	are	most	commonly	
conjunctival	autografts	or	amniotic	membrane	grafts.	Conjunctival	autografts	have	
been	used	for	the	repair	of	small	defects	with	relative	success.(47,	48)	These	can	be	taken	
from	the	fellow	eye	or	from	the	same	eye,	usually	the	superior	bulbar	conjunctiva.	This	
approach,	however,	cannot	be	used	for	the	repair	of	larger	defects	including	fornix	
reconstruction.	Furthermore,	the	trauma	to	the	donor	site	in	retrieving	a	conjunctival	
autograft	would	be	detrimental	in	autoimmune	diseases	leading	to	further	
inflammation	and	scarring.		
	
Mucosae	from	the	nasal	turbinates	and	oral	cavity	have	been	investigated	as	donor	
tissues	for	ocular	surface	reconstruction.	It	is	recognised,	however,	that	these	grafts	
are	associated	with	poor	cosmesis	and	recurrent	scarring.(49)	The	human	oral	mucous	
membrane	has	been	used	for	the	reconstruction	of	conjunctival	fornices	with	some	
success.(50,	51)	Similarly,	nasal	turbinate	mucosal	grafts	have	also	been	demonstrated	in	
the	successful	reconstruction	of	conjunctival	fornices	in	patients	with	chemical	injury	
and	cicatricial	mucosal	disease.(52,	53)	An	increase	in	mucous	production	was	
demonstrated	in	association	with	a	reduction	in	symptoms	for	the	majority	of	patients	
that	received	this	treatment.	This	approach,	however,	is	limited	by	differences	in	
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appearance	including	the	colour	of	the	tissue,	which	can	appear	unsightly	in	
comparison	to	the	translucent	appearance	of	amniotic	membrane	and	native	
conjunctiva.(54)	A	further	consideration	is	morbidity	to	the	graft	donor	site,	which	may	
be	a	limitation	for	its	use	in	patients	with	mucous	membrane	pemphigoid	due	to	
possible	disease	involvement	of	tissue	at	these	extra-ocular	mucosal	sites.		
	
To	date,	the	most	commonly	used	substrate	for	ocular	surface	reconstruction	has	been	
amniotic	membrane,	exemplified	by	its	extensive	clinical	usage.	It	is	most	commonly	
used	in	the	treatment	of	large	conjunctival	epithelial	defects	where	it	promotes	
epithelialisation	and	reduces	scarring.(55)	The	use	of	amniotic	membrane	for	the	
reconstruction	of	conjunctival	fornices,	however,	has	been	less	successful.	In	patients	
with	on	going	inflammation	recurrent	symblepharon	was	demonstrated	in	10-44%	of	
patients	and	loss	in	forniceal	depth	of	50%	or	more	occurred	four	months	after	
surgery.(56,	57)	Therefore,	outcomes	of	forniceal	reconstruction	using	amniotic	
membrane	grafts	are	poor	due	to	shrinkage	and	cicatrisation	resulting	in	recurrent	
forniceal	loss.(58)		
	
The	severity	of	ocular	damage	to	the	conjunctiva	in	mucocutaneous	and	systemic	and	
inflammatory	diseases	warrant	the	development	of	grafts	to	regenerate	the	ocular	
surface	and	reconstruct	the	fornices.	Novel	robust	conjunctival	constructs	would	
enable	visual	and	functional	rehabilitation	in	patients	with	severe	ocular	surface	
disease	in	whom	prognosis	is	poor	due	to	a	lack	of	available	therapies.	Novel	
conjunctival	equivalents	may	also	assist	in	surgical	procedures	associated	with	
conjunctival	loss	including	conjunctival	neoplasia,	pterygia	and	glaucoma	surgery.		
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1.3	 Substrates	for	conjunctival	regeneration	
1.3.1	 An	ideal	conjunctival	substrate	
An	ideal	substrate	for	the	expansion	of	conjunctival	epithelium	should	be	elastic	to	
enable	free	ocular	movement,	integrate	in	the	host	without	causing	inflammation	and	
support	a	self-renewing	conjunctival	epithelium	with	a	sub-population	of	progenitor	
and	goblet	cells.	If	a	small	defect	requires	treatment,	a	conjunctival	equivalent	that	
degrades	may	be	suitable,	such	that	it	is	eventually	replaced	by	host	conjunctiva.	Fornix	
reconstruction	however	may	benefit	from	a	non-degradable	substrate	that	is	capable	
of	maintaining	long-term	forniceal	support.		
	
1.3.2	 The	use	of	biological	substrates	for	the	ex	vivo	expansion	of	conjunctival	
epithelium	
Other	than	autologous	tissues	including	autologous	conjunctiva,	nasal	and	oral	
mucosae,	the	principal	allogeneic	biological	substrate	investigated	for	conjunctival	
regeneration	has	been	amniotic	membrane.	Amniotic	membrane	is	the	innermost	layer	
of	the	membrane	that	surrounds	the	foetus	in	utero.	Its	use	in	ophthalmic	surgery	has	
been	established	for	over	70	years	and	it	plays	a	major	role	in	ocular	surface	
reconstruction	in	current	clinical	practice.(59)	Desirable	features	include	its	lack	of	
immunogenicity,	antibacterial	and	anti-inflammatory	properties.(60-62)	The	use	of	
amniotic	membrane	for	the	protection	of	ocular	surface	defects	such	as	large	corneal	
epithelial	defects	and	chemical	burns	where	it	promotes	healing	has	been	long	
established.(63,	64)	It	can	therefore	play	a	major	role	in	the	healing	process	of	ocular	
surface	defects.	Amniotic	membrane	been	used	in	both	a	cellular	and	decellularised	
form.	Decellularisation	may	reduce	the	risk	of	disease	transmission	but	may	disrupt	
extracellular	matrix	components	and	the	ultrastructure	of	the	tissue.(65)		
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The	presence	of	progenitor	and	goblet	cells	have	been	demonstrated	in	rabbit	
conjunctival	epithelial	cell	cultures	developed	on	an	amniotic	membrane	substrate.(66)	
Stratified	conjunctival	epithelial	constructs	have	also	been	successfully	demonstrated	
on	an	amniotic	membrane	substrate.(67)	Studies	of	ex-vivo	expanded	human	
conjunctival	epithelium	on	amniotic	membrane	have	not	however,	shown	the	presence	
of	goblet	cells.(54,	68)	Human	amniotic	membrane	has	been	transplanted	into	the	eye	
both	with	and	without	the	ex-vivo	expansion	of	conjunctival	epithelium.	The	successful	
reconstruction	of	conjunctival	defects	with	ex-vivo	expanded	conjunctival	epithelium	
on	amniotic	membrane	has	been	demonstrated	for	small	defects	including	those	
following	the	removal	of	papillomata	and	pterygia	in	humans.(69,	70)	Studies	have	shown	
that	amniotic	membrane	transplantation	results	in	healing	without	significant	
inflammation	and	can	result	in	the	regeneration	of	conjunctiva.(54)		
	
The	success	of	amniotic	membrane	transplantation,	however,	depends	on	the	
underlying	disease	process.	Fornix	reconstruction	in	particular	in	the	presence	of	active	
inflammatory	disease	is	associated	with	recurrence	of	symblephara	and	forniceal	
loss.(54)	In	keeping	with	this,	a	descriptive	study	reported	12	of	17	eyes	recovered	
successfully	following	amniotic	membrane	reconstruction	of	shortened	fornices.	
Clinical	outcomes	were	favourable	in	eyes	with	symblephara	due	to	traumatic	injury	in	
contrast	to	patients	with	symblephara	due	to	mucous	membrane	pemphigoid.(71)	Other	
than	amniotic	membrane	and	oral/nasal	mucosa,	no	other	cellular	or	decellularised	
human	allogeneic	tissues	have	been	investigated	as	conjunctival	equivalents.(52,	54)	
	
1.3.2.1		 Decellularisation	of	human	tissues	
‘Biological’	scaffolds	derived	from	decellularised	tissues	have	been	successfully	
transplanted	in	humans	for	a	multitude	of	regenerative	therapies	including	skin,	heart	
valves,	vascular	repair,	bladder	and	even	trachea.(72-75)	Extracellular	matrices	or	
decellularised	scaffolds	can	be	prepared	by	the	removal	of	cellular	components	of	
tissues	and	organs.	Extracellular	matrices	are	relatively	conserved	across	species	and	
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confer	the	optimal	3D	environment	providing	a	platform	for	recellularisation	with	the	
patient’s	own	cells,	demonstrated	through	a	variety	of	organ	models.(75,	76)	The	
decellularisation	process	renders	tissues	immunologically	inert	thereby	minimising	the	
immunological	rejection	risk	and	enables	the	use	of	a	large	donor	pool.	The	key	
advantages	of	acellular	tissue	over	synthetic	substitutes	are	that	the	scaffolds	
inherently	possess	the	ultrastructure	and	gross	anatomic	structure	native	to	the	tissue	
of	origin.	The	precise	nature	of	the	3-dimensional	arrangement	of	matrix	proteins	may	
influence	cell	adhesion	with	more	appropriate	ligand	specificity.(77)	Furthermore	the	
biomechanical	properties	of	the	native	tissues	are	also	retained	and	therefore	have	the	
potential	to	influence	function.			
	
Decellularised	tissues	are	comprised	mainly	of	extracellular	matrix,	which	is	the	
secreted	product	of	cells	native	to	a	particular	organ	or	tissue.	It	therefore	provides	a	
unique	opportunity	for	regeneration	with	autologous	cells	in	which	the	unique	cues	
from	extracellular	matrices	may	provide	the	optimal	conditions	for	cell	growth.	The	
tissue	specificity	of	the	extracellular	matrix	is	proposed	to	influence	and	maintain	the	
cellular	function	and	phenotype	demonstrated	through	a	variety	of	organ	and	tissue	
models	and	even	includes	nerve	allografts,	which	have	been	used	to	repair	sensory	
defects	in	the	hand.(78)	Interactions	with	the	extracellular	matrix	have	been	shown	to	
influence	the	proliferation	and	chemotaxis	of	cells,	demonstrated	in	many	tissues	and	
include	endothelial	and	progenitor	cell	migration.(79)	The	appropriate	differentiation	of	
embryonic	stem	cells	and	regeneration	of	tissues	with	appropriate	function	has	been	
demonstrated	in	studies	of	several	organs	including	kidney,	lung	and	the	adrenal	
gland.(80-82)	Differentiation	of	tissues	along	the	appropriate	lineage	together	with	the	
appropriate	tissue	remodelling	responses	have	also	been	demonstrated	in	a	variety	of	
tissues	as	described	in	models	including	skeletal	muscle	and	vocal	cord.(77,	83,	84)	
	
Other	than	the	extracellular	matrix,	it	has	also	been	proposed	that	the	surface	topology	
and	the	3-dimensional	ultrastructure	arrangement	also	influence	cell	interaction,	
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function	and	phenotype.(77)	It	is	crucial	therefore,	that	there	is	minimal	disruption	to	
acellular	scaffold	during	the	decellularisation	treatment.	Decellularisation	can	be	
achieved	by	several	means	including	physical	(e.g.	temperature,	force	and	pressure),	
enzymatic	and	chemical	processes.	The	most	effective	agent	depends	upon	features	of	
the	tissue	including	its	cellularity,	density	and	lipid	content	and	must	be	balanced	
against	the	adverse	effects	of	extracellular	matrix	disruption.(77)	Chemical	agents	used	
in	the	decellularisation	of	tissues	include	alcohols	and	other	solvents,	hypertonic	and	
hypotonic	agents,	acids	and	bases	and	detergents.	Enzymatic	processes	often	include	
nucleases,	collagenase	and	dispase.(77)	Of	these	agents,	trypsin	and	collagenase	in	
particular	are	recognised	to	result	in	significant	extracellular	matrix	disruption.(77,	85,	86)	
Collagenase	in	particular	is	generally	used	for	applications	in	which	the	ultrastructure	of	
the	tissue	is	not	critical.		
	
1.3.1.2		 Decellularisation	of	human	amniotic	membrane		
The	human	amniotic	membrane	bears	histological	similarities	in	its	gross	structure	to	
human	conjunctiva,	as	it	also	comprises	an	epithelial	layer,	a	basement	membrane	and	
substantia	propria.	A	protocol	for	the	decellularisation	of	human	amniotic	membrane	
has	been	developed	using	a	combination	of	chemical	and	enzymatic	processes.(87)	In	
this	protocol,	hypotonic	and	hypertonic	solutions	are	used	which	cause	cell	lysis	and	
the	dissociation	of	DNA	from	proteins,	respectively,	whilst	causing	minimal	disruption	
to	the	ECM.	The	detergent	sodium	dodecyl	sulphate	(SDS)	is	used	to	solubilise	cell	
membranes,	dissociates	DNA	from	proteins	and	is	known	to	be	a	highly	effective	
decellularisation	agent.(77,	88,	89)	Finally,	the	protocol	also	includes	benzonase,	an	
endonuclease,	which	cleaves	nucleic	acids	and	effects	the	removal	of	residual	
nucleotides.(90)	Of	these	described	processes,	the	detergent	(SDS)	step	has	the	greatest	
potential	for	disrupting	the	extracellular	matrix	and	therefore	a	low	effective	
concentration	should	be	sought	and	the	residual	tissue	characterised	and	tested	for	
cytotoxicity.			
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An	animal	study	using	allogeneic	and	xenogeneic	decellularised	cornea	and	
demonstrated	successful	integration	of	corneal	tissue	with	maintenance	of	corneal	
clarity	and	cellular	ingrowth	including	nerves	(91)	The	decellularisation	of	porcine	but	
not	human	conjunctiva	has	been	reported	in	literature.	In	the	latter	study,	
decellularised	porcine	conjunctiva	was	used	as	a	substrate	for	the	transplantation	of	
limbal	stem	cells	in	a	rabbit	model.(92)	To	date,	the	decellularisation	of	human	
conjunctiva	has	not	been	reported.		
	
The	collaborators	of	this	study	at	NHSBT	already	produce	clinical	grade	acellular	dermal	
matrix	distributed	throughout	the	UK	and	have	experience	in	decellularisation,	
characterisation	and	ex-vivo	cellular	expansion	on	human	amniotic	membrane.	An	
existing	protocol	for	the	decellularisation	of	amniotic	membrane	will	therefore	be	
optimised	to	enable	the	decellularisation	of	human	conjunctiva.		
	
1.3.2	 Synthetic	substrates	for	ex-vivo	expansion	of	conjunctival	epithelium	
Numerous	synthetic	substrates	for	the	development	of	corneal	grafts	have	been	
studied	in	comparison	to	conjunctival	substrates	in	which	relatively	few	reports	exist.	
The	use	of	a	porous	glycosaminoglycan	co-polymer	matrix	has	been	described	for	the	
repair	of	full	thickness	conjunctival	defects	in	rabbits	and	the	forniceal	depth	compared	
with	an	un-grafted	wound	in	the	fellow	eye.(93)	A	similar	study	describes	the	use	of	
porous	poly	(lactide	co-glycolide)	(PGLA)	scaffold	modified	by	hyaluronic	acid	and	
collagen.(94)	In	these	studies,	forniceal	shortening	was	significantly	greater	in	the	un-
grafted	eyes.	In	both	studies,	the	un-grafted	eyes	had	irregularly	arranged	collagen	in	
keeping	with	scar	tissue	in	comparison	to	a	more	regular	collagen	deposition	
demonstrated	in	the	grafted	eye.(93)	Both	substrates	are	examples	of	a	degradable	
matrix.	It	should	be	noted	however	that	both	substrates	were	inelastic	and	lacked	an	
epithelium.(73)	In	contrast	conjunctival	epithelium	cultured	on	collagen	matrices	was	
demonstrated	to	develop	with	an	appropriate	cell	polarity	and	even	a	basement	
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membrane,	but	was	only	an	organised	monolayer.(95)	The	latter	study	confirmed	that	
substrate	modulation	influences	the	growth	characteristics	of	human	conjunctiva.		
A	more	promising	elastic	substrate	for	conjunctival	regeneration	has	been	the	use	of	
plastic	compressed	collagen.(96)	Laboratory	studies	have	demonstrated	confluent	
growth	of	conjunctival	epithelium	including	a	subpopulation	of	progenitor	cells	
identified	by	putative	stem	cell	markers	and	studies	of	colony	forming	efficiency.	The	
authors	of	this	study	report	the	ultimate	tensile	strength	of	the	substrates	and	handing	
was	similar	to	amniotic	membrane.(96)	Another	elastic	resorbable	polymer	
demonstrated	to	support	the	growth	of	conjunctival	epithelium	including	goblet	cells	is	
ultrathin	Poly	(ε-Caprolactone).(97)	Both	substrates	are	biodegradable.		
	
To	date	there	has	not	been	a	non-degradable	substrate	developed	for	the	regeneration	
of	conjunctiva.	This	may	provide	an	ideal	solution	for	the	epithelialisation	following	
fornix	reconstruction	and	long-term	maintenance	of	fornix	depth.		
	
1.3.2.1		 Expanded	polytetrafluoroethylene	(ePTFE)	
Polytetrafluoroethylene	(PTFE)	is	a	simple	polymer	composed	of	carbon	and	fluorine	
and	is	known	for	its	thermal	stability	and	its	hydrophobicity.	The	regular	arrangement	
of	fluorine	atoms	around	the	carbon	backbone	confers	lack	of	polarity	and	therefore	
chemically	inertness.(72)	A	microporous	structure	manufactured	through	heating	and	
expansion	is	called	expanded	Polytetrafluoroethylene	(ePTFE).(98)	The	microporous	
structure	allows	the	free	movement	of	gas	and	fluid	depending	upon	the	pore	size,	
which	also	determines	its	flexibility.(72)	It	has	been	widely	used	as	a	biomaterial	as	it	is	
non-reactive	with	surrounding	tissues	and	is	nondegradable	in	a	biological	
environment.	Degradation	studies	of	non-expanded	PTFE	to	oxidation	and	acid	
hydrolysis	found	PTFE	to	be	relatively	unaffected.(72)	Indeed,	degradation	studies	using	
ePTFE	are	lacking	however	no	evidence	of	systemic	or	local	toxicity	have	been	reported	
as	a	result	of	ePTFE	degradation	in	soft	tissue	applications.(99)	Furthermore,	there	are	
no	known	allergic	or	teratogenic	responses	to	this	material.(72,	73)	There	is	considerable	
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scope	to	modify	the	surface	chemistry	of	ePTFE	though	a	number	of	means	including	
gas	plasma,	which	can	render	the	material	more	hydrophilic.	It	can	also	be	impregnated	
with	a	number	of	agents	that	can	prevent	bacterial	colonisation	e.g.	with	silver	and	
chlorhexidine.(73)	
	
The	application	of	expanded	polytetrafluoroethylene	(ePTFE)	has	grown	over	the	last	
30	years	and	it	has	been	widely	used	in	a	range	of	surgical	procedures	including	mesh	
in	hernia	repairs,	gynaecological	surgery,	cardiac	and	vascular	surgery.		An	example	is	
the	PRECLUDER	membrane	used	in	the	closure	and	reconstructions	within	the	
pericardial	space.	Adhesions,	collagen	deposition	or	cellular	infiltration	could	not	been	
demonstrated	following	the	use	of	this	biomaterial.(100)	This	is	an	example	in	which	
adhesions	with	the	host	tissue	were	undesirable	but	a	non-degradable	and	non-
immunogenic	material	was	required	for	the	closure	of	a	defect.	The	PRECLUDER	
membrane	is	an	example	of	an	ePTFE	membrane	in	which	the	pore	size	<1μm	has	been	
cited	to	limit	tissue	ingrowth	and	therefore	adhesions.(100,	101)		
	
A	number	of	reports	also	describe	the	use	of	ePTFE	in	ophthalmic	surgery.	Expanded	
PTFE	has	been	successfully	used	as	a	‘stent’	for	the	short-term	forniceal	maintenance	in	
anophthalmic	patients.(104)	Similarly,	it	has	also	been	used	as	a	‘spacer’	device	for	the	
excision	of	severe	symblepharon	in	which	recurrence	can	be	prevented	by	blocking	the	
physical	reapposition	of	the	denuded	bulbar	and	tarsal	surfaces	when	re-
epithelialisation	occurs	in	the	postoperative	period.(105)	The	ePTFE	implant,	PRECLUDER	
has	also	been	used	with	low	dose	mitomycin-C	as	an	adjuvant	in	preventing	excessive	
bleb	leakage	in	penetrating	glaucoma	surgery.(106)	In	the	latter	study,	ePTFE	was	used	
as	a	device	to	prevent	excessive	filtration	of	aqueous	humour	in	a	procedure	that	
creates	an	aqueous	draining	valve	through	the	sclera	to	control	intraocular	pressure.	
The	device	was	well	tolerated	and	reduced	the	rate	of	early	hypotony	(excessive	
reduction	in	intraocular	pressure),	a	common	complication	following	filtration	surgery.	
In	these	applications	however,	ePTFE	was	used	as	a	means	of	physical	support	rather	
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than	as	a	scaffold	for	cell	seeding	and	epithelialisation.		In	a	laboratory	study,	the	
attachment	and	proliferation	of	retinal	pigment	epithelial	cells	has	been	demonstrated	
on	ammonia	gas	plasma	treated	ePTFE	forming	a	monolayer	of	functional	cells	
expressing	tight	junctional	protein	components	including	ZO-1	and	occludin.	(107,	108)	
These	examples,	together	with	reports	of	endothelial	cell	epithelialisation	demonstrate	
the	potential	for	ePTFE	as	a	substrate	for	cellular	expansion	in	tissue	engineering	
applications.	The	growth	of	conjunctival	epithelium	on	ePTFE	has	not	previously	been	
reported.		
	
1.3.2.2		 Ammonia	gas	plasma	treatment	to	alter	ePTFE	surface	chemistry		
Plasma	comprises	ionised	gas	with	positive	and	negatively	charged	particles.		Ammonia	
gas	plasma	can	be	developed	as	low	temperature	plasma	and	requires	a	vacuum	
chamber.	The	gas	plasma	resonator	is	a	device	in	which	gas	plasma	can	be	created	and	
comprises	an	airtight	chamber	connected	to	a	vacuum	pump,	gas	flow	and	electric	
power	supply.	The	air	within	the	chamber	is	evacuated	by	the	vacuum	pump	before	
ammonia	gas	is	allowed	to	enter	the	chamber	at	low	pressure.	The	gas	within	the	
chamber	is	then	energised	by	an	electrical	current,	which	creates	a	glow	discharge	and	
a	variety	of	energetic	species.	These	include	ions,	electrons,	photons	and	free	radicals.	
Surfaces	in	contact	with	plasma	are	subjected	to	energy	transfer	following	collisions	
from	the	energetic	particles.	These	changes	occur	only	at	the	surface	of	the	material	
and	therefore	do	not	affect	its	bulk	properties.	The	surface	chemistry	of	ePTFE	can	be	
altered	such	that	a	proportion	of	surface	carbon-fluorine	bonds	are	broken.	Following	
plasma	treatment,	immersion	of	the	samples	into	distilled	water	leads	to	the	formation	
of	hydroxyl	functional	groups	in	place	of	broken	carbon-fluorine	bonds,	which	renders	
the	material	more	hydrophilic	(Figure	4).	
	
There	are	many	applications	in	which	ePTFE	has	been	chemically	modified	to	promote	
adhesion	and	proliferation	of	epithelia.	Cellular	proliferation	can	be	promoted	by	
surface	modifications	including	coatings	that	are	specific	to	the	antigenic	cues	required	
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by	the	specific	cell	type.	The	successful	endothelialisation	of	vascular	ePTFE	grafts,	for	
example,	have	been	demonstrated	following	the	use	of	ePTFE	coated	with	
heparin/collagen	films	comprising	functionalised	CD133.(102)	Similarly,	gas	plasma	
modification	of	ePTFE	incorporates	hydroxyl	(-OH)	groups	on	the	surface	rendering	it	
hydrophilic	and	conducive	to	cell	attachment.	Furthermore,	it	has	also	been	found	that	
protein	adsorption	increases	with	the	-OH	group	density	found	on	the	PTFE	surface.(103)	
When	the	surface	chemistry	of	these	materials	is	modified,	there	is	potential	for	tissue	
ingrowth	e.g.	mesh	in	hernia	repair	in	which	tissue	ingrowth	within	internodal	spaces	
has	been	demonstrated	histologically	and	low	hernia	recurrence	and	infection	rates	
reported.(73)		
	
	
			
	
	
	
	
	
Figure	4:	Illustration	of	the	surface	chemical	change	in	ePTFE	through	ammonia	gas	plasma	
treatment	and	immersion	in	distilled	water.	Energy	from	gas	plasma	breaks	some	of	the	surface	
carbon	fluorine	bonds,	which	are	replaced	by	hydroxyl	functional	groups	on	contact	with	water.		
	
	
1.3.2.3		 Determination	of	the	hydrophilicity	of	materials	through	contact	angle	
analysis		
The	contact	angle	is	the	angle	at	thermodynamic	equilibrium	of	a	liquid	droplet	where	
it	meets	a	solid	interface	and	a	gas/vapour	interface.	This	allows	estimation	of	the	
wettability	of	the	measured	surface	by	the	Young	equation	and	defines	the	molecular	
interactions	of	liquid,	gas	and	solid	material	(Figure	5).	The	Young-Laplace	equation	can	
ascertain	the	shape	of	the	liquid/gas	interface	through	Young’s	equation.(109)		
OH H20 	Ammonia	gas	plasma	
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Figure	5:	Illustration	of	a	droplet	on	a	solid	surface	with	the	measurements	required	in	Young’s	
equation.	LG	defines	the	gas-liquid	interfacial	energy	(surface	tension),	SG	defines	the	solid-
vapour	interfacial	energy	and	SL	defines	the	solid-liquid	interfacial	energy.	The	equilibrium	
contact	angle	can	be	derived	from	the	relationship	between	these	variables	through	Young’s	
equation:γSG-γSL-γLG	cos	θc=0.(109)		
	
1.4	 Culture	conditions	for	the	ex-vivo	expansion	of	human	conjunctival	
epithelial	cells		
Traditional	cell	culture	methods	for	the	expansion	of	conjunctival	epithelial	cells	
include	co-culture	with	inactivated	murine	3T3	feeder	layers	(immortalised	mouse	
fibroblasts)	and	the	use	of	foetal	calf	serum	(FCS).(110)	Although	these	culture	methods	
improve	cell	stratification	and	morphology,	they	are	not	ideally	suited	to	clinical	
transplant	applications	given	the	risk	of	transfer	of	xenobiotic	proteins	and	infective	
agents.	Some	research	groups	have	demonstrated	that	successful	development	of	
stratified	conjunctival	epithelium	can	be	achieved	through	the	use	of	autologous	or	
cord	blood	serum.(111)	
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There	have	been	numerous	published	protocols	for	the	culture	of	conjunctival	epithelia	
using	basal	media	varying	from	bronchial	epithelial	growth	medium,	RPMI,	DMEM/F12	
and	keratinocyte	serum	free	media.(11,	70,	112-114)	The	vast	majority	of	recent	studies	
avoiding	the	use	of	serum	and	murine	3T3’s,	however,	have	instead	used	a	basal	
medium	of	keratinocyte	serum	free	media.	Indeed,	over	recent	years,	the	successful	
development	of	conjunctival	epithelium	has	been	possible	using	serum	free	
alternatives.	(67,	97,	115,	116)	Keratinocyte	serum	free	media	does	however	require	bovine	
pituitary	extract	(BPE)	to	promote	epithelial	proliferation.	Interestingly,	positive	
detection	of	MUC5AC	mRNA	has	been	demonstrated	in	stratified	rabbit	conjunctival	
epithelium	developed	in	keratinocyte	serum	free	growth	media.(116)	Studies	have	also	
shown	comparable	proliferative	potential,	stratification	and	differentiation	
characteristics	including	a	goblet	cell	subpopulation	demonstrated	through	positive	
MUC5AC	staining	of	primary	conjunctival	epithelial	cells	when	cultured	in	basal	media	
DMEM/F12	with	human	serum,	BPE	or	FCS.(117)	In	most	culture	protocols,	the	cell	
primary	cell	cultures	were	initiated	with	a	DMEM/F12	media	containing	FBS	and	
epidermal	growth	factor	(EGF)	before	changing	to	the	keratinocyte	serum	free	
media.(67,	97,	111)	
	
There	is	no	consensus	on	the	optimal	growth	media	for	conjunctival	epithelium,	
particularly	in	the	context	of	the	requirement	for	an	optimal	subpopulation	of	
progenitor	and	goblet	cells.	Marked	similarities	were	also	found	between	culture	media	
protocols	established	both	for	the	expansion	of	the	HCjE-Gi	cell	line	and	primary	
human	conjunctival	epithelium.(67-70,	97,	113,	118)		
	
	
1.5	 Characterisation	of	human	conjunctival	epithelium	
The	human	conjunctival	epithelium	is	derived	from	bipotent	progenitor	cells,	which	
differentiate	into	stratified	squamous	epithelial	keratinocytes	in	addition	to	goblet	cells	
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that	resemble	glandular	epithelia.	Proposed	markers	for	the	identification	of	
conjunctiva	epithelium	based	on	markers	of	differentiation	are	described.		
	
1.5.1	 Goblet	cell	markers	
Goblet	cells	have	been	demonstrated	to	originate	from	bipotent	progenitor	cells	which	
also	have	the	potential	to	differentiate	into	keratinocytes.(18)	Cytokeratin	7	(CK7)	and	
the	intracellular	gel	forming	mucin	MUC5AC	have	been	proposed	as	markers	of	goblet	
cells.(11)	Only	goblet	cells	amongst	all	ocular	surface	epithelia	secrete	the	large	gel	
forming	mucin	MUC5AC.(28)	MUC5AC	is	found	in	the	tear	film	and	is	the	result	of	
secretion	through	the	process	of	exocytosis	by	goblet	cells.	(17)	MUC5AC	is	a	high	
molecular	weight	glycoprotein.		
	
Alternative	methods	of	identifying	goblet	cells	based	on	their	mucin	content	include	
UEA-1	(Ulex	Europaeus	Agglutinin-1)	lectin,	HPA	lectin	(Helix	pomatia	agglutinin),	
Periodic	Acid	Schiff	(PAS)	and	Alcian	Blue.(11)	Lectins	are	a	group	of	proteins	that	bind	
specific	carbohydrate	groups.	UEA-1	binds	to	glycoproteins	and	glycolipids	containing	
α-linked	fructose	residues	and	glycoconjugates.	Cells	high	in	mucins	therefore	can	be	
identified	by	the	binding	of	these	molecules	and	have	been	demonstrated	in	studies	to	
localise	to	goblet	cells	in	culture.(11)	PAS	is	a	stain	used	to	identify	glycolipids,	
glycoproteins	and	mucins.	Similarly,	Alcian	blue	also	identifies	polysaccharides	and	
mucopolysaccharides.	All	of	these	staining	methods	other	than	MUC5AC	detection	
therefore	identify	transmembrane	mucins	present	on	conjunctival	epithelial	
keratinocytes	in	addition	to	goblet	cells	containing	MUC5AC.	PAS	also	identifies	
basement	membranes.			
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1.5.2	 Progenitor	cell	markers	
A	rapid	turnover	of	conjunctival	epithelium	occurs	throughout	life.	An	earlier	study	
proposed	the	a	uniform	distribution	of	progenitor	cells	throughout	the	conjunctiva	
based	upon	clonogenic	ability	of	forniceal	and	bulbar	conjunctiva.(18)	More	recently,	
however,	Immunohistochemical	analysis	of	progenitor	cell	markers	and	colony-forming	
efficiency	determined	that	progenitor	cells	occur	in	greatest	frequency	within	the	
inferior	conjunctival	fornix	and	medial	canthus.(19,	119)		
	
Conjunctival	stem	cells	may	be	identified	by	a	number	of	cell	markers	through	
immunological	detection	and	polymerase	chain	reaction	(PCR).	A	relatively	well-studied	
marker	is	p63,	interest	in	which	initially	arose	in	the	1990’s	when	it	was	found	that	the	
absence	of	p63	had	deleterious	effects	on	the	regenerative	potential	of	epidermis	and	
stratified	epithelia.(120)	It	was	since	suggested	that	a	defect	in	p63	resulted	in	a	defect	in	
stem	cell	renewal.	Although	the	precise	role	of	p63	in	the	differentiation	and	apoptotic	
pathways	is	unclear,	cumulative	evidence	suggests	that	p63	has	a	role	in	epidermal	
stem	cell	renewal.	Furthermore,	a	reduction	in	p63	mRNA	expression	has	been	
correlated	with	a	reduction	in	the	proliferative	capacity	of	human	epidermal	
epithelium.(121)	Its	role	in	progenitor	rather	than	differentiated	cells	is	also	supported	
by	the	absence	of	p63	transcription	factors	in	paraclones	of	limbal	and	epidermal	cells	
that	were	present	in	holoclones.(122)	There	are	6	isoforms	of	p63	and	the	isoform	more	
extensively	studied	in	epithelial	cells	is	ΔNp63α.(9)	Indeed,	p63	detects	basal	
conjunctival	epithelial	cells	in	general	whereas	ΔNp63α	is	found	in	a	much	smaller	
population	of	cells	with	stem	cell	like	characteristics.(122,	123)	Of	the	p63	isoforms,	the	
ΔNp63α	isoform	has	been	identified	as	the	predominant	subtype	in	ocular	surface	
epithelia.	(9)		
	
The	ATP	binding	cassette	sub-family	G	member	2	(ABCG2)	is	the	ATP	binding	and	
transporter	protein	and	is	also	a	commonly	used	marker	for	the	identification	of	
progenitor	cells	in	ocular	surface	epithelia	(cornea	and	conjunctiva).	Budak	and	
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colleagues	identified	ABCG2	as	a	candidate	stem	cell	marker	and	demonstrated	the	
active	efflux	of	the	dye	Hoechst	33342	was	mediated	by	the	ABGC2	transporter.(8)	This	
population	of	cells	could	be	separated	as	a	side	population	representing	<1%	of	cells	by	
fluorescence	activated	cell	sorting.	The	cells	demonstrated	behaviour	in	keeping	with	
progenitor	cells	including	slow	cycling	and	clonogenic	capacity	in	vitro.(8)	Budak	and	
colleagues	also	demonstrated	by	immunohistochemistry	the	presence	of	ABCG2	basal	
conjunctival	epithelial	cells	found	in	clusters.(8)	
	
Putative	stem	cell	markers	in	of	the	conjunctiva	include	ABCG2	and	ΔNp63.		There	are	
no	definitive	stem	cell	markers	of	the	conjunctiva	and	these	markers	may	detect	
transiently	amplifying	cells	in	addition	to	true	stem	cells	and	therefore	will	be	broadly	
regarded	in	this	study	as	progenitor	cell	markers.		
	
1.5.3	 Cytokeratins	
Cytokeratins	are	polypeptides	that	form	the	intermediate	filament	system	in	epithelia	
of	which	there	are	30	related	polypeptides.	They	are	broadly	described	within	two	
groups:	type	1(neutral-basic)	and	type	2(acidic).	Epithelia	may	be	characterised	by	the	
specific	pair	(type	1	with	type	2)	of	cytokeratins	that	are	expressed	in	the	cells.	
Cytokeratin	expression	may	be	altered	in	disease	states,	differentiation	and	are	
differentially	expressed	between	epithelia.	Furthermore,	within	conjunctival	
epithelium,	cytokeratin	expression	can	be	used	to	identify	conjunctival	epithelial	cells	
from	goblet	cells	and	therefore	can	be	regarded	markers	of	differentiation.	The	
differential	expression	of	cytokeratins	in	corneal	and	conjunctival	epithelia	has	been	
recognised.	The	cytokeratin	pair	CK3/12	have	long	been	recognised	as	markers	of	
corneal	epithelia	whereas	CK13,	CK19,	CK7	and	MUC5AC	have	been	considered	
markers	of	conjunctival	epithelia.(10,	124-127)	The	specificity	of	some	markers	such	as	CK3	
and	CK19	for	corneal	and	conjunctival	specificity,	however,	has	been	questioned	by	a	
number	of	authors.(124,	128,	129)	In	a	recent	immunocytochemical	characterisation	study	it	
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was	determined	that	CK13	and	CK7	could	be	locallised	to	all	conjunctival	epithelial	
layers	and	suprabasal	limbal	epithelium	whereas	MUC5AC	was	specific	only	to	
conjunctiva.(124)	CK19,	however,	was	found	in	all	conjunctival	layers	but	was	also	
detected	in	the	suprabasal	limbus	and	peripheral	corneal	epithelia.(124)	Qi	and	
colleagues	locallised	CK4	and	CK7	to	superficial	layers	of	bulbar	conjunctiva,	whereas	
both	markers	were	absent	in	corneal	epithelium.(130)	Based	upon	this	evidence,	this	
study	will	therefore	utilise	CK4,	CK7,	MUC5AC	and	CK19	as	markers	of	conjunctival	
epithelium.		
	
Cytokeratin	7	(CK7)	is	characteristic	of	glandular	epithelia	and	is	found	in	lacrimal	tissue	
amongst	other	apocrine	glands	and	tracheal	epithelium.(125)	Studies	in	animal	and	
human	conjunctival	epithelium	have	found	that	CK7	staining	cells	have	morphological	
features	including	secretory	vesicles	in	keeping	with	goblet	cells.	It	has	been	suggested	
that	the	CK7	filament	may	facilitate	the	exocytosis	of	mucin	by	interacting	more	
specifically	with	the	contractile	apparatus	of	the	goblet	cell,	which	is	not	otherwise	
present	in	conjunctival	cells	of	an	epithelial	phenotype.(125)	Indeed,	the	upregulation	of	
CK7	has	been	demonstrated	on	inductive	differentiation	of	goblet	cells	in	conjunctival	
epithelial	cultures	with	a	γ-secretase	inhibitor.	CK7	expressing	cells	in	the	latter	study	
also	expressed	MUC5AC	and	exhibited	morphological	characteristics	in	keeping	with	
goblet	cells.(131)	
	
Conflicting	results	have	been	reported	over	the	expression	of	CK7	between	cells	of	a	
goblet	cell	phenotype	and	conjunctival	keratinocytes.(11,	132)		The	reason	behind	this	
relates	to	the	clone	of	antibody	used	in	which	the	OV/TL	clone	binds	to	all	conjunctival	
epithelial	cells	whereas	the	RCK	105	clone	has	greater	specificity.(133)	Cytokeratin	4	
(CK4)	expression	has	been	found	in	conjunctival	keratinocytes	that	exhibit	an	
epithelioid	rather	than	a	glandular	cell	morphology	suggesting	CK4	expressing	
conjunctival	epithelia	are	keratinocytes	that	differ	both	morphologically	and	
phenotypically	from	conjunctival	goblet	cells.	CK4	positive	cells	have	been	locallised	to	
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conjunctival	epithelium	and	often	reported	within	its	superficial	layers.(134)	CK19	
however	is	a	recognised	marker	of	conjunctival	epithelium	and	its	expression	has	been	
reported	throughout	the	conjunctival	epithelium	in	both	in	vivo	and	in	vitro	studies.	(10,	
124,	127,	130,	135)	CK19	is	therefore	used	in	this	study	as	a	pan-conjunctival	epithelial	
marker.	
	
1.5.4	 Proliferation	versus	apoptotic	markers	
There	are	a	multitude	of	candidate	markers	that	may	be	used	to	study	proliferation	and	
apoptosis.	Proliferating	cell	nuclear	antigen	(PCNA)	and	Caspase-3	expression	however	
have	been	well	documented	in	conjunctival	epithelia.		
	
Caspase	is	a	proteolytic	enzyme	involved	in	the	apoptosis	of	mammalian	cells.	
Subgroups	of	caspases	also	have	a	recognised	role	in	inflammation	(caspase	-1,	-4,	-5,	-
12).	Caspases	can	also	be	grouped	by	function	either	as	initiators	or	executors	of	
apoptosis.(136)	Of	these,	caspase-3	is	known	for	its	role	in	the	execution	of	apoptosis.	
The	activation	of	apoptosis	occurs	via	the	B-cell	lymphoma	2	(Bcl-2)	family	of	proteins	
and	is	initiated	in	response	to	cellular	stress	from	a	variety	of	stimuli	including	cytotoxic	
drugs	or	irreparable	DNA	damage.(136)	Caspase-3	has	been	exploited	in	numerous	
studies	as	a	marker	of	apoptosis	in	conjunctival	epithelial	cells	including	human	
conjunctival	cell	lines	and	primary	conjunctival	epithelial	cells.(49,	137-139)		
		
Proliferating	cell	nuclear	antigen	(PCNA)	is	found	in	all	replicating	eukaryotic	cells	and	
plays	a	role	in	the	replication	of	DNA.	PCNA	had	a	central	role	in	the	s-phase	of	the	cell	
cycle	during	which	this	protein	provides	a	platform	for	the	protein-protein	and	DNA-
protein	interactions	that	occur	during	DNA	replication,	repair,	chromatin	formation	and	
remodelling,	and	the	cohesion	of	sister	chromatids.(140,	141)	The	immunological	
detection	of	PCNA	has	been	extensively	used	for	the	characterisation	of	human	cells	
including	conjunctival	epithelium.(133,	134)	
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1.6	 Flow	cytometry		
Flow	cytometry	is	a	scientific	application	that	enables	the	quantitative	analysis	of	cells	
in	suspension.	The	principle	of	flow	cytometry	is	that	particle	detection	is	based	on	the	
light	scattering	properties	of	cells	when	excited	by	laser.(142)	The	fluidics	within	this	
system	is	designed	to	carry	a	stream	of	fluid	with	cells	in	single	file	to	the	lasers	within	
the	system.	Multiple	lasers	exist	within	the	flow	cytometer,	illuminating	the	particles	at	
varying	frequency.(142)	Any	scattered	light	and	emitted	fluorescence	is	focussed	and	
detected	(Figure	6).	The	technique	mostly	requires	the	fluorescent	labelling	of	cells	to	
identify	the	cell	associated	marker	being	studied,	whereby	the	fluorescence	emitted	by	
cells	is	detected	after	excitation	from	the	respective	laser	at	the	required	absorbance	
wavelength.	The	technique	therefore	allows	multiparametric	analysis	of	cell	
populations	from	several	lasers	simultaneously.		
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	6:	Illustration	of	the	principle	of	flow	cytometry.	A	heterogeneous	population	of	cells	
labelled	with	fluorescent	antibodies	and	markers	in	solution	is	directed	into	single	file	within	a	
stream	of	fluid.	Laser	light	sources	excite	cells	and	the	light	scattering	characteristics	and	
emitted	fluorescence	is	detected	to	enable	quantitative	analysis	of	heterogeneous	cell	
populations.(142)	
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Both	indirect	and	direct	antibody-staining	methods	have	been	employed	in	the	analysis	
of	conjunctival	epithelia.	Monoclonal	or	polyclonal	antibodies	can	be	directed	to	the	
antigen	of	interest	and	a	fluorochrome	conjugated	secondary	antibody	targeted	to	the	
specific	immunoglobulin	and	species	subtype	of	the	primary	antibody.	Flow	cytometric	
analysis	can	be	undertaken	as	single	or	multicolour	analysis	involving	laser	excitation	
from	multiple	channels.	The	fluorochromes	are	chosen	at	extremes	of	wavelengths	to	
each	other	in	multicolour	analysis	to	avoid	overlap	in	detected	fluorescence.		
	
	
1.6.1	 Flow	cytometry	for	the	analysis	of	conjunctival	epithelial	cells		
Flow	cytometry	has	been	used	for	the	analysis	of	inflammatory	markers	in	dry	eye	
disease	and	rosacea.(143,	144)		In	a	murine	laboratory	cell	culture	study,	conjunctival	
goblet	cells	were	enumerated	by	flow	cytometry	using	cytokeratin	specific	antibodies	
CK4	(conjunctival	epithelial	cells),	CK7	(goblet	cells)	and	MUC5AC	(goblet	cells).(145)	In	
another	study	of	conjunctival	brush	cytology	specimens,	the	side	scatter	and	forward	
scatter	pattern	of	human	conjunctival	epithelial	cells	have	been	characterised	and	CK7	
used	as	a	marker	of	conjunctival	goblet	cells.(146)	The	application	of	flow	cytometry	for	
the	quantitative	analysis	of	intracellular	markers	characterising	progenitor	cells	in	
conjunctiva	has	not	however	been	previously	reported.		
	
1.7	 Mucous	membrane	pemphigoid	
Of	the	cicatrising	eye	diseases,	ocular	mucous	membrane	pemphigoid	(MMP)	is	
encountered	with	greatest	frequency	in	patients	under	review	in	UK	corneal	and	
external	eye	disease	clinics.(36)	Furthermore,	the	risk	of	sight	threatening	disease	with	
advancing	ocular	mucous	membrane	pemphigoid	has	been	regarded	as	‘high	risk’	in	an	
international	consensus	review.(33)	For	this	reason,	it	will	be	considered	here	as	a	
priority	treatment	group	and	described	in	greater	detail.		
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MMP	encompasses	a	group	of	acquired	autoimmune	diseases	characterised	by	a	type	II	
hypersensitivity	response	at	the	epithelial	basement	membrane	zone.	There	is	
recognised	variation	in	both	clinical	presentation	and	circulating	autoantibodies	to	
target	auto-antigens	in	MMP,	which	suggests	significant	disease	heterogeneity.(147)	
Suspected	antigens	include	bullous	pemphigoid	antigens	1	and	2,	β4	integrin,	type	VII	
collagen	and	laminins	5	and	6,	present	in	lamina	lucida	transmembrane	
hemidesmosomes.(33,	148-150)	Clinically,	this	results	in	inflammation,	blistering	and	
ulceration,	which	ultimately	result	in	fibrosis	and	scarring.	MMP	affects	mucous	
membranes	in	varying	frequency	and	pattern	involving	the	mouth,	upper	airway	tracts,	
oesophagus,	conjunctiva,	anus	and	genitalia.(147)			
	
Ocular	involvement	is	typically	bilateral	and	characterised	by	conjunctival	injection,	
blistering	and	ulceration,	which	lead	to	subepithelial	scarring	and	fibrosis.	This	results	
in	forniceal	shortening,	further	advancing	cicatrising	change	and	may	ultimately	lead	to	
ankyloblepharon	(adhesions	between	the	eyelids)	and	‘frozen	globe’	(adhesion	
between	the	eyelids	and	globe	together	with	ankyloblepharon).		There	is	wide	variation	
in	the	presentation	of	MMP	in	which	it	may	be	seen	in	the	clinical	setting	with	signs	of	
acute	inflammation	in	combination	with	chronic	cicatrisation.	Delayed	presentation	is	
typical	however	with	low-grade	inflammation	resulting	in	slowly	progressive	
cicatrisation.(151,	152)	Patients	typically	present	with	established	cicatrising	eye	disease	
and	signs	including	forniceal	shortening,	conjunctival	keratinisation	and	symblephara.	
The	diagnosis	is	also	often	missed	due	to	the	non-specific	nature	of	ocular	irritation	due	
to	dryness,	conjunctival	injection	and	sub-epithelial	fibrosis	that	is	subtle	in	early	
disease.(33)	A	longitudinal	study	of	ocular	mucous	membrane	pemphigoid	patients	
found	younger	patients	with	early	onset	disease	had	more	signs	of	conjunctival	
inflammation	and	rapidly	advancing	disease.(36)	It	is	also	of	interest	to	note	that	42%	of	
patients	demonstrated	disease	progression	without	detectable	signs	of	conjunctival	
inflammation	based	on	the	degree	of	conjunctival	injection	measured	at	clinic	visits.(36)	
This	demonstrates	the	importance	of	assessment	of	disease	activity	both	in	terms	of	
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conjunctival	inflammation	and	cicatrisation,	which	represents	chronic	change.	Early	
diagnosis	and	accurate	assessment	of	disease	activity	and	progression	is	therefore	
crucial	to	the	management	of	this	challenging	condition.		
	
A	pro	forma	was	therefore	developed	for	use	in	corneal	and	external	eye	disease	clinics	
at	St	Paul’s	Eye	Unit,	Royal	Liverpool	University	Hospital.	A	new	pro	forma	was	
designed	with	the	intention	of	including	relevant	aspects	of	the	examination	that	would	
assist	the	clinician	in	the	assessment	of	both	a)	disease	progression	and	b)	disease	
activity.	Components	of	existing	grading	systems	have	been	used	or	adapted	and	their	
pertinent	features	discussed	within	sections	1.7.1	and	1.7.2.		
	
	
1.7.1		 Grading	systems	to	detect	progression	of	cicatrisation	in	ocular	mucous	
membrane	pemphigoid		
The	accurate	documentation	and	staging	of	ocular	MMP	is	fraught	with	difficulty	due	to	
lack	of	standardisation	of	staging	methods	between	clinicians,	observer	errors	in	the	
quantification	of	cicatricial	progression	and	the	insidious	nature	of	the	disease	process	
itself.	It	has	been	recognised	that	cicatrisation	may	advance	in	the	absence	of	
measureable	conjunctival	inflammatory	signs.	It	follows	therefore	that	ocular	MMP	
warrants	assessment	both	in	terms	of	conjunctival	inflammation	and	cicatricial	features	
to	determine	disease	activity	and	progression.	Several	grading	systems	for	cicatrisation	
have	developed	to	grade	the	severity	of	clinical	features	and	are	described	in	this	
section.			
	
The	Foster	grading	system(153)	
The	staging	system	by	Foster	categorised	the	disease	subjectively	into	stages	I-IV.	
	
Foster	stages	
I	 Subconjunctival	scarring	and	fibrosis	
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II	 Fornix	foreshortening	(of	any	degree)	
III	 Presence	of	symblepharon	(of	any	degree)	
IV	 Ankyloblepharon,	frozen	globe		
	
The	Mondino	and	Brown	grading	system	(46)	
Mondino	and	Brown	developed	a	grading	system	that	described	forniceal	shrinkage	in	
terms	of	the	percentage	loss	of	forniceal	depth.	
	
Mondino	stages		
I	 0-25%	loss	of	inferior	fornix	depth	
II	 25-50%	loss	of	inferior	fornix	depth	
III	 50-75%	loss	of	inferior	fornix	depth	
IV	 75-100%	loss	of	inferior	fornix	depth	
	
Tauber	grading	system(154)	
The	Tauber	grading	system	utilised	Foster	staging	I-IV	but	included	sub-divisions	for	
stages	II	and	III	to	describe	the	degree	of	fornix	foreshortening	(as	described	by	
Mondino	and	Brown)	and	degree	of	involvement	by	symblepharon	respectively.		
	
Stage	II	 Percentage	loss	inferior	fornix	depth	
a-d*	
Stage	III	 Percentage	horizontal	involvement	by	symblephara	
a-d*	
	
*a-d	(describes	subdivisions	within	II	and	III)		
a	 0-25%	
b	 25-50%	
c	 50-75%	
d	 75-100%	
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Rowsey	grading	system(155)	
Rowsey	developed	a	system	to	objectively	measure	more	subtle	changes	in	ocular	
mucous	membrane	pemphigoid	than	previous	methods.	This	was	based	upon	three	
measurements	taken	at	5,	6	and	7	o’clock	from	the	limbus	to	the	posterior	lid	margin	
with	the	eye	in	dextroelevation,	upgaze	and	laevoelevation	(Figure	7).	The	
measurements	are	taken	with	a	rule	to	the	nearest	millimetre	with	the	lower	lid	held	
under	maximal	traction	before	the	globe	position	is	affected.	An	aggregate	score	was	
then	calculated	with	a	maximal	score	of	45	whereby	the	normal	score	was	15mm	for	
each	measurement.		
	
	
	
Figure	7:	Diagram	demonstrating	the	measured	areas	for	the	Rowsey	scoring	system.	The	
diagram	above	shows	the	three	measurements	that	are	taken	from	the	limbus	to	the	lid	margin	
at	5,	6	and	7	o’clock	from	the	corneal	limbus.	Taken	from	Rowsey	et	al.	Arch	Ophthalmol.	
2004;122:179-184.		
	
	
Tauber-Liverpool	method(156)	
The	grading	systems	described	so	far	(Foster,	Mondino	and	Tauber)	grade	loss	of	
forniceal	depth	by	estimation	of	the	percentage	reduction	in	the	fornix	depth,	which	is	
the	distance	from	the	posterior	lower	lid	margin	to	the	fornix.	Difficulties	in	this	
estimation	may	arise	due	to	the	poor	definition	of	the	fornix	itself	due	to	the	presence	
of	subtarsal	fibrosis	and	conjunctival	corrugations.	Furthermore,	these	staging	systems	
	 40	
would	not	detect	subtle	change	given	the	levels	of	staging	represent	marked	changes	in	
fornix	depth.	The	Tauber-Liverpool	method	is	an	adaption	of	the	systems	previously	
described	by	Tauber	and	Mondino	and	measures	both	the	vertical	forniceal	depth	and	
horizontal	involvement	by	measurements	taken	along	the	bulbar	conjunctival	surface.		
	
Vertical	forniceal	depth	
This	is	measured	to	the	nearest	millimetre	between	the	limbus	at	6	o’clock	and	the	
superior	edge	of	the	fibrosis	with	the	lid	held	gently	under	traction	and	the	eye	held	in	
upgaze.	This	value	is	then	subtracted	from	10	and	multiplied	by	10	to	give	the	
percentage	fornix	shortening	from	which	grade	a-d	(Tauber	staging)	is	determined.		
	
Horizontal	grading	
The	horizontal	shortening	is	measured	objectively	by	using	a	clear	rule	and	measuring	
the	horizontal	distance	from	the	medial	and	lateral	canthus	2mm	above	the	start	of	the	
inferior	fibrosis.	The	combined	width	of	any	symblepharon	present	is	then	subtracted	
from	the	total	conjunctival	horizontal	width	to	define	the	percentage	horizontal	
shortening.		
	
	
	
Figure	8:	A	photographic	example	of	the	Liverpool-Tauber	grading	system.	Taken	from	Reeves.	
G.	Graefes	Arch	Clin	Exp	Ophthalmol	(2012)	250:611–618.	An	example	of	grading	is	shown	in	
the	above	photographs	with	measurements	(mm)	as	follows:	a)	vertical	grading	(10-5)	
x10=50%;	b)	horizontal	grading	e.g.	(27-(6+1+1+4))/27x100=56%	
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The	main	advantage	of	the	Tauber-Liverpool	system	is	that	it	would	allow	small	
changes	to	be	detected.	In	contrast	to	the	Rowsey	system,	the	Liverpool-Tauber	system	
attempts	to	quantify	the	distance	of	the	bulbar	conjunctiva	between	the	limbus	and	
the	edge	of	the	subtarsal	fibrosis	using	10mm	as	an	average	reference	value.	This	
removes	potential	variation	between	observers	in	terms	of	the	degree	of	traction	
applied	to	the	eyelid	whilst	enabling	the	detection	of	smaller	degrees	of	change	than	
the	traditional	Foster,	Mondino	and	Tauber	systems.		
	
Given	the	variation	in	the	described	methods	thus	far	and	lack	of	consensus	thus	far	on	
the	appropriate	grading	system	to	use	for	MMP	patients,	all	will	be	included	within	the	
pro	forma	for	comparison.	A	fornix	ruler	will	also	be	used	to	measure	the	central	fornix	
depth	of	both	the	upper	and	lower	fornices	as	previously	described	by	Williams	and	
colleagues.(157)	Staging	systems	described	thus	far	only	measure	cicatricial	change	in	
the	lower	fornix.	The	upper	fornix	measurement	in	particular	may	be	of	significant	
clinical	value	given	that	it	is	otherwise	notoriously	difficult	to	assess	and	quantify	
objectively.		
	
1.7.2	 Assessment	of	the	involvement	of	the	ocular	surface	and	eyelids	to	
grade	disease	progression	in	MMP	
The	described	staging	systems	grade	cicatrisation	but	not	the	level	of	inflammatory	
activity	present	at	the	time	of	examination.	Several	methods	have	been	reported	for	
the	grading	of	bulbar	conjunctival	hyperaemia	including	the	Oxford	grading	system,	
Efron,	and	International	Eye	Research	grading.(158-161)	A	grading	scheme	for	conjunctival	
inflammation	specific	to	ocular	MMP	has	been	adapted	by	Saw	et	al.	from	an	original	
report	describing	inflammatory	activity	by	Elder.(162)	The	adapted	grading	scheme	has	
been	used	in	research	including	clinical	trials	of	ocular	MMP	patients.(163,	164)	This	
grading	system	is	a	five-point	scale	based	on	standard	photographs,	which	may	be	used	
to	grade	inflammation	in	each	sector	of	bulbar	conjunctiva	(Figure	9).	This	has	
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therefore	been	used	as	part	of	the	Liverpool	pro	forma	for	the	assessment	of	MMP	
patients	(Appendix).		
	
	
	
	
Figure	9:	Ocular	inflammation	grading	system	by	Saw	et	al.	This	grading	system	demonstrates	a	
5-point	grading	of	ocular	inflammation	from	‘minimal’	to	‘limbitis’.	Taken	from:	Saw,	V.	P.	Dart,	
J.	K.	Rauz,	S.	et	al.	(2008)	Immunosuppressive	therapy	for	ocular	mucous	membrane	
pemphigoid	strategies	and	outcomes.	Ophthalmology.	115(2):253-261.	(163,	164)	
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There	are	no	known	validated	scoring	systems	for	the	grading	of	corneal	or	lid	
involvement	in	MMP	patients.	A	grading	system	for	the	assessment	of	corneal	disease	
was	sought	from	the	literature	to	grade	corneal	involvement	appropriate	to	MMP	
patients.	Sotozono	and	colleagues	published	a	grading	method	for	the	documentation	
of	disease	severity	in	Stevens-Johnson	syndrome,	which	included	grading	of	
conjunctivalisation,	neovascularisation,	opacification,	keratinisation	and	
symblepharon.(165)	An	observer	may	grade	disease	severity	by	comparing	standard	
photographs	to	the	clinical	assessment	of	the	patient	undertaken	at	the	slit	lamp	
(Figure	10).	As	Stevens-Johnsons	syndrome	is	an	inflammatory	ocular	surface	disease	
with	a	similar	ocular	signs	to	that	found	in	MMP,	it	was	felt	that	this	grading	system	
would	be	appropriate	to	use.	The	corneal	conjunctivalisation,	neovascularisation	and	
opacification	components	of	this	grading	scheme	were	therefore	included	the	pro	
forma.	The	grading	of	lid	deformities	was	also	included	in	the	pro	forma	and	was	an	
adaptation	of	existing	grading	schemes	for	entropion/ectropion.(166,	167)	Unfortunately,	
no	grading	schemes	specific	to	cicatrising	eye	disease	could	be	found	in	the	literature.	
The	adapted	entropion/ectropion	grading	systems	are	simplified	versions	of	that	
previously	described	in	the	literature	and	include	documentation	of	whether	the	
medial	or	lateral	aspect	of	the	upper	or	lower	eyelids	are	involved	(Figure	11,	
Appendix).		
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Figure	10:	Photographs	for	the	grading	of	ocular	surface	manifestations	of	Stevens-Johnson	
syndrome	as	reported	by	Sotozono	et	al.	(2007).	These	images	were	taken	from	the	original	
publication:	Sotozono	et	al.	(2007)	New	grading	system	for	the	evaluation	of	chronic	ocular	
manifestations	in	patients	with	Stevens-Johnson	syndrome.	Ophthalmology.	114:1294–1302.	
(165)	The	conjunctivalisation,	neovascularization	and	opacification	components	of	the	grading	
system	were	used	in	the	MMP	pro	forma.		
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Figure	11:	Figure	to	show	the	original	reported	grading	schemes	(a)	and	the	adapted	versions	
(b)	for	the	documentation	of	entropion	and	ectropion.	The	entropion	and	ectropion	scales	
were	taken	from	and	adapted	from	Kemp	et	al.	(1986)	and	Moe	at	al.	(2000)	respectively.	(166,	
167)	
Ectropion	Grading	Scale	
	
0		 Normal	eyelid	appearance	and	
function	
I		 Normal	appearance	but	symptomatic;	
eyelid	laxity	present	on	examination	
II		 Scleral	show	without	eversion	of	lower	
eyelid	
III		 Ectropion	without	eversion	of	lacrimal	
punctum	
IV		 Advanced	ectropion	with	eversion	of	
lacrimal	punctum	from	lacrimal	lake	
V		 Ectropion	with	complication	(eg,	
conjunctival	metaplasia,retraction	of	
anterior	lamella,	or	stenosis	of	lacrimal	
system)	
	
L		 Predominantly	lateral	
M		 Predominantly	medial	
LM		 Combined	medial	and	lateral	
r		 Previous	revision*		
a)	
Adapted	ectropion	grading	scale		
	
• 0-normal	appearance		
• 1-scleral	show	without	eversion	of	
lower	lid	
• 2-ectropion	with	eversion	of	lid	but	
without	eversion	of	lacrimal	punctum	
• 3-advanced	ectropion	with	eversion	of	
lacrimal	punctum	from	lacrimal	lake	
	
	
	
	
M=	Medial,	L=Lateral	
Entropion	Grading	Scale	
	
Minimal		 -Apparent	migration		
meibomian	glands		
-Conjunctivalisation	of	lid	
margin	
-Lash/globe	contact	on	
up-gaze	
	
Moderate		 -Apparent	migration	of		
meibomian	glands		
-Conjunctivalisation	of	lid		
margin	
-Lash/globe	contact	in	
primary	position	
-Thickening	of	tarsal	plate	
-Lid	retraction	
	
Severe			 -Gross	lid	distortion		
-Metaplastic	lashes		
-Presence	of	keratin	
plaques		
-Lid	retraction	causing		
incomplete	closure			
Adapted	entropion	grading	scale		
	
• 0-normal	appearance	
• 1-posterior	lid	border	inverted	
(apparent	migration	of	meibomian	
glands)	
• 2-posterior	lid	margin	inverted	to	
intermarginal	strip	or	lid	retraction	
• 3-whole	lid	margin	including	
anterior	border	inverted	or		
lid	retraction	resulting	in	
incomplete	closure		
	
M=	Medial,	L=Lateral	
b)	
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The	grading	of	ocular	dryness	is	also	great	importance	in	MMP	(please	see	section	
1.2.1).	A	grading	scheme	for	the	measurement	of	ocular	dryness	specific	to	MMP	
patients	could	not	be	found,	however,	a	number	of	grading	schemes	for	ocular	dryness	
were	obtained	from	the	literature.(158-160,	168)	One	of	the	most	widely	used	schemes	is	
the	Oxford	grading	scheme.	This	was	included	in	the	pro	forma	in	its	unadapted	form	
(Figure	12).(158)	Its	advantages	include	the	apparent	ease	in	its	administration;	
especially	given	the	pictorial	comparisons	seen	below	and	also	that	it	grades	both	
corneal	and	conjunctival	epithelial	involvement.	It	follows	therefore	that	this	could	be	
appropriate	for	use	in	MMP	patients.		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	12:	Figure	to	show	the	Oxford	grading	scheme	as	described	by	Bron	et	al.	Taken	from	
Bron	et	al.	(2003)	Grading	of	corneal	and	conjunctival	staining	in	the	context	of	other	dry	eye	
tests.	Cornea.	22(7):	640-50.		
	 	
0		 Absent		
I	 Minimal		
II		 Mild		
III		 Moderate		
IV		 Marked		
V		 Severe		
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1.8	 Aims	and	objectives	
A	pliable,	degradable	graft	derived	from	decellularised	conjunctival	tissue	may	suit	
indications	for	a	conjunctival	transplant	where	structural	rigidity	is	not	a	requirement,	
for	example	following	excision	of	conjunctival	lesions.	Decellularised	conjunctiva	would	
offer	all	the	advantages	of	an	extracellular	matrix	scaffold,	such	that	it	closely	
resembles	native	tissue	but	has	the	advantage	of	reduced	antigenicity.	In	contrast,	a	
non-degradable	conjunctival	construct	derived	from	ePTFE	capable	of	greater	physical	
support	may	suit	applications	such	as	forniceal	reconstruction.		
	
This	study	will	develop	two	such	substrates,	each	with	differing	physical	and	
biochemical	properties	that	may	address	a	range	of	transplantation	requirements.	The	
aims	and	objectives	of	this	project	are	broadly	categorised	below.	
	
To	develop	ePTFE	as	a	substrate	for	conjunctival	epithelial	expansion		
• Investigate	the	effect	of	ammonia	gas	plasma	treatment	on	the	proliferation	
and	phenotype	of	a	human	conjunctival	cell	line.	
• Investigate	the	potential	of	ammonia	plasma	treated	ePTFE	to	support	primary	
conjunctival	epithelium	
	
To	develop	decellularised	human	conjunctiva	as	a	biological	substrate	for	conjunctival	
expansion	
• Develop	a	novel	protocol	for	the	decellularisation	of	human	conjunctiva.		
• Determine	cytotoxicity,	biochemical	alteration	and	DNA	content	of	
decellularised	tissue.	
• Cultivate	conjunctival	epithelium	on	decellularised	conjunctival	tissue	and	
characterise	the	mechanical	properties	and	histology	of	the	tissue	in	
comparison	to	amniotic	membrane	and	ePTFE.	
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Clinical	application	of	novel	conjunctival	substrates		
• Develop	a	pro	forma	for	the	documentation	of	clinical	signs	and	disease	activity	
in	MMP	patients.		
• Describe	MMP	disease	sequelae	in	a	small	group	of	patients	attending	corneal	
and	external	eye	disease	clinics	at	the	Royal	Liverpool	Hospital.	
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2.	 Methods		
2.1	 Expanded	polytetrafluoroethylene	(ePTFE)	
2.1.1	 Ammonia	plasma	treatment	of	ePTFE	
Commercially	available	ePTFE	(0.64µm	thickness,	0.4µm	pore	size)	was	obtained	from	
Goodfellows	Ltd	(Cambridge,	UK),	divided	into	2x2cm	samples	and	mounted	in	tissue	
culture	scaffolds;	Cell	Crown	inserts	(Scaffdex	Ltd);	Figure	13.	The	ePTFE	sheets,	
therefore,	derived	support	from	the	cell	crown	rather	like	a	scaffold.	It	was	also	
straightened	such	that	it	was	held	as	a	flat	sheet	on	which	the	surface	chemistry	was	
subsequently	altered	by	exposure	to	ammonia	gas	plasma.	Larger	3x3cm	sections	of	
ePTFE	were	also	taken	of	which	some	were	left	untreated	and	some	were	subjected	to	
ammonia	gas	plasma	treatment	to	enable	the	acquisition	of	contact	angle	
measurements	to	measure	hydrophilicity.		
	
	
	
Figure	13:	Photographs	demonstrating	the	cell	crown	cell	culture	inserts	with	ePTFE	mounted	
within	it.	a)	Two	components	of	the	cell	crown.	On	the	left,	the	cell	crown	is	shown	upside	
down	with	the	ePTFE	membrane	placed	across	it	(solid	arrow).	The	ring	on	the	right	hand	side	
(dashed	arrow)	fits	over	the	membrane,	securing	it	into	place.	b)	This	photograph	shows	the	
ePTFE	membrane	mounted	in	the	base	of	the	cell	crown.	Each	of	these	was	placed	within	a	well	
of	a	standard	12-well	culture	plate	for	cell	culture	experiments	after	sterilisation	(section	2.3.2).		
a)	 b)	
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Ammonia	plasma	treatment	of	samples	was	achieved	by	placing	the	ePTFE	mounted	
cell	crowns	inside	the	reaction	chamber	of	helical	plasma	resonator	system,	built	in-
house	using	a	previously	described	method.(108)	The	plasma	resonator	system	briefly	
comprised	a	half	wave	helical	resonator	plasma	system	assembled	by	a	glass	tube	
around	which	a	100-turn	copper	wire	was	directly	wound.	The	system	had	a	resonant	
frequency	of	13.6MHz	and	power	<1W.(169,	170)	Samples	were	treated	at	a	flow	rate	of	
ammonia	of	85sccm	for	two	minutes	at	1.2x10-1mbar	pressure.(108,	171,	172)	Some	
samples	were	placed	on	the	stage	with	the	underside	of	the	ePTFE	membrane	side	
flush	against	the	stage	such	that	only	the	inside	of	the	cell	culture	insert	was	exposed	
to	ammonia	gas	plasma	(single	sided	treatment).	Samples	designated	for	ammonia	
plasma	treatment	on	both	the	inside	of	the	cell	culture	insert	and	its	underside	were	
placed	on	the	stage	on	their	side	to	allow	exposure	to	gas	plasma	on	both	sides	of	the	
membrane	(double	side	ammonia	plasma	treatment).		
	
After	removing	the	samples	from	the	reaction	chamber,	samples	were	immediately	
immersed	in	distilled	water	at	room	temperature	for	24	hours.	The	cell	crowns	with	the	
mounted	ePTFE	were	allowed	to	dry	at	room	temperature	before	they	were	sterilised	
using	a	ultra	violet	(UV)	cross-linking	machine,	CL-1000	U.V.	Crosslinker,	(UVP,	
Cambridge,	UK)	for	5	minutes	(1500w)	each	side	prior	to	use	in	cell	culture	
experiments.		
	
2.1.2	 Contact	angle	analysis	of	ePTFE	
Static	contact	angle	analysis	was	undertaken	on	ammonia	treated	and	untreated	ePTFE	
to	determine	a	change	in	wettability	using	the	DSA	100	Kruss	Drop	Shape	Analyser	
(Kruss,	GmbH).		This	is	an	optical	contact	angle	measurement	device	that	estimates	the	
wetting	properties	of	localised	areas	on	a	solid	surface.			
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The	DSA	software	supplied	with	the	equipment	was	used.	Prior	to	analysis	the	stage	
was	appropriately	set	and	a	‘normal	sessile	drop’	selected	for	analysis	from	the	
software	options.	A	live	image	was	visualised	on	the	computer’s	monitor	and	the	
dispensing	needle	visualised	within	the	centre	of	the	image.	A	10μL	drop	was	dispensed	
and	an	image	of	the	droplet	taken.	The	contact	angle	was	determined	after	selecting	
the	contact	angle	settings	for	a	sessile	drop	fitting	for	contact	angles	greater	than	90	
degrees	and	height/width-method	for	angles	less	than	90	degrees.	This	was	repeated	
six	times	on	randomly	selected	areas	of	the	ammonia	plasma	treated	ePTFE	and	
untreated	ePTFE.		
	
	
2.2	 Cells	and	tissues		
All	cell	culture	was	undertaken	under	aseptic	conditions	in	a	class	II	biological	safety	
cabinet	(Walker)	cleaned	with	Virkon®	(DuPont)	and	70%	ethanol.	Cell	incubation	was	
within	a	37°C	incubator	(New	Brunswick)	maintained	with	in	air	with	5%	CO2.		
	
2.2.1	 Culture	of	a	human	conjunctival	cell	line		
A	human	conjunctival	cell	line	donated	by	Gipson	laboratories	(HCjE-Gi),	Schepens	Eye	
Research	Institute,	Harvard	Medical	School,	Boston,	USA	was	cultured	using	an	adapted	
protocol	from	their	laboratories.	Cells	were	seeded	at	the	required	cell	density	by	
dispensing	a	calculated	volume	of	a	solution	of	even	cell	suspension.	Cell	
number/density	was	determined	using	a	haemocytometer.		
	
At	an	early	stage	of	culture,	cells	were	grown	in	an	‘early	grow	formula’	(Media	1):	
Keratinocyte	serum	free	medium	(K-SFM,	Invitrogen),	2ng/ml	epidermal	growth	factor	
(Invitrogen),	0.25%	bovine	pituitary	extract	(Invitrogen),	1%	penicillin-streptomycin	
(Sigma),	0.4mM	calcium	chloride	(Sigma).	Approximately	90%	of	the	existing	media	was	
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removed	and	replaced	every	2-3	days	using	media	that	was	pre-warmed	at	37°C.	Cell	
cultures	were	grown	in	75cm2	tissue	culture	flasks	(Greiner)	in	incubators	at	37°C	in	air	
with	5%	carbon	dioxide	(CO2).		
	
At	70-100%	confluence,	Media	2	was	used	and	comprised	a	50:50	mix	of	the	early	grow	
formula	and	DMEM:F12	(Invitrogen)	with	1%	penicillin-streptomycin	and	10%	foetal	
calf	serum	(FCS)	and	cultures	were	airlifted	such	that	the	media	fluid	level	was	at	the	
air-liquid	interface	as	described	in	section	2.3.		
	
2.2.1.1		 Passage	of	conjunctival	epithelial	cells	
Passaging	of	cell	cultures	was	undertaken	at	70-100%	cell	confluence.	Any	remaining	
media	in	the	culture	flasks	was	removed	and	replaced	with	TrypLE™	(1x	solution,	
Invitrogen).	This	agent	was	used	to	dissociate	cells	from	the	tissue	culture	plates	by	
incubation	in	the	TrypLE™	solution	at	37°C	in	air	with	5%	CO2	for	10	minutes	or	until	
complete	dissociation	was	apparent	on	phase	contrast	microscopy.	A	neutralising	
media	was	added	to	the	dissociated	cell	suspension	to	create	a	50:50	mix	and	
centrifuged	at	1000rpm/180g	for	5	minutes.	The	neutralising	media	comprised	a	50:50	
mix	of	DMEM	and	F12	media	(Invitrogen),	10%	FCS,	3.5g/l	HEPES,	1%	penicillin-
streptomycin	(Sigma).	The	resulting	cell	suspension	was	resuspended	in	media	1	
(section	2.2.1)	for	further	culture	or	storage	as	required.		
	
2.2.1.2		 Cryopreservation		
Any	surplus	HCjE-Gi	cells	were	stored	long-term	in	liquid	nitrogen.	Cells	were	
dissociated	from	tissue	culture	flasks	using	TrypLE™	(Invitrogen)	as	described	in	section	
2.2.1.1	and	resuspended	in	900μl	media	1	and	100μl	dimethylsulphoxide	(DMSO)	
(Sigma)	by	continuous	mixing	of	the	tube	and	placed	in	cryovials	(Starlab).	All	cryovials	
were	subsequently	placed	in	isopropanol	containers	(Nunc)	in	a	freezer	at	-80oC.	The	
isopropanol	solution	subjects	the	cryovials	to	gradual	temperature	decline	from	room	
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temperature	to	-80oC	at	a	rate	of	1oC	per	minute.	After	24	hours,	the	cryovials	were	
placed	in	liquid	nitrogen	dewars	for	long-term	storage.			
	
2.2.2	 Retrieval	of	human	conjunctival	tissue	and	culture	of	primary	
conjunctival	cells	
	
2.2.2.1	Retrieval	of	cadaveric	conjunctiva	
Ethical	approval	was	obtained	from	the	National	Health	Service	(NHS)	Health	Research	
Authority	(NRES	committee	North	West)	titled	‘Isolation,	characterisation	and	
expansion	of	human	ocular	surface	(corneal	and	conjunctival)	stem	cells’;	REC	
reference	11/NW/0766	protocol	number	4182.	The	ethical	approval	enabled	the	
retrieval	of	human	conjunctival	tissue	from	deceased	patients	at	the	Royal	Liverpool	
University	Hospital	in	whom	consent	had	been	obtained	from	the	next	of	kin	for	the	
use	of	tissues	in	research.	Consent	was	obtained	either	through	the	University	of	
Liverpool’s	Research	Eye	Bank	or	by	the	National	Retrieval	Centre	of	NHS	Blood	and	
Transplant,	based	in	Speke,	Liverpool.	All	practices	were	in	keeping	with	The	Human	
Tissue	Act	(Human	Tissue	Act	2004),	the	European	Union	Tissues	and	Cells	Directive	
(Tissues	and	Cells	Directive	2004)	and	the	Data	Protection	Act	(Data	Protection	Act,	
1998).		
	
Methods	for	the	dissection	of	conjunctiva	were	developed	following	trial	of	several	
variations	to	the	technique.	In	summary,	a	single	long	section	of	tissue	was	retrieved	by	
performing	a	360°	peritomy	followed	by	a	long	temporal	relaxing	incision	and	excision	
of	tissue	in	a	clockwise	or	anticlockwise	direction	extending	as	far	into	the	conjunctival	
fornices	as	possible	to	remove	all	bulbar	and	as	much	forniceal	conjunctival	tissue	as	
possible.	This	method	was	in	keeping	with	the	Royal	College	of	Ophthalmologists	
standards	for	transplantation	and	research.	Conjunctival	epithelium	was	retrieved	from	
both	eyes	from	each	donor	as	soon	as	possible	after	death.	Tissues	were	logged	
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consecutively	according	to	the	numbering	system	of	The	Research	Eye	bank,	University	
of	Liverpool.		The	age	and	gender	of	the	donor	was	recorded	together	with	the	number	
of	hours	that	lapsed	between	time	of	death	and	retrieval.	Retrieved	tissue	was	either	
stored	in	2-3ml	phosphate	buffered	saline	(PBS;	Invitrogen)	at	-40°C	or	dissected	for	
culture	immediately.		
	
2.2.2.2		 Explant	culture	of	primary	human	conjunctival	cells		
Fresh	human	bulbar/forniceal	conjunctival	tissue	was	dissected	from	its	underlying	
Tenon’s	capsule	layer	and	divided	into	approximately	1x1mm	tissue	sections	for	use	as	
explants.	Five	explants	were	seeded	on	decellularised	conjunctival	tissue	sections	
mounted	(section	2.5)	within	tissue	cell	crowns	(Scaffdex	Ltd.)	orientated	such	that	the	
basement	membrane	side	faced	the	substrate.	The	tissue	explants	were	cultured	for	
the	first	24	hours	in	DMEM/F12	media	with	10%	fetal	calf	serum,	1%	
penicillin/streptomycin	(Invitrogen).	The	subsequent	11	days	in	culture	were	in	the	
following	serum	free	media:	K-SFM	(Invitrogen),	0.2ng/ml	EGF	(Invitrogen),	25μg/ml	
BPE	(Invitrogen),	0.4mM	CaCl2,	1%	penicillin/streptomycin.	After	12	days	in	culture,	the	
tissues	were	airlifted	(as	per	section	2.3)	and	the	following	media	used	up	to	day	28	in	
culture:	K-SFM	(Invitrogen),	10ng/ml	EGF,	1.2mM	CaCl2,	1%	penicillin/streptomycin,	
transferrin	5µg/ml	Insulin	5µg/ml,	triiodothyronine	1.4ng/ml,	adenine	12µg/ml,	
hydrocortisone	0.4µg/ml	epidermal	growth	factor	10ng/ml.	Media	levels	were	
monitored	up	to	twice	daily	and	media	replenished	as	required	to	ensure	that	the	
liquid	volume	met	the	air-liquid	interface.		
	
2.2.2.3		 Culture	of	cells	on	decellularised	tissues	using	explants	and	isolated	
cell	suspensions	
Cells	from	the	same	tissue	donor	were	used	to	repopulate	decellularised	amniotic	
membrane	and	conjunctival	substrates.	Decellularisation	of	substrates	was	completed	
using	the	described	protocol	in	section	2.5.1	using	0.05%	SDS	(w/v)	and	mounted	into	
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Cell	Crowns	(Scaffdex	Ltd.).	The	conjunctival	tissue	was	divided	into	explants	within	
hours	of	eye	retrieval.	Five	randomly	selected	explants	were	cultured	directly	on	the	
decellularised	tissues.	The	remaining	explants	were	seeded	on	tissue	culture	plates	to	
allow	expansion	of	conjunctival	epithelium	over	10	days	so	that	adequate	cell	numbers	
developed	to	enable	the	seeding	of	1	x	105	cells/cm2	isolated	cells	in	suspension	onto	
decellularised	substrates	at	a	later	date.	After	5	days	in	culture,	the	explants	were	
removed	from	the	culture	plates	and	the	newly	developed	epithelium	continued	to	
divide.	After	10	days,	the	conjunctival	epithelium	was	dissociated	with	TryPLE	for	7	
minutes.	Agitation	of	the	cell	suspension	was	undertaken	by	using	a	pipette	to	take	up	
and	release	the	suspension	repeatedly	such	that	cells	disaggregated	in	a	50:50	mix	of	
neutralising	media	as	previously	described	(section	2.2.1.1).	Both	the	explants	and	
isolated	cells	were	seeded	in	DMEM/F12	media	with	10%	fetal	calf	serum,	1%	
penicillin/streptomycin	(Invitrogen).	After	24	hours,	the	media	was	replaced	with	
serum	free	media	as	described	in	section	2.2.1.	The	experiments	were	completed	in	
triplicate	using	both	decellularised	amniotic	membrane	and	decellularised	conjunctiva.	
	
2.3	 Cell	culture	on	substrates	
2.3.1	 Culture	of	cells	on	cell	culture	inserts	
Thincerts	(Greiner)	were	used	as	a	positive	control	in	experiments	of	synthetic	
substrates.	These	cell	culture	inserts	are	produced	from	clear	polystyrene	housings,	
and	polyethylene	terephthalate	(PET)	capillary	pore	membranes.	This	was	used	as	a	
positive	control	in	cell	culture	experiments	were	it	is	referred	to	as	PET	membrane.	As	
stated	by	the	manufacturer,	the	membrane	culture	surface	has	undergone	a	‘physical	
surface	treatment	’	to	improve	cell	adherence	and	growth.	Several	pore	size	diameters	
are	available,	however,	the	0.4m	pore	size	specification	was	used	for	consistency	
between	the	PET	and	the	ePTFE	tested	in	these	experiments.	The	cell	culture	inserts	
were	manufactured	to	fit	in	culture	plates	such	that	there	was	a	space	between	the	
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culture	insert	and	bottom	of	the	culture	plate	where	the	media	fluid	level	could	be	
controlled	(Figure	14).	The	process	of	‘airlifting’	required	the	media	level	to	be	adjusted	
to	the	level	of	the	air-liquid	interface	at	the	membrane.	This	method	required	regular	
monitoring	of	the	fluid	levels	to	ensure	that	the	fluid	level	was	maintained	at	the	air-
liquid	interface.		
	
	
	
Figure	14:	Diagram	to	illustrate	the	process	of	airlifting	cell	culture	inserts.	The	insert	(blue)	can	
be	placed	in	a	cell	culture	well	(black)	and	is	supported	such	that	it	is	suspended	within	the	
well.	The	media	(yellow)	is	inserted	and	shown	here	to	correspond	to	the	air-liquid	interface	of	
the	cellular	layer	(purple).		
	
2.3.2	 Culture	of	cells	on	ePTFE	membrane		
In	substrate	experiments	involving	the	ePTFE	membrane,	a	novel	method	for	airlifting	
was	developed	whereby	the	membrane	mounted	cell	crown	was	placed	on	top	of	a	
ring	shaped	device	that	allowed	a	higher	volume	of	media	in	the	culture	plate	whilst	
airlifting	(Figure	15).	In	preliminary	work,	it	was	found	that	although	regular	
replacement	of	media	was	required,	the	cultures	were	less	likely	to	dry	out	using	the	
ring	devices	than	without	given	that	a	larger	volume	of	media	could	be	dispensed	when	
airlifting.	The	ring	devices	were	designed	and	made	by	JB,	at	the	University	of	Liverpool	
workshop	services.	During	the	airlifting	culture	phase	of	experiments,	media	was	
replaced	once	to	twice	per	day.		
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Figure	15:	Photographs	of	the	ring	device	and	the	placement	of	these	ring	devices	within	
culture	plates	to	enable	airlifting	of	cultures.	a)	This	ring	shaped	device	was	designed	and	made	
by	University	of	Liverpool	workshop	services	(JB).	This	was	sized	to	enable	the	cell	crown	to	be	
positioned	6mm	above	the	base	of	the	well	plate.	Media	was	dispensed	within	this	gap,	filling	
the	well	to	the	air-liquid	interface	for	the	airlifting	of	cultures.	b)	This	photograph	shows	a	12-
well	plate	with	the	ring	device	in	each	well.	This	holds	the	cell	crowns	6mm	above	the	base	of	
each	well.	These	were	used	for	cell	culture	experiments	involving	the	ePTFE	substrates.		
	
	
2.4	 Cell	culture	and	characterisation	experiments	to	assess	synthetic	
substrates	
2.4.1	 Cell	seeding	density	
Cell	seeding	density	experiments	were	undertaken	to	determine	an	optimal	seeding	
density	for	all	subsequent	experimental	work.	Cell	culture	protocols	used	for	HCjE-Gi	
cells	describe	a	change	in	media	after	7	days	in	culture	when	cells	are	75-100%	
confluent.	This	was	therefore	the	optimal	goal	to	reach.	The	substrates	used	for	this	
experiment	were	ePTFE	that	was	ammonia	plasma	treated	on	the	inner	surface	(cell	
culture	surface),	untreated	ePTFE	and	PET	(polyethylene	terephthalate)	membrane	in	
triplicate.	Cells	were	seeded	on	triplicates	of	substrates	at	a	density	of	1x103,	1x104	and	
1x105	cells/cm2.	Cultures	were	fixed,	stained	with	DAPI	(4',	6-diamidino-2-phenylindole,	
a)	
b)	
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Sigma),	and	photomicrographs	taken	(Nikon	TiE,	Japan)	after	1,4	and	7	days	in	culture.	
The	number	of	cells	per	area	from	5	random	areas	of	each	sample	were	manually	
counted	for	each	of	the	substrates	in	triplicate	and	expressed	as	the	mean	per	sample	
per	substrate.	Each	photographed	field	was	acquired	using	the	x20	magnification	
microscope	lens	which	produced	a	photograph	with	a	surface	area	of	12,420μm2.	
	
2.4.2	 Optimisation	of	media	protocol	
Established	cell	culture	protocols	using	HCjE-Gi	cells	describe	a	change	in	media	from	
an	‘early	grow’	(media	1)	to	a	‘late	grow’	(media	2)	formulation	once	75-100%	
confluent.	Given	that	the	substrates	used	were	opaque,	the	cell	density	could	not	be	
assessed	without	risk	of	damage	to	cells.	A	number	of	cell	culture	protocols	were	
therefore	tested	using	HCjE-Gi	cells	seeded	at	1x105/cm2	on	the	ammonia	plasma	
treated	ePTFE,	untreated	ePTFE	(negative	control)	and	PET	membrane	(positive	
control)	in	triplicate	to	determine	a	suitable	media	protocol	for	the	culture	of	HCjE-Gi	
cells	on	ePTFE.	Media	protocols	were:	A)	media	2	only;	B)	media	1	for	7	days	followed	
by	media	2;	C)	media	1	for	3	days	followed	by	media	2;	D)	media	1	with	1%	BSA	
(Sigma).	Cultures	were	fixed	and	stained	with	phalloidin	and	DAPI	after	1,3,7,10	and	14	
days	in	culture.	The	number	of	cells	per	area	from	5	random	areas	of	each	sample	were	
manually	counted	for	each	of	the	substrates	in	triplicate	and	expressed	as	the	mean	
per	sample	per	substrate.		
	
2.4.3	 Comparing	cell	counts	on	ePTFE	with	ammonia	plasma	treatment	on	
one	and	both	sides	
Cell	counts	were	repeated	on	a	further	experiment	that	was	repeated	on	three	
separate	occasions	with	triplicate	samples	within	each	experimental	group.	This	was	
undertaken	to	determine	with	greater	accuracy	the	cell	density	that	would	develop	on	
each	of	the	test	substrates	over	a	period	of	28	days.	It	was	also	unknown	whether	
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exposing	the	ePTFE	to	ammonia	gas	plasma	within	the	gas	plasma	resonator	on	one	
side	only	or	both	sides	would	result	could	influence	the	cell	density.	This	variable	was	
also	therefore	introduced.	Cell	counts	were	undertaken	following	2,	14,	21	and	28	days	
in	culture	using	the	haemocytometer	method	to	determine	the	number	of	cells	found	
on	the	substrate	per	cm2	following	disassociation.	Cultures	were	also	fixed	and	stained	
with	DAPI,	phalloidin,	and	UAE-1	(Ulex	Europaeus	lectin;	Genetex)	at	all	time	points	
studied	and	representative	photomicrographs	taken	using	a	fluorescence	microscope	
(Nikon)	and	confocal	imaging	system	(Zeiss	LSM	510).		
	
2.4.4	 Fixation	of	substrate	cultures	and	staining	with	fluorescent	markers	
Samples	used	for	staining	were	cultured	in	triplicate	and	fixed	at	the	time	points	
measured	in	the	experiment.	Optimal	methods	for	fixation	and	permeabilisation	were	
determined	together	with	the	optimal	concentration	of	staining	agents:	UAE-1	lectin,	
phalloidin	and	DAPI	(Table	2).	Fixation	was	undertaken	with	4%	paraformaldehyde	
(Sigma)	for	10	minutes	prior	to	staining	samples	with	phalloidin.	Samples	were	also	
stained	with	ice-cold	methanol	(Sigma)	for	10	minutes	prior	to	staining	with	UAE-1	
lectin	(Genetex).	Substrates	were	washed	three	times	in	phosphate	buffered	saline	
(PBS;	Invitrogen)	prior	to	incubation	with	phalloidin	or	UAE-1	lectin	stains	at	varying	
concentrations	as	in	Table	2,	both	for	1	hour	at	room	temperature.	Substrates	were	
subsequently	washed	three	times	in	PBS	and	stained	with	DAPI	for	10	minutes.	Stained	
cells	were	imaged	using	confocal	microscopy	(Zeiss	LSM	510).		
	
Staining	agent	 Supplier	 Dilution	
DAPI	 Thermo	fisher	 1:1000	
Phalloidin	 Abcam		 1:1000	
UAE-1	Lectin	 Vector	labs	 1:500	
	
Table	2:	Details	of	fluorescent	staining	agents	with	their	optimised	dilutions	used	for	the	
analysis	of	cell	cultures	developed	on	synthetic	substrates.		
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2.4.5	 Determining	cell	density	using	a	haemocytometer	
Cells	were	dissociated	from	the	substrates	using	0.05%	trypsin-EDTA	(Sigma)	under	
incubation	at	37°C	with	5%	carbon	dioxide	for	5	minutes.	The	removal	of	all	cells	from	
the	substrates	was	confirmed	by	the	absence	of	DAPI	staining	of	substrates	following	
the	removal	of	dissociated	cells.	Cells	suspended	in	a	known	volume	were	counted	
using	a	haemocytometer.	A	20μl	solution	was	placed	within	the	haemocytometer	
counting	chamber,	viewed	under	a	phase	contrast	microscope	and	counted	within	each	
of	the	four-1mm2	corner	squares	of	the	grid	and	the	mean	number	of	cells	in	1mm2	
calculated.	All	cells	within	the	grid	were	counted	together	with	those	in	contact	with	
the	top	and	left	side	of	all	border	gridlines.	Cells	in	contact	with	the	bottom	and	right	
side	of	the	border	gridlines	were	not	included	as	per	standard	practice.		
	
2.4.6	 Flow	cytometry		
The	data	collected	by	flow	cytometry	can	be	presented	in	histogram	format	of	a	single	
parameter,	emission	wavelengths	or	in	dot	plots	or	density	plots	that	display	the	
correlation	between	two	parameters.	The	software	(Flowing	2.5,	Turku	Centre	for	
Biotechnology)	allows	the	selection	of	one	or	more	cell	populations	of	interest	for	
quantification	in	terms	of	the	percentage	of	cells	that	it	represents.	All	the	cell	markers	
used	in	this	study	were	intracellular	markers.	The	HCjE-Gi	cells	required	dissociation	
from	their	culture	substrate	with	TryPLE	for	10	minutes	at	37oC.	Following	dissociation,	
the	cells	were	fixed	with	2%	paraformaldehyde	for	10	minutes	and	then	washed	three	
times	by	mixing	the	cells	in	wash	buffer	(gentle	vortex)	and	centrifugation.	The	wash	
buffer	comprised	1%	BSA	(w/v)	and	0.1%	sodium	azide	(w/v)	and	centrifugation	at	
1000rpm/180g	for	5	minutes	was	undertaken.	Cells	were	then	resuspended	in	ice-cold	
methanol	for	30	minutes	at	4oC.	Cells	were	subsequently	blocked	using	10%	goat	serum	
for	30	minutes	at	room	temperature.		
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Primary	antibody	incubation	was	in	1%	goat	serum	for	1	hour	at	4oC.	All	incubation	
steps	were	for	30	minutes	at	4oC.	Following	primary	incubation	with	the	CK19,	CK7,	
MUC5AC	and	CK4	antibodies,	cells	were	stained	with	the	secondary	antibody	
(secondary	incubation	step)	with	goat	anti-mouse	IgG	H&L	Alexafluor	405	(ab175660,	
Abcam)	at	a	dilution	of	1:500.	Cells	with	the	primary	antibodies	ΔNp63	and	caspase-3	
were	stained	with	the	donkey	anti-rabbit	Alexafluor	647	(Poly	4064,	Biolegend)	
secondary	antibody	at	a	dilution	of	1:1000.	An	additional	incubation	step	using	FITC-
conjugated	UAE-1	lectin	(Vector	labs)	at	a	dilution	of	1:500	was	undertaken	for	all	
samples	stained	with	cytokeratin	and	MUC5AC	primary	antibodies.		Cells	were	washed	
three	times	between	each	of	the	steps	described.	The	optimal	dilution	for	each	
antibody	was	initially	determined	by	testing	a	range	of	primary	and	secondary	antibody	
dilutions	along	with	the	isotype	control	at	corresponding	dilutions	to	that	of	the	
primary	antibody;	rabbit	IgG	isotype	control	(Thermo	Fisher	Scientific),	mouse	IgG1	
isotype	control	(ab91353,	Abcam),	Mouse	IgG2	isotype	control	(ab91361,	Abcam).		
	
	
Antibody	 Clone	 Supplier	 Dilution	
CK19	 Ab52625	 Abcam	 1:100	
CK7	 RCK105	 Abcam	 1:100	
CK4	 6B10	 Abcam	 1:50	
MUC5AC	 45MI	 Abcam	 1:25	
ABCG2	
(FITC	conjugated)	
5D3	 Millipore	 1:25	
p63	 ΔN	 Biolegend	 1:50	
caspase-3	 Asp-175	 Cell	Signalling	 1:50	
PCNA	
(FITC	conjugated)	
PC10	 Santacruz	 1:50	
	
Table	3:	Table	of	antibodies	used	for	flow	cytometry	with	the	respective	clone,	supplier	and	
optimised	dilution		
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2.4.7	 Validation	experiment	to	ensure	appropriate	use	of	the	HCjE-Gi	cell	line	
A	preliminary	experiment	was	undertaken	to	ensure	that	immunological	detection	of	
the	caspase-3	antibody	by	flow	cytometry	would	increase	in	HCjE-Gi	cells	grown	under	
environmental	stress.	Cultures	of	HCjE-Gi	cells	grown	on	tissue	culture	that	had	been	
deprived	of	fresh	media	for	one	week	and	left	outside	the	incubator	at	room	
temperature	for	24	hours	were	compared	with	HCjE-Gi	cells	cultured	under	optimal	
conditions	(media	replaced	every	2-3	days	and	kept	in	a	cell	culture	incubator	in	air	
with	5%	CO2).		Quantitative	assessment	of	caspase-3	expression	by	flow	cytometry	was	
undertaken	using	methods	described	in	section	2.4.6.		
	
The	cell	line	was	also	validated	to	ensure	that	the	expression	of	all	the	cell	markers	
used	in	this	study	did	not	vary	significantly	with	the	passage	of	cells	used.	Cells	of	
passage	2	and	28	were	analysed	by	flow	cytometry	using	the	full	panel	of	antibodies	
(section	2.4.6,	Table	3)	after	14	days	culture	using	standard	culture	protocols	that	
described	in	section	2.2.1.		The	cells	were	cultured	on	tissue	culture	plates	in	triplicate	
for	each	cell	marker	studied.		
	
2.4.8	 Assessing	the	phenotype	of	cultures	with	advancing	time	and	by	
substrate	
An	experiment	was	undertaken	to	determine	the	phenotype	of	HCjE-Gi	cells	and	their	
subpopulations	with	advancing	time	in	culture	on	tissue	culture	polystyrene	and	on	test	
substrates.	The	test	substrates	studied	were:	treated	ePTFE	exposed	to	ammonia	gas	
plasma	(section	2.1.1)	on	a)	one	side	(single	side	treatment)	and	b)	both	sides	(double	
side	treatment),	PET	membrane	(positive	control)	and	untreated	ePTFE	(negative	
control).	HCjE-Gi	cells	were	seeded	at	a	density	of	1x105/cm2.	Samples	were	analysed	in	
three	separate	experimental	sessions	for	each	marker	studied	after	14	and	28	days	in	
culture.		
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An	equivalent	similar	experiment	was	also	undertaken	using	primary	conjunctival	cells.	
The	cells	were	cultured	from	conjunctival	explants	expanded	on	tissue	culture	
polystyrene	as	described	for	expansion	on	decellularised	tissue	(section	2.2.2.1)	over	a	
10-day	period.	Cells	were	subsequently	dissociated	and	seeded	at	a	density	of	
1x105/cm2	on	double	side	treated	ePTFE	and	PET	substrates.	The	untreated	ePTFE	and	
single	side	ammonia	plasma	treated	ePTFE	from	previous	experiments	could	not	be	
used	in	this	experiment	owing	to	the	low	cell	number	available	for	this	experiment	and	
the	necessity	for	significant	cell	numbers	per	sample	required	to	obtain	reliable	results	
by	flow	cytometry.	The	experiment	was	undertaken	on	three	separate	occasions	using	
tissue	from	a	different	donor	for	each	experimental	run.		
	
The	cells	were	fixed	and	analysed	by	flow	cytometry	for	a	range	of	conjunctival	
epithelial	markers	after	14	and	28	days	in	culture.	Co-staining	of	CK7	with	UAE-1	lectin	
and	ABCG2	with	ΔNp63	(see	section	2.4.6)	was	quantified	by	setting	the	appropriate	
voltage	gate.	The	gate	determined	the	percentage	of	cells	with	dual	fluorochrome	
staining	via	a	2-parameter	dot	plot	where	the	gates	were	determined	with	prior	
analysis	of	single	parameter	histograms.	For	all	other	samples	in	which	there	was	only	a	
single	antigen	of	interest,	histograms	were	used	for	quantification.	Flowing	software	
version	2.5	was	used	for	all	analyses.	
	
	
2.5	 Decellularisation	of	human	conjunctiva	and	its	characterisation	
2.5.1	 Decellularisation	of	human	conjunctiva		
A	protocol	for	the	decellularisation	of	human	conjunctiva	was	developed	by	adaptation	
of	an	existing	protocol	by	variation	of	a	range	of	sodium	dodecyl	sulphate	(SDS)	
dilutions.	The	original	protocol	based	on	a	previously	optimised	protocol	for	the	
decellularisation	of	human	amniotic	membrane	at	NHS	Blood	and	Transplant.(87)	Fresh	
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or	frozen	conjunctival	tissue	(at	-40°C)	was	allowed	to	thaw	at	room	temperature	and	
washed	in	distilled	water	at	200rpm	at	25°C	and	placed	in	a	hypotonic	buffer	(0.1%	
EDTA,	10mM	TRIS,	1%	penicillin-streptomycin)	at	200rpm	at	4°C	for	21	hours.	The	
tissue	was	then	placed	in	a	detergent	buffer	(10mM	MgCl2,	10mM	TRIS,	0.05-0.5%	SDS,	
0.1%	EDTA,	pH	8,	1%	penicillin-streptomycin)	at	25°C	for	24	hours,	agitated	in	an	orbital	
incubator	(Table	4).	Tissue	were	washed	three	times	in	a	wash	buffer	(PBS,	0.1%	EDTA)	
and	placed	in	a	nuclease	buffer	(1U/ml	benzonase,	10mM	MgCl2,	50	mM	TRIS,	pH	8,	
1%	penicillin-streptomycin)	for	37°C	for	3	hours	at	200rpm	(Table	4).	Tissues	were	
washed	twice	for	20	minutes	at	200rpm	at	25°C	in	the	wash	buffer	and	finally	twice	at	
20	minutes	in	PBS	with	1%	penicillin-streptomycin.		
	
	
Reagent		 Source	
Sterile	water	for	irrigation	 Baxter	
Tris	buffered	isotonic	saline	(TBS)	 Inverclyde	
NaCl	 Sigma	
EDTA	disodium	salt	 VWR	
TRIS	 VWR	
MgCl2	 VWR	
HCl	37%	 VWR	
NaOH	 Sigma	
Penicillin/streptomycin	 Sigma	
Benzonase		 Novogen	
	
	
Table	4:	Table	of	reagents	used	for	decellularisation	and	their	source.		
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2.5.2	 DNA	extraction	and	quantification	
A	5mm	trephine	(5mm)	was	used	to	cut	triplicate	samples	of	tissue	and	each	sample	
weighed.	DNA	extraction	was	undertaken	using	a	commercially	available	kit	(Easy-
DNATM	gDNA	purification	kit,	Invitrogen,	UK)	using	a	previously	described	protocol	
using	Easy-DNA	solutions	and	chloroform.(173)	In	brief,	samples	were	incubated	in	an	
orbital	incubator	(225rpm)	for	20	hours	at	60°C	with	in	a	protein	degradation	solution.	
The	supernatant	following	centrifugation	was	used	for	DNA	precipitation.	This	involved	
using	100%	and	80%	ethanol	suspensions	and	chloroform	with	repeated	centrifugation	
steps	using	the	upper	aqueous	phase	prior	to	digestion	with	RNAse	(Easy	DNATM	kit,	
Invitrogen).	DNA	quantification	was	achieved	using	a	commercially	available	kit	
(PicoGreen,	Invitrogen)	and	a	standard	curve	was	drawn	following	the	preparation	of	a	
range	of	calf	thymus	DNA	standards,	also	stained	with	PicoGreen.	The	DNA	in	cellular	
and	decellularised	samples	was	quantified	following	the	acquisition	of	fluorescence	
readings	(FLX	800	microplate	fluorescence	reader,	Biotek,	UK)	whereby	absorbance	
units	were	converted	to	the	equivalent	corresponding	DNA	concentration	using	the	
standard	curve	from	the	same	experimental	run.			
	
DNA	quantification	was	undertaken	to	determine	the	DNA	in	cellular	conjunctiva	and	
the	resulting	tissue	subjected	to	three	variations	in	the	decellularisation	process	based	
upon	the	SDS	dilution	used.	Tissue	samples	were	obtained	from	each	experimental	
group:	cellular	(untreated)	conjunctival	tissue	and	treatment	groups:	0.05%,	0.1%	and	
0.5%	SDS	(w/v).	Three	experimental	repeats	were	used	for	each	of	the	tissues	sections,	
which	in	turn	were	also	taken	in	triplicate	from	each	experimental	group	(n=9	for	each	
test	group).	The	standard	curve	measurement	and	calculations	were	repeated	for	a	
subsequent	experiment	using	only	the	0.05%	(w/v)	SDS	decellularisation	protocol	with	
conjunctival	tissue	from	three	separate	donors	in	triplicate	with	experimental	repeats	
as	described	earlier.	This	was	undertaken	to	ensure	reproducibility	of	the	
decellularisation	process	using	0.05%	(w/v)	SDS.		
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2.5.3	 Collagen	denaturation		
A	collagen	denaturation	assay	was	undertaken	whereby	hydroxyproline,	a	product	of	
collagen	denaturation,	was	detected	through	colorimetric	absorbance	values	using	a	
previously	described	technique.(173)	In	brief,	three	tissue	samples	from	each	test	group	
were	used	with	triplicate	experimental	repeats	from	each	tissue	sample	(n=9	for	each	
test	group	studied).	A	5mm	trephine	was	used	to	cut	tissue	biopsies.	A	subgroup	of	
samples	were	treated	with	0.1N	NaOH	for	16	hours	at	25°C	and	used	as	the	positive	
control	whereas	samples	treated	with	50mM	gluteraldehyde	at	25°C	were	used	as	
negative	controls	for	hydroxyproline	estimation.	The	test	samples	were	treated	with	
10mg/ml	alpha-chymotrypsin	for	24	hours	at	37°C.	Denatured	collagen	results	in	the	
release	of	hydroxyproline	into	the	supernatant	along	with	a	corresponding	colour	
change	using	Elrich’s	reagent.	Controls	with	pre-determined	hydroxyproline	
concentrations	and	samples	were	similarly	treated	as	follows:	12N	HCL	was	added	to	a	
sample	of	each	supernatant	and	autoclaved	for	60	minutes	at	121°C	18	psi.	Chloramine	
T	reagent	was	then	added	to	each	sample	at	25°C	for	25	minutes.	The	subsequent	
addition	of	Elrich’s	reagent	at	65°C	for	20	minutes	results	in	a	colour	change	that	
corresponds	to	the	concentration	of	hydroxyproline	in	solution.	Quantification	of	
hydroxyproline	was	undertaken	using	a	microplate	reader	(ELX	808,	Biotek,	UK)	
whereby	a	standard	curve	was	drawn	from	known	similarly	treated	serial	dilutions	of	
the	hydroxyproline	control.		
	
2.5.4	 In	vitro	contact	cytotoxicity	testing		
A	standard	method	for	determining	contact	cytotoxicity	was	employed	as	outlined	by	
the	Biological	evaluation	of	medical	devices-	part	5	(2009);	ISO	10993-5.	Conjunctival	
tissue	decellularised	with	0.05%	SDS	(w/v)	(section	2.5.1)	was	tested	for	evidence	of	
cytotoxicity	in	vitro	using	a	culture	of	primary	human	skin	fibroblasts	(kindly	donated	
by	S.Rathbone,	NHS	Blood	and	transplant,	Liverpool)	and	a	human	conjunctival	cell	line	
(HCjE-Gi	cells)	in	triplicate.	A	disposable	5mm	trephine	was	used	to	divide	sections	of	
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decellularised	tissue,	which	were	attached	to	24-well	plates	with	SteristripsTM	(3M,	UK).	
Cyanoacrylate	glue	(RS	components,	UK)	and	Steri-stripsTM	alone	were	used	as	negative	
and	positive	controls	respectively.	All	samples	were	tested	in	triplicate	and	against	two	
cell	types:	primary	human	skin	fibroblasts	and	HCjE-Gi	cells.	1x105	cells	were	seeded	in	
each	well	and	incubated	for	48	hours	in	a	cell	culture	incubator	with	air	and	5%	CO2	at	
37°C.	HCjE-Gi	cells	culture	was	undertaken	using	earlier	described	methods	(section	
2.2.1).	Primary	human	skin	fibroblasts	were	cultured	in	DMEM	(Sigma),	10%	Foetal	calf	
serum	(Sigma),	1%	penicillin/streptomycin	(Invitrogen).	After	48	hours	in	culture	the	
samples	with	fixed	in	serial	ethanol	dilutions:	50%,	70%,	and	100%,	each	for	5	minutes	
at	room	temperature.	After	removal	of	the	100%	ethanol,	the	samples	were	allowed	to	
air	dry	before	20%	Giemsa	solution	(Sigma)	was	added	for	5	minutes	at	room	
temperature.	The	samples	were	then	rinsed	in	distilled	water	and	photographed	on	an	
inverted	microscope	(Leica	090-135-002,	UK).		
	
2.5.5	 Biomechanical	testing		
Tensile	strength	testing	is	an	important	test	in	the	field	of	material	science	in	which	a	
material	is	subjected	to	tension	at	a	controlled	rate	until	the	material	is	deformed	
beyond	repair	and	eventually	breaks.	The	tension	is	applied	by	placing	the	sample	
between	two	clamps	holding	the	tissue	that	move	apart	at	a	controlled	rate.	The	
elongation	of	the	material	is	measured	against	the	force	applied.	The	change	in	gauge	
length	is	used	to	calculate	the	engineering	stress	σ	through	the	following	equation:	
	
	σ=Force	(newtons)	/Cross	section	area	(m2)										
	
Strain	(ε)	is	defined	as	the	deformation	of	the	material	due	to	strain	and	can	be	
expressed	as	the	following	equation:		
	
	 ε=	change	in	length	(extension)/original	length	
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Young’s	modulus	of	elasticity	is	the	resistance	that	a	given	material	has	to	deformation	
in	an	elastic	(non-permanent)	manner	when	a	tensile	force	is	applied.	It	is	determined	
by	the	stress	and	strain	defined	by	the	following:		
	 E=	σ/	ε	
	
The	Lloyd	Instruments	Universal	Testing	machine	(LRX	plus,	Lloyds	instruments,	UK	was	
used	to	determine	the	tensile	strength	of	tissue	samples.	Conjunctival	sections	were	
divided	into	approximately	15mm	x	3mm	sections	and	held	within	clamps.	The	
thickness,	length	and	width	of	each	sample	were	individually	measured	with	Vernier	
callipers	(Digimatic	CD-6”C,	Mitutoyo	UK;	resolution	0.01mm).	Three	measurements	of	
width	and	thickness	were	taken	from	each	sample	and	the	average	thickness	
calculated.	Each	sample	was	pulled	with	a	5N	load	cell	and	data	including	stress,	strain	
and	elastic	modulus	were	generated	by	Nexgen	software	(Canada).	A	minimum	of	4	
samples	were	tested	from	3	different	donors	(n=15	and	n=14	respectively)	from	each	of	
the	cellular	and	decellularised	tissue	test	groups.		
	
	
2.6	 Histology	and	immunohistochemistry	decellularised	tissues	and	
recellularised	constructs	
2.6.1	 Preparation	of	tissues	for	histology	and	immunohistochemistry	
Tissue	samples	were	unfolded	into	1x1cm	tissue	biopsy	capsules	(Cell	Safe,	Leica)	and	
fixed	by	immersion	in	4%	paraformaldehyde	for	24	hours.	The	tissue	biopsy	capsules	
were	then	placed	into	tissue	histology	cassettes	and	were	processed	through	a	
histology	tissue	processor	(Citadel	2000,	Thermo	Shandon,	UK)	over	a	20	hour	cycle	
comprising	serial	immersion	in	3.7%	neural	buffered	formaldehyde	(Sigma),	100%	
ethanol,	xylene	(Leica)	and	Formula	R	paraffin	(Surgipath,	UK).	Tissue	samples	were	
removed	from	the	tissue	biopsy	capsules	following	tissue	processing	and	embedded	in	
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a	paraffin-embedding	unit	(Shandon,	UK).	Following	wax	embedding,	5-10μm	samples	
were	cut	using	a	microtome	(Finesse	325,	Thermo	Shandon,	UK).	Sections	of	5-10μm	
were	used	in	preference	to	thinner	sections.	Mounting	and	staining	with	thinner	
sections	(2-5μm)	was	initially	attempted,	however,	problems	were	encountered	
including	poor	adhesion	to	slides,	shearing	and	loss	of	the	tissue,	which	prevented	
further	analysis.	Triplicate	samples	were	taken	from	at	least	three	separate	areas	of	the	
tissue	sections.	Tissue	sections	were	mounted	onto	silanised	glass	slides	(Dako)	after	
placing	the	tissue	sections	in	an	electrothermal	tissue	float	bath	(Cole-Parmer)	at	40°C.	
Wet	mounted	slides	were	placed	onto	an	electrothermal	slide	drying	bench	at	45°C	for	
10	minutes	before	leaving	overnight	in	a	drying	oven	at	37°C.		
	
2.6.2	 Histology		
Tissue	sections	were	deparaffinised	using	a	standard	method	of	serial	immersion	into	5	
minutes	in	xylene	(Leica)	and	then	100,	90	and	70%	ethanol	washes.	Staining	with	
Haematoxylin	and	Eosin	(H&E,	Leica)	was	performed	for	10	minutes,	rinsed	in	running	
tap	water,	dipped	in	1%	acid-alcohol	(Leica),	rinsed	in	running	tap	water	and	immersed	
in	Eosin	(Leica)	for	5	minutes.	The	slides	were	rinsed	again	in	running	tap	water,	and	
dehydrated	by	serial	immersion	into	ethanol	70,	90	and	100%	in	30	second	intervals	
prior	to	further	placement	into	xylene	for	10	minutes	before	mounting	onto	glass	slides	
with	DPX	(Sigma)	and	glass	coverslips	(Thermo	Scientific).		
	
Staining	with	Periodic	acid	Schiff	(Sigma)	was	undertaken	by	de-parrafinisation	as	
described	above	before	slides	were	immersed	in	Periodic	Acid	Solution	for	5	minutes,	
rinsed	three	times	in	distilled	water,	immersed	in	Schiff’s	reagent	for	15	minutes	and	
finally	washed	in	running	tap	water.	Glass	coverslips	were	mounted	as	previously	
described.		
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Staining	with	van	Gieson’s	stain	was	undertaken	on	deparaffinised	and	dehydrated	
tissue	sections.	Slides	were	placed	in	Van	Gieson’s	stain	(Surgipath,	UK)	for	5	minutes	
and	then	rinsed	in	running	tap	water.	Similarly,	staining	with	DAPI	(4',	6-diamidino-2-
phenylindole)	was	undertaken	following	deparaffinisation	and	dehydration,	before	
mounting	the	slides	with	fluorescent	mounting	medium	(Dako).		
	
Tissue	sections	were	examined	and	imaged	using	an	Olympus	BX60	microscope	
(Olympus,	UK)	and	photomicrographs	taken	of	representative	sections	from	a	
minimum	of	9	stained	tissue	sections	from	each	tissue	block	studied.		
	
2.6.3	 Immunohistochemistry		
Several	antigen	retrieval	methods	were	tested	on	tissues	for	each	studied	antibody	to	
identify	the	optimal	method.	The	methods	included	incubation	with	trypsin	for	30	
minutes	at	37oC,	incubating	with	0.01M	citrate	acetate	buffer	pH6	(Sigma)	in	a	
microwave	for	5-15	minutes,	and	immersion	in	target	retrieval	solution	(Dako)	for	5-20	
minutes	in	a	water	bath	at	95oC.	The	optimal	method	for	all	antibodies	studied	was	the	
target	retrieval	solution	method.	Slides	were	washed	between	each	step	in	a	wash	
buffer	comprising	0.05%	tween	(Sigma),	8.76	%	NaCl	(Sigma),	6.05%	TRIS	(VWR),	pH	
7.6.	Immunohistochemical	staining	was	undertaken	using	the	EnvisionTM	kit	HRP	anti-
mouse/rabbit	(Dako).	Slides	were	incubated	with	a	peroxidase	block	(0.03%	hydrogen	
peroxide,	EnvisionTM	kit)	for	10	minutes,	followed	by	blockage	with	20%	goat	serum	to	
prevent	non-specific	binding	for	30	minutes	(Dako)	prior	to	incubation	with	primary	
antibodies	at	varying	dilutions	(Table	5)	for	3	hours	at	room	temperature.	The	
appropriate	secondary	anti-mouse/rabbit	horseradish	peroxidase	(EnvisionTM	kit)	was	
placed	on	tissue	samples	for	30	minutes	at	room	temperature.	The	chomogen,	3-
amino-9-ethylcarbazole	(AEC,	EnvisionTM	kit)	produced	pigmentation	of	the	immune-
positive	areas	on	tissue	samples	over	5-10	minutes.		Slides	were	mounted	in	Aquatex	
mounting	media	(Merck	Millipore)	and	imaged	on	an	Olympus	BX60	microscope.	A	
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representative	photograph	was	taken	from	the	centre	of	each	stained	tissue	section	
from	a	minimum	of	9	tissue	sections.		Each	section	was	taken	from	triplicate	tissue	
samples	each	from	three	separate	areas	of	the	paraffin	embedded	tissue	block.		
	
Antibody	 Clone	 Supplier	 Dilution	
CK19	 Ab52625	 Abcam	 1:400	
CK7	 RCK105	 Abcam	 1:500	
CK4	 6B10	 Abcam	 1:200	
ABCG2	 BXP-21	 Millipore	 1:50	
p63	 ΔN	 Biolegend	 1:50	
Caspase-3	 CPP-32	 Cell	Signalling	 1:50	
PCNA	 PC10	 Santacruz	 1:50	
Laminin	 L9393	 Sigma	 1:200	
Fibronectin	 F3648	 Sigma	 1:250	
Collagen	IV	 Ab19808	 Abcam	 1:400	
	
Table	5:	Table	of	antibodies	used	for	immunohistochemistry	with	the	respective	clone,	supplier	
and	optimised	dilution		
	
	
2.7	 Recellularisation	of	decellularised	conjunctiva	with	primary	
conjunctival	epithelium	
2.7.1	 Explant	culture	experiments	with	and	without	the	orientation	of	
basement	membrane	of	conjunctiva	
Initial	experiments	were	undertaken	using	conjunctival	tissue	in	which	the	orientation	
and	presence	of	basement	membrane	had	not	been	confirmed	or	marked	prior	to	the	
decellularisation	process.	In	subsequent	experiments,	the	conjunctiva	was	examined	
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under	a	microscope	to	confirm	the	presence	of	conjunctiva	(rather	than	tenon’s	or	
adipose	tissue)	and	was	marked	by	placing	5/0	nylon	sutures	on	the	shinier	side	of	the	
membrane	in	an	attempt	to	orientate	the	basement	membrane	following	
decellularisation.	Five	explants	were	taken	from	a	single	donor	seeded	on	each	
substrate	(i)	basement	membrane	present	and	(ii)	basement	membrane	not	
present/not	easily	identifiable,	in	triplicate.	
	
2.7.2	 Comparison	of	conjunctival	epithelial	cultures	using	tissue	from	
different	donors	for	explants	and	decellularised	substrates	
This	experiment	was	undertaken	to	explore	the	variability	in	explant	tissue	outgrowth	
and	whether	the	decellularised	tissue	itself	has	any	influence	on	the	degree	of	
outgrowth.	Decellularised	tissues	that	had	been	stored	at	-40oC	were	thawed	for	use	in	
this	experiment.	Experiments	were	completed	using	triplicate	samples	in	which	
conjunctival	explant	tissue	from	three	separate	donors	(15/17/19)	was	used	on	each	of	
the	decellularised	tissue	samples	from	three	other	donors	(9/5/13).	Following	28	days	
in	culture,	the	tissues	were	fixed	and	paraffin	embedded	as	described	in	section	2.6.1.	
A	minimal	of	3	tissue	sections	was	taken	from	3	areas	in	each	wax	paraffin	block.	
Representative	photographs	from	the	centre	of	the	tissue	sample	were	taken.	Amniotic	
membrane	was	used	as	a	control	tissue	on	which	explants	from	each	of	the	donor’s	
conjunctival	explants	were	cultured.	
	
2.8	 Statistical	analysis	
All	statistical	analysis	was	undertaken	using	SPSS	22.0	(IBM).	Data	was	tested	for	
variance	homogeneity	and	distribution.	A	log	transformation	of	the	data	was	used	to	
meet	the	variance	assumptions	for	the	ANOVA	test.	This	was	used	to	analyse	data	from	
the	following	sets;	contact	angle	analysis,	cell	count,	DNA	content,	and	tensile	strength	
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testing.	Bonferroni	post-hoc	tests	were	applied	to	enable	a	more	detailed	
interpretation	of	the	interactions	between	individual	pairs	of	treatment	groups	in	the	
model.	The	paired	t-test	was	used	to	analyse	hydroxyproline	content	in	the	collagen	
denaturation	test	between	cellular	and	decellularised	samples.		
	
The	ANCOVA	model	for	change	was	used	to	determine	the	effect	of	advancing	time	and	
substrate	on	numerous	cell	markers	assessed	by	flow	cytometry	in	conjunctival	cells.	
The	change	in	percentage	expression	of	a	given	marker	between	day	14	and	28	was	the	
dependent	variable,	and	the	interactions	calculated	for	the	effect	of	substrate	and	time	
with	the	value	at	day	14	as	the	co-variance	factor.	The	Holm-Bonferroni	correction	was	
applied.	This	accounted	for	the	total	number	of	ANCOVA	tests	performed	and	was	
based	upon	an	initial	α	value	of	0.05.	The	uncorrected	p	values	have	been	presented	
but	only	the	p	values	significant	following	Holm-Bonferroni	correction	are	displayed.	In	
tests	where	statistical	significance	was	determined,	post-hoc	contrasts	were	
ascertained	and	a	further	Holm-Bonferroni	correction	was	applied	to	determine	
differences	between	the	substrates	studied.	All	statistical	analyses	undertaken	were	
verified	for	their	appropriateness	by	a	statistician	(GC)	in	The	Department	of	Eye	and	
Vision	Science,	Institute	of	Ageing	and	Chronic	Disease,	University	of	Liverpool.		
	
	
2.9	 Detection	and	monitoring	of	ocular	mucous	membrane	
pemphigoid	patients		
2.9.1	 Developing	a	pro	forma		
A	pro	forma	was	developed	for	the	documentation	of	clinical	signs	in	ocular	mucous	
membrane	pemphigoid	(MMP)	patients	to	facilitate	improved	documentation.	It	was	
developed	in	consultation	with	the	Corneal	and	External	Eye	Disease	team	at	St	Paul’s	
Eye	Unit,	Royal	Liverpool	University	Hospital	NHS	Trust.	The	pro	forma	may	enable	
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clinicians	to	standardise	the	grading	of	clinical	signs	and	also	provides	opportunities	to	
establish	a	database	of	patients	who	may	benefit	from	future	cellular	replacement	
therapies.	Based	on	the	literature	review,	the	Tauber-Kaye	method	was	used.	It	has	
proven	inter-rater	and	intra-rater	reliability	and	offers	additional	quantitative	
information	to	those	of	Tauber,	Mondino	and	Foster.	(156)	The	pro	forma	also	included	
the	traditional	Tauber,	Mondino	and	Foster	grading	systems	together	with	
photography	and	fornix	depth	measurement	using	a	fornix	ruler	to	determine	whether	
there	is	any	additional	value	from	these	methods.		
	
All	the	aforementioned	methods	do	not	include	any	documentation	of	the	presence	of	
eyelid	signs,	conjunctival	inflammation	or	corneal	involvement.	Methods	previously	
used	in	clinical	studies	of	conjunctival	inflammation	and	corneal	involvement	and	have	
been	included	in	the	pro	forma.(33,	163)	There	have	been	no	validated	grading	schemes	
for	cicatricial	lid	disease	and	therefore	a	documentation	scheme	was	developed	from	
other	(non-cicatrising)	entropion	and	ectropion	grading	systems	so	that	its	severity	and	
location	(medial/lateral)	could	be	documented.(166,	174)	The	presence	or	absence	of	
lagophthalmos,	trichiasis,	co-existing	ocular	pathology	and	visual	acuity	was	also	
included.		
	
The	aim	of	this	part	of	the	study	was	to	allow	a	small	group	of	patients	with	ocular	
MMP	to	be	assessed	to	enable	discussion	of	potential	treatment	strategies	for	ocular	
surface	reconstruction.	It	also	provided	an	opportunity	to	collect	pilot	data	that	could	
help	inform	further	development	of	the	pro	forma	for	use	in	future	clinical	studies	
(Appendix	1).		
	
2.9.2	 Assessing	MMP	using	the	MMP	pro	forma	
The	purpose	of	the	case	series	was	not	to	obtain	a	representative	sample	of	MMP	
patients	attending	corneal	and	external	eye	disease	clinics	in	general,	but	to	obtain	a	
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small	sample	with	any	ocular	involvement	to	enable	a	small	pilot	study	to	help	develop	
the	MMP	pro	forma.		The	cases	acquired	for	this	study	were	recruited	opportunistically	
over	a	3-month	period.	Patients	attending	a	corneal	and	external	eye	disease	clinic	
(Professor	S	B	Kaye,	St	Paul’s	Eye	Unit,	Royal	Liverpool	University	Hospital)	were	
examined	after	the	purpose	of	the	examination	was	explained	and	consent	obtained.	
Patients	were	examined	at	a	slit	lamp	and	measurements	were	taken	for	the	Foster,	
Tauber,	and	Tauber-Liverpool	grading	schemes	using	a	disposable	ruler.	Corneal	
dryness	grading	scores	were	taken	according	to	the	Oxford	grading	scheme.(158)	The	
corneal	and	lid	grading	was	undertaken	after	examination	according	the	pro	forma.	A	
perspex	fornix	ruler	was	designed	and	produced	by	University	of	Liverpool	workshop	
services	(JB):	Figure	16.	Fornix	depth	measurements	were	taken	after	the	application	of	
proxymetacaine	0.5%	(w/v)	drops	(Minims).	Measurements	were	taken	on	gentle	
insertion	of	the	fornix	rule	to	the	maximum	depth	of	the	upper	and	lower	fornix	at	the	
midline.	
	
	
	
	
	
	
	
	
	
Figure	16:	Photograph	of	the	Perspex	fornix	ruler.	Each	gradation	corresponds	to	1mm.	The	
graded	section	is	inserted	into	the	upper	and	lower	fornices.	The	thickness	of	the	Perspex	
measuring	arm	of	the	fornix	ruler	is	1mm.			
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Chapter	3:	Results		
3.1	 Optimisation	of	culture	methods	for	the	ex	vivo	expansion	of	
conjunctival	epithelium	on	synthetic	substrates	
3.1.1	 Ammonia	plasma	treatment	of	ePTFE	
Untreated	ePTFE	as	received	from	the	manufacturer	is	known	to	be	hydrophobic.	This	
was	apparent	from	the	formation	of	a	spherical	water	droplet	on	its	surface	when	a	
known	volume	was	dispensed.	This	was	in	contrast	to	a	water	droplet	of	the	same	
volume	dispensed	on	ammonia	plasma	treated	ePTFE,	which	assumed	a	flatter	shape,	
exhibiting	greater	spread	on	the	surface	of	the	material.	This	indicated	increased	
wettability	of	the	treated	ePTFE	and	was	confirmed	through	static	contact	angle	
analysis	(Figure	6).	The	contact	angle	of	a	droplet	of	water	formed	on	ammonia	treated	
ePTFE	was	significantly	more	acute	than	those	that	were	untreated	(71.08o	vs.	131.22o	
respectively;	p=0.02).		
	
	 N	 Minimum	 Maximum	 Mean	 +/-SD	
Untreated	
ePTFE	
6	 127.4	 135.9	 131.2	 3.2	
Ammonia	
plasma	treated	
ePTFE	
6	 67.3	 74.8	 71.1	 2.6	
	
	
Table	6:	Static	contact	angle	analysis	of	untreated	and	ammonia	gas	plasma	treated	ePTFE.	Six	
readings	were	taken	from	randomly	selected	areas	on	ammonia	plasma	treated	and	untreated	
ePTFE.	10μl	water	was	automatically	dispensed	and	contact	angle	between	the	water	droplet	
and	material	recorded	by	an	inbuilt	video	recorder.	Statistical	analysis	showed	a	difference	at	a	
p=0.02	level	between	treated	and	untreated	ePTFE.		
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3.1.2	 Cell	seeding	density	analysis		
The	highest	cell	seeding	density	was	demonstrated	on	all	substrates	following	7	days	in	
culture	by	seeding	1x105	cells/cm2	cells	(Figures	17-19).	The	highest	cell	density	was	
noted	on	the	PET	membrane	(Figure	18)	and	lowest	on	the	untreated	ePTFE	(Figure	
19).	Low	cell	density	was	observed	on	untreated	ePTFE,	which	was	approximately	25%	
of	treated	ePTFE,	even	at	the	highest	cell	seeding	density	after	7	days	in	culture.	Cell	
density	on	untreated	ePTFE	was	also	characterised	by	markedly	high	variance	owing	to	
patchy	growth	whereby	cells	were	visualised	on	some	areas	within	a	photographed	
field,	whereas	the	complete	absence	of	cells	was	observed	in	other	areas.	There	was	an	
approximately	4-fold	greater	cell	density	after	7	days	in	culture	on	ammonia	plasma	
treated	ePTFE	when	cells	were	seeded	at	1x105/cm2	compared	to	1x104/cm2.	This	is	in	
contrast	to	PET	membrane	whereby	the	cell	density	after	7	days	in	culture	when	cells	
were	seeded	at	1x104/cm2	was	approximately	75%	of	that	seeded	at	1x105/cm2.	The	
representative	photomicrographs	displayed	evenly	spaced	cell	nuclei	at	a	high	density	
on	the	plasma	treated	ePTFE	at	day	7	(Figure	20).	The	chosen	cell	seeding	density	for	
subsequent	experiments	was	therefore	determined	as	1x105/cm2	for	subsequent	
experimental	work.	Statistical	analysis	by	ANOVA	found	a	significant	association	
between	cells	per	photographed	field	and	time	(p<0.001),	and	cells	per	photographed	
field	and	cell	seeding	density	(p=0.006)	overall	across	all	test	substrates.						
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Figure	17:	Histogram	to	show	number	of	cells	counted	per	photographed	field	with	advancing	
time	and	increasing	cell	seeding	density	on	ammonia	plasma	treated	ePTFE.	This	graph	shows	
the	number	of	cells	counted	manually	in	each	photographed	field	(+/-SD)	at	20x	magnification	
over	set	time	points	(day	1,	4	and	7).	Each	photographed	field	was	12,420μm2.	Five	areas	per	
photographed	field	were	counted	from	triplicate	samples	(n=15	within	each	experimental	
group).		
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Figure	18:	Histogram	to	show	number	of	cells	counted	per	photographed	field	with	advancing	
time	and	increasing	cell	seeding	density	on	PET	membrane.	This	graph	shows	the	number	of	
cells	counted	manually	in	each	photographed	field	(+/-SD)	at	20x	magnification	over	set	time	
points	(day	1,	4	and	7).	Each	photographed	field	was	12,420μm2.	Five	areas	per	photographed	
field	were	counted	from	triplicate	samples	(n=15	within	each	experimental	group).	
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Figure	19:	Histogram	to	show	number	of	cells	counted	per	photographed	field	with	advancing	
time	and	increasing	cell	seeding	density	on	untreated	ePTFE.	This	graph	shows	the	number	of	
cells	counted	manually	in	each	photographed	field	(+/-SD)	at	20x	magnification	over	set	time	
points	(day	1,	4	and	7).	Each	photographed	field	was	12,420μm2.	Five	areas	per	photographed	
field	were	counted	from	triplicate	samples	(n=15	within	each	experimental	group).		 	
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Figure	20:	Representative	photomicrographs	of	cultured	substrates	fixed	and	stained	with	DAPI	
(blue	fluorescent	nuclear	stain)	after	7	days	in	culture.	All	membranes	were	seeded	at	a	density	
of	1x105	cells/cm2:	a)	ammonia	plasma	treated	ePTFE	b)	PET	membrane	c)	untreated	ePTFE.	
Scale	bars	100μm.	
	
3.1.3	 Effect	of	media	on	HCjE-Gi	cell	proliferation	
Four	media	protocols	were	tested	to	determine	an	optimal	protocol	for	the	culture	of	
HCjE-Gi	cells	and	are	outlined	below.	Media	1	was	an	‘early	grow’	formula	whereas	
media	2	was	used	at	a	later	stage	when	70-100%	confluent	to	encourage	stratification	
and	differentiation	(please	see	section	2.2.1	and	2.4.2).	
	
Media	protocol	A:	Media	2	used.	
Media	protocol	B:	Media	1	used	and	changed	to	Media	2	after	7	days.	
Media	protocol	C:	Media	1	used	and	changed	to	Media	2	after	3	days.	
Media	protocol	D:	Media	1	supplemented	with	1%	BSA	used.	
	
Statistical	analysis	by	ANOVA	found	significant	associations	between	cells	per	
photographed	field	and	days	in	culture	(p<0.001),	and	days	in	culture	(p<0.001)	and	
media	protocol	(p<0.001)	overall	across	all	test	substrates.	The	highest	cell	density	was	
demonstrated	when	cells	were	cultured	on	PET	membrane	regardless	of	the	media	
protocol	used	(Figures	21,	23,	25,	27).	Cells	grew	at	the	lowest	density	using	media	
protocol	D	(K-SFM	media	supplemented	with	1%	BSA)	across	all	substrates	(Figure	27).	
c)	a)	 b)	
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Cell	density	was	also	limited	with	the	use	of	media	protocol	A	(media	2	only)	in	which	
cell	density	did	not	rise	above	150	cells/photographed	field	after	14	days	in	culture	on	
any	substrate	(Figure	21).	Furthermore,	the	use	of	media	protocols	A	and	D	resulted	in	
an	overall	decline	in	cell	density	in	contrast	to	protocols	B	and	C	in	which	an	increase	
was	demonstrated	with	advancing	time	across	all	substrates.	Cell	density	was	relatively	
stable	from	the	starting	point	at	day	one	on	PET	membrane	with	use	of	media	protocol	
A,	whereas	the	cell	density	on	treated	and	untreated	ePTFE	declined	from	day	1	to	14.	
This	is	in	contrast	to	cell	density	on	PET	using	media	protocol	D	in	which	a	higher	cell	
density	was	demonstrated	at	day	1,	however,	a	more	rapid	decline	in	cell	density	
occurred	in	comparison	to	treated	and	untreated	ePTFE	where	cell	density	was	lower	
but	more	stable	with	advancing	time	in	culture	(Figure	27).	
	
Media	protocol	B	and	C	(media	1	changed	to	2	at	after	7	and	3	days	respectively)	
resulted	in	a	greater	cell	density	than	with	the	use	of	media	protocols	A	and	D	at	all	
time	points	that	increased	with	advancing	time	in	culture	(Figure	23,	25).	The	greatest	
cell	density	developed	from	the	use	of	media	protocol	B	in	which	cell	density	at	day	14	
was	449	cells/photographed	field	on	ammonia	plasma	treated	ePTFE	and	522	
cells/photographed	field	on	PET	membrane	respectively	(Figure	23).	Cell	density	on	
untreated	ePTFE	reached	approximately	2/3	that	achieved	using	ammonia	plasma	
treated	ePTFE	with	media	protocol	B	(Figure	23).	Cell	density	was	lower	using	media	
protocol	C	across	all	substrates,	however,	increased	with	advancing	time	in	culture	on	
treated	ePTFE	and	PET	membranes	(Figure	25).	A	decline	in	mean	cell	density	was	
apparent	after	7	days	in	culture,	however,	on	untreated	ePTFE	(Figure	25).	Qualitative	
results	from	nuclear	staining	undertaken	in	parallel	with	cell	counts	are	in	keeping	with	
the	described	observations.	Qualitatively,	cells	appear	evenly	spread	across	the	
materials,	demonstrated	by	even	spacing	between	nuclei	demonstrated	by	DAPI	
staining	(Figures	22,24,26,28).	Cells	grown	on	ammonia	plasma	treated	ePTFE	and	PET	
membrane	at	day	14	appeared	confluent	as	demonstrated	by	the	confluence	of	f-actin	
staining	in	contrast	to	the	sparse	cell	growth	observed	on	untreated	ePTFE	(Figure	29).		
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Figure	21:	Histogram	to	show	mean	number	of	cells	counted	per	photographed	field	with	
advancing	time	on	ammonia	plasma	treated	ePTFE,	untreated	ePTFE	and	PET	membrane	using	
media	protocol	A.	Cells	were	seeded	at	1x105/cm2	on	all	substrates.	This	graph	shows	the	
number	of	cells	(+/-SD)	counted	manually	in	each	photographed	field	at	20x	magnification	over	
set	time	points	day	1,3,7,10	and	14.	Each	photographed	field	was	12,420μm2.	Five	areas	per	
photographed	field	were	counted	in	triplicate	samples	(n=15	within	each	group).		
	
	
	
	
	
	
Figure	22:	Representative	photomicrographs	of	DAPI	stained	cells	after	14	days	in	culture	using	
media	protocol	A.	All	substrates	were	seeded	at	a	density	of	1x105	cells/cm2:	a)	ammonia	
plasma	treated	ePTFE	b)	untreated	ePTFE	c)	PET.	Scale	bars	100μm.	
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Figure	23:	Histogram	to	show	the	mean	number	of	cell	photographed	per	photographed	field	
with	advancing	time	on	ammonia	plasma	treated	ePTFE,	untreated	ePTFE	and	PET	membrane	
using	media	protocol	B.	Cells	were	seeded	at	1x105/cm2	on	all	substrates.	This	graph	shows	the	
number	of	cells	(+/-SD)	counted	manually	in	each	photographed	field	at	20x	magnification	over	
set	time	points	day	1,3,7,10	and	14.	Each	photographed	field	was	12,420μm2.	Five	areas	per	
photographed	field	were	counted	in	triplicate	samples	(n=15	within	each	group).		
	
	
	
	
	
Figure	24:	Representative	photomicrographs	of	cultured	substrates	fixed	and	stained	with	DAPI	
after	14	days	in	culture	using	media	protocol	B.	All	substrates	were	seeded	at	a	density	of	1x105	
cells/cm2:	a)	ammonia	plasma	treated	ePTFE	b)	untreated	ePTFE	c)	PET.	Scale	bars	100μm.	
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Figure	25:	Histogram	to	show	the	mean	number	of	cell	photographed	per	photographed	field	
with	advancing	time	on	ammonia	plasma	treated	ePTFE,	untreated	ePTFE	and	PET	membrane	
using	media	protocol	C.	Cells	were	seeded	at	1x105/cm2	on	all	substrates.	This	graph	shows	the	
number	of	cells	(+/-SD)	counted	manually	in	each	photographed	field	at	20x	magnification	over	
set	time	points	day	1,3,7,10	and	14.	Each	photographed	field	was	12,420μm2.	Five	areas	per	
photographed	field	were	counted	in	triplicate	samples	(n=15	within	each	group).		
	
	
	
	
	
Figure	26:	Representative	photomicrographs	of	cultured	substrates	fixed	and	stained	with	DAPI	
after	14	days	in	culture	using	media	protocol	C.	All	substrates	were	seeded	at	a	density	of	1x105	
cells/cm2:	a)	ammonia	plasma	treated	ePTFE	b)	untreated	ePTFE	c)	PET.	Scale	bars	100μm.	
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Figure	27:	Histogram	to	show	the	mean	number	of	cell	photographed	per	photographed	field	
with	advancing	time	on	ammonia	plasma	treated	ePTFE,	untreated	ePTFE	and	PET	membrane	
using	media	protocol	D.	Cells	were	seeded	at	1x105/cm2	on	all	substrates.	This	graph	shows	the	
number	of	cells	(+/-SD)	counted	manually	in	each	photographed	field	at	20x	magnification	over	
set	time	points	day	1,3,7,10	and	14.	Each	photographed	field	was	12,420μm2.	Five	areas	per	
photographed	field	were	counted	in	triplicate	(n=15	samples	within	each	group).		
	
	
	
	
	
Figure	28:	Representative	photomicrographs	of	cultured	substrates	fixed	and	stained	with	DAPI	
after	14	days	in	culture	using	media	protocol	D.	All	substrates	were	seeded	at	a	density	of	
1x105	cells/cm2:	a)	ammonia	plasma	treated	ePTFE	b)	untreated	ePTFE	c)	PET.	Scale	bars	
100μm.	
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Figure	29:	Representative	photomicrographs	of	HCjE-Gi	cells	after	14	days	in	culture	using	
media	protocol	B	on	ammonia	plasma	treated	ePTFE	(a),	untreated	ePTFE	(b)	and	PET	
membrane	(c).	Green	staining	is	phalloidin	(f-actin)	and	blue	nuclear	staining	is	the	result	of	
DAPI	uptake.	Confluent	morphology	was	demonstrated	on	both	treated	ePTFE	and	PET	and	
sparse	growth	found	on	untreated	ePTFE.	Phalloidin	staining	was	abundant	however	individual	
fibres	were	difficult	to	visualise	with	this	stain	on	PET	membrane.	Nuclei	appear	smaller	in	size	
on	the	PET	compared	with	treated	ePTFE	substrates.	Scale	bars	50μm.		
	
3.2	 Ex	vivo	expansion	of	conjunctival	epithelium	on	synthetic	
substrates	
3.2.1	 Comparison	on	cell	density	between	substrates	including	ammonia	
plasma	treatment	of	one	or	both	sides	of	ePTFE	
The	cell	density	at	day	28	was	higher	when	the	ePTFE	was	exposed	to	the	ammonia	gas	
plasma	on	both	sides	of	the	material	rather	than	treatment	only	on	the	side	intended	
for	cell	seeding;	p<0.001	(Figure	30).	This	difference	was	marked	after	14	days	in	
culture.	Cell	counts	at	all	time	points	studied	were	lowest	on	the	untreated	ePTFE	and	
a)	 b)	
c)	
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highest	on	the	PET	membrane	(Figure	30).	Statistically	significant	differences	were	
found	between	all	substrates	studied	(P<0.0001).		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	30:	Cell	density	of	HCjE-Gi	cells	grown	on	ammonia	plasma	treated	ePTFE,	PET	
membrane	and	untreated	ePTFE	with	advancing	time.	Cells	were	cultured	using	media	protocol	
B	seeded	at	1x105/cm2.	Data	has	been	log	transformed	to	allow	parametric	statistical	analysis	
by	ANOVA.	The	overall	model	was	significant	p<0.001	for	the	effect	of	both	time	point	and	
substrate.	Bonferroni	post-hoc	tests	of	the	difference	between	pairs	(both	time	points	an	
substrate)	in	any	combination	were	also	highly	significant;	p<0.001.			
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3.2.2	 Morphology	of	conjunctival	cultures	developed	on	synthetic	substrates	
Along	with	cell	density,	the	morphology	of	cultures	was	also	studied.	F-actin	staining	
demonstrated	by	red	fluorescent	staining	with	phalloidin	together	with	the	blue	
nuclear	staining	from	DAPI	shows	confluent	growth	on	PET	and	treated	ePTFE	towards	
the	mid	to	late	time	points	(Figures	31-37).	Sparse	growth	was	demonstrated	on	
untreated	ePTFE	at	all	time	points	studied.	Phalloidin	staining	was	somewhat	difficult	
to	assess	in	PET	cultures,	as	the	actin	fibres	were	not	visible	as	discretely	as	they	were	
with	cells	imaged	on	ePTFE	substrates.	This	was	overcome	by	UAE-1	lectin,	which	
demonstrated	the	cell	morphology	of	HCjE-Gi	cells	on	all	the	substrates	clearly	by	
staining	of	cell	membranes	together	with	intracellular	mucin	(Figures	38-44).	The	
morphology	of	cells	on	PET	membrane	demonstrated	that	cultured	cells	were	smaller	
in	size	with	proportionally	smaller	nuclei	in	comparison	to	those	cultured	on	ammonia	
treated	ePTFE	indicated	by	the	outline	of	the	cells	through	UAE-1	lectin	staining	(Figure	
40).	The	shapes	of	the	cells	were	epithelioid	and	assumed		‘cobblestone’	morphology	
on	all	the	substrates.	Although	the	cells	and	their	nuclei	were	smaller	on	PET	
membrane,	no	other	significant	morphological	differences	in	HCjE-Gi	cell	morphology	
were	qualitatively	demonstrated	between	PET	and	all	other	ePTFE	substrate	cultures.	
This	was	demonstrated	through	UAE-1	lectin	and	phalloidin	staining	(Figures	31-44).	
Although	the	cells	on	untreated	ePTFE	appeared	‘rounded’	in	appearance	initially,	they	
became	more	epithelioid	in	appearance	with	advancing	time	in	culture	as	the	cell	
density	increased.	The	cell	density	appeared	the	lowest	on	untreated	ePTFE	and	lower	
on	single	sided	treated	than	double	side	treated	ePTFE,	qualitatively,	in	keeping	with	
the	cell	density	analysis	(Figure	30).		 	
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Figure	31:	Representative	photomicrographs	of	nuclear	and	f-actin	staining	of	HCjE-Gi	cells	
cultured	on	ammonia	plasma	treated	ePTFE,	PET	and	untreated	ePTFE	after	2	days	in	culture.	
Cell	size	appears	smaller	on	PET	membranes	however	cell	density	appeared	greatest.	Lowest	
cell	density	was	apparent	on	untreated	ePTFE	with	cells	more	‘rounded’	in	appearance	than	on	
ammonia	plasma	treated	ePTFE	substrates.	Scale	bars	50μm.	
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Figure	32:	Representative	photomicrographs	of	nuclear	and	f-actin	staining	of	HCjE-Gi	cells	
cultured	on	ammonia	plasma	treated	ePTFE,	PET	and	untreated	ePTFE	after	14	days	in	culture.	
Cell	size	appeared	the	smallest	with	greatest	density	on	PET	membrane.	Similar	morphology	
was	apparent	on	treated	ePTFE	and	PET	membrane.		Lowest	cell	density	with	‘rounded’	cells	
was	apparent	on	untreated	ePTFE.	Cultures	were	more	confluent	on	double-side	treated	ePTFE	
than	single	side	treated	ePTFE.	Scale	bars	50μm.	
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Figure	33:	Representative	photomicrographs	of	nuclear	and	f-actin	staining	of	HCjE-Gi	cells	
cultured	on	ammonia	plasma	treated	ePTFE,	PET	and	untreated	ePTFE	after	21	days	in	culture.	
Lowest	cell	density	was	apparent	on	untreated	ePTFE	however	there	is	greater	variation	in	the	
size	and	shape	of	the	nuclear	material	than	on	any	other	substrate.	Cultures	were	more	
confluent	on	double	side	treated	ePTFE	than	following	single	side-treatment	and	cells	appear	
to	have	more	of	cobblestone	morphology	than	on	other	substrates.	Scale	bars	50μm.	
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Figure	34:	Representative	confocal	z-stack	series	of	single	side	ammonia	plasma	treated	ePTFE	
after	28	days	of	HCjE-Gi	cell	culture:	a)	phalloidin	(f-actin	staining)	(b)	DAPI	(nuclear)	staining.	
Five	slices	have	been	taken,	each	in	4.5-5μm	intervals	whereby	the	top	and	bottom	of	the	z-
stack	had	been	manually	set	after	the	focus	points	at	the	top	and	bottom	of	the	cell	cultures	
were	located.	Scale	bars	50μm.	
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Figure	35:	Representative	confocal	z-stack	series	of	double	side	ammonia	plasma	treated	
ePTFE	after	28	days	of	HCjE-Gi	cell	culture:	a)	phalloidin	(f-actin	staining)	(b)	DAPI	(nuclear)	
staining.	Five	slices	have	been	taken,	each	in	4.5-5μm	intervals	whereby	the	top	and	bottom	of	
the	z-stack	had	been	manually	set	after	the	focus	points	at	the	top	and	bottom	of	the	cell	
cultures	were	located.	Scale	bars	50μm.		
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Figure	36:	Representative	confocal	z-stack	series	of	PET	membrane	after	28	days	of	HCjE-Gi	cell	
culture:	a)	phalloidin	(f-actin	staining)	(b)	DAPI	(nuclear)	staining.		Five	slices	have	been	taken,	
each	in	4.5-5μm	intervals	whereby	the	top	and	bottom	of	the	z-stack	had	been	manually	set	
after	the	focus	points	at	the	top	and	bottom	of	the	cell	cultures	were	located.	Scale	bars	50μm.	
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Figure	37:	Representative	confocal	z-stack	series	of	untreated	ePTFE	after	28	days	of	HCjE-Gi	
cell	culture:	a)	phalloidin	(f-actin	staining)	(b)	DAPI	(nuclear)	staining.		Five	slices	have	been	
taken,	each	in	4.5-5μm	intervals	whereby	the	top	and	bottom	of	the	z-stack	had	been	manually	
set	after	the	focus	points	at	the	top	and	bottom	of	the	cell	cultures	were	located.	Scale	bars	
50μm.	
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Figure	38:	Representative	photomicrographs	of	nuclear	and	UAE-1	staining	of	HCjE-Gi	cells	
cultured	on	ammonia	plasma	treated	ePTFE,	PET	and	untreated	ePTFE	after	2	days	in	culture.	
Lowest	cell	density	was	apparent	on	untreated	ePTFE.	Overall	greater	UAE-1	(intracellular	and	
membrane	associated)	staining	was	apparent	on	cells	cultured	on	ePTFE	than	PET	membrane	in	
which	staining	appeared	more	discrete	and	mostly	membrane	associated.	Scale	bars	50μm.		
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Figure	39:	Representative	photomicrographs	of	nuclear	and	UAE-1	staining	of	HCjE-Gi	cells	
cultured	on	ammonia	plasma	treated	ePTFE,	PET	and	untreated	ePTFE	after	14	days	in	culture.	
Lowest	cell	density	was	apparent	on	untreated	ePTFE.	The	greatest	intensity	of	UAE-1	staining	
appeared	on	PET	membrane	and	double	side	treated	ePTFE.	Staining	of	cell	membranes	
showed	the	cell	size	was	greater	on	ePTFE	cell	cultures	than	PET	cell	cultures.	Scale	bars	50μm.		
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Figure	40:	Representative	photomicrographs	of	nuclear	and	UAE-1	staining	of	HCjE-Gi	cells	
cultured	on	ammonia	plasma	treated	ePTFE,	PET	and	untreated	ePTFE	after	21	days	in	culture.	
Lowest	cell	density	was	demonstrated	on	untreated	ePTFE,	whereas	the	greatest	density	was	
demonstrated	on	PET	membrane	and	double	side	treated	ePTFE.	Cell	size	was	greater	on	ePTFE	
cell	cultures	than	PET	cell	cultures,	and	was	more	pronounced	on	double	side	treated	ePTFE,	
especially	amongst	the	cells	with	greater	intracellular	staining.		Scale	bars	50μm.		
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Figure	41:	Representative	confocal	z-stack	series	of	single	side	treated	ePTFE	after	28	days	of	
HCjE-Gi	cell	culture:	a)	UAE-1	lectin	staining,	b)	DAPI	(nuclear)	staining.	Five	slices	have	been	
taken,	each	in	4.5-5μm	intervals	whereby	the	top	and	bottom	of	the	z-stack	had	been	manually	
set	after	the	focus	points	at	the	top	and	bottom	of	the	cell	cultures	were	located.	Scale	bars	
50μm.		
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Figure	42:	Representative	confocal	z-stack	series	of	double	side	treated	ePTFE	after	28	days	of	
HCjE-Gi	cell	culture:	a)	UAE-1	lectin	staining,	b)	DAPI	(nuclear)	staining.	Five	slices	have	been	
taken,	each	in	4.5-5μm	intervals	whereby	the	top	and	bottom	of	the	z-stack	had	been	manually	
set	after	the	focus	points	at	the	top	and	bottom	of	the	cell	cultures	were	located.	Scale	bars	
50μm.	
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Figure	43:	Representative	confocal	z-stack	series	of	PET	membrane	after	28	days	of	HCjE-Gi	cell	
culture:	a)	UAE-1	lectin	staining,	b)	DAPI	(nuclear)	staining.	Five	slices	have	been	taken,	each	in	
4.5-5μm	intervals	whereby	the	top	and	bottom	of	the	z-stack	had	been	manually	set	after	the	
focus	points	at	the	top	and	bottom	of	the	cell	cultures	were	located.	Scale	bars	50μm.	
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Figure	44:	Representative	confocal	z-stack	series	of	untreated	ePTFE	after	28	days	of	HCjE-Gi	
cell	culture:	a)	UAE-1	lectin	staining,	b)	DAPI	(nuclear)	staining.		Four	slices	have	been	taken,	
each	after	3μM	whereby	the	top	and	bottom	of	the	z-stack	had	been	manually	set	after	the	
focus	points	at	the	top	and	bottom	of	the	cell	cultures	were	located.	Scale	bars	50μm.		
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3.3	 Retrieved	human	conjunctiva	
Human	conjunctiva	was	retrieved	from	26	eyes	of	13	tissue	donors.	Six	donors	were	
male	and	7	donors	were	female	with	a	mean	age	of	84.2	years	(range	65-92).	The	mean	
time	to	retrieval	was	20.4	hours	(range	7-32	hours).		
	
	
Donor	number	 Gender	 Age	 Time	to	retrieval	(hours)	
1,	2	 Male	 84	 19	
3,	4	 Male	 87	 7	
5,	6	 Female	 96	 29	
7,	8	 Male	 76	 26	
9,	10	 Female	 80	 16	
11,	12	 Female	 90	 12	
13,	14	 Male	 92	 24	
15,	16	 Male	 77	 9	
17,	18	 Female	 88	 19	
19,	20	 Female	 65	 23	
21,	22	 Female	 85	 																					28	
23,	24	 Male	 84	 22	
25,	26	 Female	 91	 32	
	
Table	7:	Table	of	the	age	and	gender	of	tissue	donors	together	with	the	post-mortem	retrieval	
time.	The	donor	eyes	were	designated	numbered	sequentially,	left	eye	followed	by	right	eye.		 	
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3.4	 Preliminary	optimisation	and	validation	of	the	HCjE-Gi	cell	line	and	
flow	cytometry			
3.4.1	 Optimisation	of	antibody	staining	for	flow	cytometry		
Many	of	the	antibodies	identified	for	this	study	were	not	conjugated	to	a	
fluorochrome.	Testing	the	optimal	dilution	for	both	the	primary	and	secondary	
antibody	was	undertaken	before	any	experimental	work	was	conducted.	The	
incubation	period	was	also	optimised.	The	optimal	protocol	was	determined	when	a	
shift	in	fluorescence	was	clearly	detectable	with	minimal	overlap	from	a	non-stained	
population.	For	example,	several	concentrations	of	UAE-1	lectin	were	tested	with	
variations	in	length	of	incubation,	however,	this	did	not	have	a	significant	effect	(Figure	
45).	In	contrast,	greater	separation	of	cell	populations	was	observed	by	variation	in	the	
dilution	of	UAE-1	lectin.	An	optimal	concentration	of	1:500	at	an	incubation	time	of	30	
minutes	was	determined.		
	
The	detected	fluorescence	of	samples	treated	with	unconjugated	primary	and	
secondary	antibodies	were	compared	against	their	respective	isotype	controls.	In	
addition,	the	secondary	antibody	alone	was	also	tested	at	varying	dilutions	to	find	an	
optimal	balance	between	bright	staining	and	non-specific	binding.		The	percentage	of	
the	cell	population	that	represented	a	positively	stained	population	was	determined	by	
quantitative	analysis	of	the	cell	population	that	emitted	fluorescence	at	a	greater	
intensity	to	the	control	samples:	i)	the	respective	isotype	control	in	combination	with	
its	secondary	antibody	ii)	the	secondary	antibody	alone.	Experiments	for	each	antibody	
were	therefore	undertaken	using	secondary	antibody	alone	in	addition	to	with	each	
dilution	of	the	primary	and	the	secondary	antibody	combination	and	the	corresponding	
concentration	of	isotype	control.	The	example	of	antibody	optimisation	shown	in	
Figure	46	demonstrates	a	degree	of	non-specific	antibody	binding.	This	optimisation	
step	determined	that	the	greatest	separation	in	cell	populations	was	detectable	(and	
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therefore	least	non	specific	binding	occurred)	when	the	dilution	of	primary	and	
secondary	antibody	was	used	at	1:50	and	1:1000	respectively.		
	
	
	
	
	
	
Figure	45:	Fluorescence	channel	histograms	of	HCjE-Gi	cells	demonstrating	the	resulting	
fluorescence	after	staining	with	various	concentrations	of	UAE-1	lectin	over	30	(b)	and	60	(c)	
minutes.	The	dashed	line	on	all	the	histograms	and	arrow	on	the	histogram	of	the	unstained	
control	sample	(a)	indicates	the	fluorescence	beyond	which	staining	was	regarded	as	positive.	
These	histograms	demonstrate	that	there	was	little	effect	of	incubation	time	and	therefore	30	
minutes	was	sufficient.	At	all	the	antibody	dilutions	studied,	there	was	marked	separation	of	
the	histogram	from	an	unstained	(control)	sample	of	cells,	however,	the	1:500	dilution	was	
optimal.		
Unstained	
a)	
1:100,	30	minutes	 1:500,	30	minutes	 1:1000,	30	minutes	 1:2000,	30	minutes	
b)	
1:100,	60	minutes	 1:500,	60	minutes	 1:1000,	60	minutes	 1:2000,	60	minutes	
c)	
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Figure	46:	The	histograms	above	show	the	results	at	the	optimal	determined	dilutions	of	the	
primary	ΔNp63	antibody	and	secondary	antibody	(1:50	primary	and	1:1000	secondary)	
compared	with	an	isotype	control	and	the	secondary	antibody	in	isolation.	Other	variables	
tested	but	not	displayed	above	included:	primary	antibody	dilutions	1:100,	1:250:	in	all	
combinations	with	secondary	antibody	dilutions	1:100,	1:500,	1:1500.	The	positively	stained	
peak	was	determined	from	primary	and	secondary	antibody	combinations,	which	exceeded	the	
fluorescence	of	both	the	isotype	control	and	secondary	antibody	in	combination	and	to	the	
secondary	antibody	alone	at	the	same	dilutions.	Importantly,	the	shift	in	the	histogram	curve	
was	such	that	there	was	minimal	overlap	with	the	histogram	curve	of	the	control	samples	
described.	The	dotted	lines	and	arrows	indicate	the	area	of	histogram	from	which	a	logical	
‘gate’	was	placed	to	determine	the	percentage	of	cells	that	were	deemed	positive	for	ΔNp63	
expression.		
Isotype	control	with	secondary	
antibody	1:1000	
Secondary	antibody	only	1:1000	
	ΔNp63	1:50,	secondary	antibody	
1:1000	
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3.4.2	 Characterisation	of	primary	HCjE-Gi	conjunctival	cell	line	with	flow	
cytometry	
The	antibody	optimisation	experiments	shown	in	previously	described	section	(3.4.1)	
enabled	the	determination	of	optimal	primary	and	secondary	antibody	staining	
protocols	to	undertake	flow	cytometry.	Optimisation	was	undertaken	for	all	the	
antibodies	studied	and	representative	experiments	have	been	displayed	to	illustrate	
how	this	was	conducted.	Characterisation	of	the	prepared	sample	began	with	adjusting	
the	forward	and	side	scatter	voltages	and	compensation	to	obtain	optimal	scatter	
characteristics	from	which	the	cell	population	was	identified	(Figure	47).	The	same	
voltage	settings	were	used	for	all	subsequent	experimental	work.	Figure	47	displays	the	
cell	population	that	was	gated	for	subsequent	analysis.	Each	stained	cell	sample	was	
analysed	in	conjunction	with	its	relevant	isotype	control.	An	isotype	control	of	a	
corresponding	dilution	was	included	in	each	experimental	run	for	each	antibody	that	
was	used.	The	antibody	staining	characteristics	together	with	the	relevant	isotype	
controls	are	shown	in	histograms	for	both	primary	conjunctival	cells	and	the	HCjE-Gi	
cell	line	(Figure	48).	The	gating	criteria	regarded	as	positive	antibody	staining	was	
determined	from	the	point	on	the	x	axis	at	which	the	histogram	curve	for	the	isotype	
control	tapers	with	increasing	fluorescence.	Illustrative	examples	are	shown	in	Figure	
48.			
	
	 	
	
Figure	47:	Dot	plot	of	side	scatter-height	(SSC-H)	against	forward	scatter	height	(FSC-H)	of	HCjE-
Gi	(a)	and	primary	conjunctival	cells	(b).	The	dots	occurring	at	the	bottom	left	of	the	plot	(low	
FSC-H	and	SSC-H)	are	particulates/debris.		
a)	 b)	
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Figure	48	(displayed	below	and	over	pages	110-114):	Histograms	to	show	the	fluorescence	
detected	in	primary	conjunctival	epithelial	cells	and	HCjE-Gi	cells	after	staining	as	described	in	
section	2.4.6:	a)	CK19,	b)	CK4,	c)	CK7,	d)	UAE-1	lectin,	e)	MUC5AC,	f)	PCNA,	g)	caspase-3,	h)	
ΔNp63,	i)	ABCG2.	The	dotted	lines	and	arrows	indicate	the	region	the	‘gates’	were	set	such	that	
cells	emitting	fluorescence	above	that	detected	in	the	relevant	isotype	controls	(all	histograms	
on	the	left	hand	side)	were	deemed	positively	stained.	The	red	arrows	on	the	histograms	on	
the	right	hand	side	demonstrate	the	positive	antibody	stained	population	determined	by	
setting	a	logical	gate	based	on	the	emitted	fluorescence	of	the	isotype	control	samples	
illustrated	on	the	histograms	on	the	left	hand	side	with	blue	arrows.	The	percentage	of	cells	
positively	stained	for	the	antigen	of	interest	were	quantified	using	an	analytical	software	tool	
for	flow	cytometry	data	(Flowing	2.5).			
	
	
	
	
	
	
	
	
a)	
Primary	conjunctival	
cells	
HCjE-Gi	cells	
CK19	
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b)	 CK4	
CK7	c)	
HCjE-Gi	cells	
Primary	conjunctival	
cells	
Primary	conjunctival	
cells	
HCjE-Gi	cells	
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e)	 MUC5AC	
HCjE-Gi	cells	
Primary	conjunctival	
cells	
UAE-1	lectin	d)	
Primary	conjunctival	
cells	
HCjE-Gi	cells	
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f)	 PCNA	
HCjE-Gi	cells	
Primary	conjunctival	
cells	
Caspase-3	g)	
Primary	conjunctival	
cells	
HCjE-Gi	cells	
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h)	 ΔNp63	
ABCG2	i)	
HCjE-Gi	cells	
HCjE-Gi	cells	
Primary	conjunctival	
cells	
Primary	conjunctival	
cells	
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3.4.3	 Determining	the	utility	of	caspase-3	as	a	marker	for	the	identification	of	
apoptotic	cells	in	conjunctival	epithelia	
Figure	49	shows	the	shift	in	fluorescence	along	the	APC	(far-red)	channel	of	the	cell	
population	stained	with	caspase-3	with	the	isotype	controls.	This	revealed	greater	than	
100-fold	expression	of	caspase-3	in	the	deprived	cells	(43.5%)	compared	to	those	that	
had	been	maintained	in	optimal	culture	conditions	(0.36%).		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	49:	Histograms	of	fluorescence	detected	following	staining	with	caspase-3	in	healthy	
and	deprived	cultures.	H2	indicates	the	‘gates’	set	using	a	flow	cytometry	analysis	software	
program	such	that	cells	emitting	fluorescence	levels	above	that	detected	in	the	isotype	controls	
(in	the	range	indicated	by	H2)	were	regarded	as	positively	stained.	This	enabled	the	
quantification	of	the	cell	population	in	terms	of	the	percentage	of	the	cells	present	in	this	gated	
region.		
Isotype	
control	
Isotype	
control	
Deprived	cell	
cultures	
Healthy	cell	
cultures	
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3.4.4	 Validation	of	the	cell	line		
Quantitatively,	the	expression	levels	of	all	cell	markers	were	very	similar	between	HCjE-
Gi	cells	of	passage	2	and	28	at	arrival	from	source	(donated	cell	line),	and	no	
statistically	significant	differences	were	demonstrated.	Based	on	this	data,	HCjE-Gi	cells	
between	passages	2	and	28	were	deemed	suitable	for	use	in	subsequent	experiments.		
	
	
	
Passage	2	mean	(+/-
SD)	percentage	of	cells	
Passage	28	mean	(+/-
SD)	percentage	of	cells	
p	value		
CK4	 0.22	(0.07)	 0.23	(0.09)	 0.89	
CK7	 2.63	(0.78)	 2.58	(1.11)	 0.95	
CK19	 								98.8	(0.61)	 									99.1	(0.21)	 0.47	
MUC5AC	 0.18	(0.04)	 0.17(0.08)	 0.87	
Lectin	 								44.59	(2.61)	 										46.3	(3.35)	 0.52	
Np63	 									54.9	(11.2)	 										53	(15.6)	 0.78	
ABCG2	 										25.4	(3.63)	 									22.2(4.5)	 0.39	
ABCG2	+													
Np63	 										24	(3.29)	 									21.7	(4.75)	
																					0.54	
Caspase3	 	0.15	(0.03)	 0.12	(0.03)	 0.41	
PCNA	 								98.9	(0.02)	 									98.3	(0.12)	 0.41	
	
Table	8:	Table	to	show	percentage	expression	of	conjunctival	markers	in	HCjE-Gi	cells	of	
passage	2	and	28.	Triplicate	samples	for	each	marker	within	each	cohort	(passage	2	and	
passage	28)	were	analysed	by	flow	cytometry.	Similar	levels	of	markers	in	terms	of	the	
percentage	of	cells	detected	was	apparent	between	cells	of	passage	2	and	28	with	no	
differences	confirmed	by	statistical	analysis	(ANOVA).		
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3.5	 Analysis	of	conjunctival	epithelial	phenotype	with	advancing	time	
on	synthetic	substrates	by	flow	cytometry		
3.5.1	 HCjE-Gi	cell	phenotype	with	advancing	time	in	culture	on	synthetic	
substrates	
Almost	all	HCjE-Gi	cells	were	found	to	express	CK19	(≥96%)	across	all	substrates	at	14	
and	28	days	in	culture.	No	statistically	significant	differences	in	CK19	or	CK4	expression	
were	observed	with	respect	to	advancing	time.	The	highest	expression	of	CK4	was	
demonstrated	on	PET	and	untreated	ePTFE	substrates,	whereby	significant	post-hoc	
test	differences	were	found:	PET	had	greater	CK4	expression	than	double	side	treated	
ePTFE,	and	untreated	ePTFE	had	greater	CK4	expression	than	double	side	treated	
ePTFE;	p<0.01	(Figure	50,	Table	11).	CK7	expression	increased	with	advancing	time	in	
culture	together	with	the	proportion	of	cells	co-expressing	CK7	and	UAE-1	lectin	across	
all	substrates	studied	with	significant	differences	demonstrated	between	the	untreated	
ePTFE	and	all	other	substrates	studied;	p<0.0001	(Figures	51	and	55).	CK7/CK7+	UAE-1	
lectin	expression	on	untreated	ePTFE	(mean	78%)	was	more	than	3-fold	higher	than	
that	on	double	side	ammonia	plasma	treated	ePTFE	(mean	25%)	and	more	than	double	
that	on	PET	and	single	side	ammonia	treated	ePTFE	(mean	32%	and	38%	respectively):	
Figure	55.			
	
UAE-1	lectin	expression	varied	significantly	with	substrate	but	not	with	advancing	time:	
p=0.001,	p=0.64	respectively	(Figure	54).	After	28	days	in	culture,	highest	UAE-1	
expression	was	found	on	double	side	treated	ePTFE	and	untreated	ePTFE.	Significant	
differences	were	found	in	post-hoc	tests	between	untreated	ePTFE	and	both	PET	
membrane	and	single	side	ammonia	plasma	treated	ePTFE	(p<0.007).	Significant	
differences	were	also	demonstrated	between	double	side	ammonia	plasma	treated	
ePTFE	and	PET	membrane;	p<0.007	(Figure	54).		
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MUC5AC	detection	was	low	at	both	day	14	and	day	28	on	all	substrates	whereby	it	
represented	less	than	0.75%	of	all	cells	(Figure	53).	No	statistically	significant	
differences	in	MUC5AC	detection	were	demonstrated	between	the	substrates	studied	
however	expression	significantly	increased	with	advancing	time	in	culture	overall;	
p=0.33,	p<0.001	respectively.	The	highest	MUC5AC	levels	were	detected	on	double	and	
single	side	ammonia	treated	ePTFE	at	day	28,	which	were	almost	twice	that	expressed	
in	PET	membrane	cultures.		
	
ΔNp63	was	expressed	in	large	proportion	of	cells	(≥90%)	and	this	level	remained	high	
with	advancing	time	in	culture	(Figure	56).	No	significant	variation	with	respect	to	
substrate	or	advancing	time	in	culture	could	be	demonstrated	after	Holm-Bonferroni	
correction:	p=0.096,	p=0.007	respectively.	In	contrast,	the	ABCG2	expression	was	lower	
than	ΔNp63	at	day	14	and	appeared	to	decline	with	advancing	time	in	culture,	however	
this	was	not	statistically	significant	and	variance	was	relatively	high	(Figure	57).	
Significantly	higher	ABCG2	expression	was	found	on	double	side	treated	ePTFE	than	
that	on	single	side	treated	ePTFE	and	untreated	ePTFE	after	28	days	in	culture:	p=0.008	
and	p=0.004	between	double	side	ammonia	plasma	treated	ePTFE	and	untreated	
ePTFE	and	double	side	ammonia	treated	ePTFE	and	single	side	ammonia	treated	ePTFE	
respectively	(Figure	57,	Table	11).	No	significant	difference	in	ABCG2	expression	was	
demonstrated	between	cultures	from	double	side	ammonia	plasma	treated	ePTFE	and	
PET	membranes.		A	significant	difference	was	however	demonstrated	in	the	co-
expression	of	ABCG2	and	ΔNp63	(Figure	58).	The	highest	ABCG2/	ΔNp63	co-expression	
was	demonstrated	on	double	side	treated	ePTFE.	This	was	significantly	higher	than	on	
any	other	substrate	studied;	p<0.01	in	post-hoc	tests	between	double	side	treated	
ePTFE	and	all	other	substrates	studied	(Table	11).		
	
PCNA	levels	did	not	change	significantly	with	advancing	time:	p=0.024	(Figure	60).	No	
statistically	significant	differences	in	PCNA	expression	were	demonstrated	between	
substrates	(p=0.146),	however	the	lowest	levels	were	found	on	untreated	ePTFE	at	14	
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and	28	days	in	culture.	Caspase-3	expression	was	relatively	low	across	all	substrates	at	
14	days	in	culture	and	did	not	increase	with	advancing	time	overall:	p=0.163	(Figure	
59).	There	was,	however,	an	almost	10-fold	greater	caspase-3	expression	at	28	days	in	
culture	on	untreated	ePTFE	than	any	other	substrate.	Caspase-3	expression	was	
significantly	higher	on	untreated	ePTFE	than	all	other	test	substrates;	p<0.0001	(Table	
11).		
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	50:	Histogram	to	show	percentage	expression	of	CK4	on	ammonia	plasma	treated	
ePTFE,	untreated	ePTFE	and	PET	after	14	and	28	days	in	culture.	ANCOVA	overall	model	
substrates;	p<0.0001;	time	p=0.152.	Error	bars	+/-SD.	
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Figure	51:	Histogram	to	show	percentage	expression	of	CK7	on	ammonia	plasma	treated	
ePTFE,	untreated	ePTFE	and	PET	after	14	and	28	days	in	culture.	ANCOVA	overall	model	
substrates	and	time;	p<0.001.	Error	bars	+/-SD.	
	
	
	
	
	
	
	
	
	
	
Figure	52:	Histogram	to	show	percentage	expression	of	CK19	on	ammonia	plasma	treated	
ePTFE,	untreated	ePTFE	and	PET	after	14	and	28	days	in	culture.	ANCOVA	overall	model	
substrates	p=0.975;	time	p=0.88.	Error	bars	+/-SD.	
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Figure	53:	Histogram	to	show	percentage	expression	of	MUC5AC	on	ammonia	plasma	treated	
ePTFE,	untreated	ePTFE	and	PET	after	14	and	28	days	in	culture.	ANCOVA	overall	model	
substrate	p=0.033;	time	p<0.0001.	Error	bars	+/-SD.	
	
	
	
	
	
	
	
	
	
	
Figure	54:	Histogram	to	show	percentage	expression	of	UAE-1	lectin	on	ammonia	plasma	
treated	ePTFE,	untreated	ePTFE	and	PET	after	14	and	28	days	in	culture.	ANCOVA	overall	model	
substrate	p=0.001;	time:	p<0.641.	Error	bars	+/-SD.	
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Figure	55:	Histogram	to	show	percentage	expression	of	CK7	and	UAE-1	lectin	co-expression	on	
ammonia	plasma	treated	ePTFE,	untreated	ePTFE	and	PET	after	14	and	28	days	in	culture.	
ANCOVA	overall	model	substrate	and	time	point:	p<0.0001.	Error	bars	+/-SD.	
	
	
	
	
	
	
	
	
	
	
Figure	56:	Histogram	to	show	percentage	expression	of	ΔNp63	on	ammonia	plasma	treated	
ePTFE,	untreated	ePTFE	and	PET	after	14	and	28	days	in	culture.	ANCOVA	overall	model	
substrates	p=0.007;	time	p=0.096.		Error	bars	+/-SD.	
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Figure	57:	Histogram	to	show	percentage	expression	of	ABCG2	on	ammonia	plasma	treated	
ePTFE,	untreated	ePTFE	and	PET	after	14	and	28	days	in	culture.	ANCOVA	overall	model	
substrates	p=0.003;	time	p=0.137.	Error	bars	+/-SD.	
	
	
	
	
	
	
	
	
Figure	58:	Histogram	to	show	percentage	expression	of	ABCG2	and	ΔNp63	on	ammonia	
plasma	treated	ePTFE,	untreated	ePTFE	and	PET	after	14	and	28	days	in	culture.	ANCOVA	
overall	model	substrates	p=0.001;	time	p=0.008.	Error	bars	+/-SD.	
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Figure	59:	Histogram	to	show	percentage	expression	of	Caspase-3	on	ammonia	plasma	treated	
ePTFE,	untreated	ePTFE	and	PET	after	14	and	28	days	in	culture.	ANCOVA	overall	model	
substrates	p=<0.0001;	time	p=0.163.	Error	bars	+/-SD.	
	
	
	
	
	
	
	
	
	
Figure	60:	Histogram	to	show	percentage	expression	of	PCNA	on	ammonia	plasma	treated	
ePTFE,	untreated	ePTFE	and	PET	after	14	and	28	days	in	culture.	ANCOVA	overall	model	time	
p=0.024;	substrates	p=0.146.	Error	bars	+/-SD.	
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Marker		 P	value	
CK7	 0.0001	
CK7/UAE-1	lectin	co-
expression	
0.0001	
MUC5AC	 0.0001	
	
	
Table	9:	Table	of	cell	markers	in	which	a	statistically	significant	change	was	demonstrated	with	
advancing	time	in	culture.	Raw	p	values	from	the	ANCOVA	are	displayed.	Only	p	values	
statistically	significant	following	correction	by	Holm-Bonferroni	for	multiple	testing	hypotheses	
are	displayed.			
	
	
	
Marker		 P	value	
CK7	 0.0001	
CK7	+	UAE-1	lectin	 0.0001	
UAE-1	lectin	 0.001	
CK4	 0.0001	
Caspase-3	 0.0001	
ABCG2	 0.003	
ABCG2+	NP63	 0.001	
	
	
Table	10:	Table	of	cell	markers	in	which	a	statistically	significant	difference	was	demonstrated	
between	substrates.	Raw	p	values	from	the	ANCOVA	are	displayed.	Only	p	values	statistically	
significant	following	correction	by	Holm-Bonferroni	for	multiple	testing	hypotheses	are	
displayed.			
	
	
	
	 125	
Marker		 Post-hoc	contrasts;	p	value	and	pairs	of	data	
CK7	 p<0.0001:	U	vs.	D;	U	vs.	S;	U	vs.	P	
CK7	+	UAE-1	lectin	 p<0.0001;	U	vs.	D,	U	vs.	S,	U	vs.	P	
UAE-1	lectin	 p<0.007:	D	vs.	P,	U	vs.	S,	U	vs.	P	
CK4	 p<0.01:	D	vs.	P,	D	vs.	U	
Caspase-3	 p<0.0001:	D	vs.	U,	U	vs.	P,	U	vs.	S	
ABCG2	 p=0.008	D	vs.	U											p=0.004	D	vs.	S	
ABCG2+	ΔNp63	 p≤0.001	D	vs.	U,	D	vs.	S,	D	vs.	P	
	
	
Table	11:	Table	of	cell	markers	in	which	a	statistically	significant	difference	was	demonstrated	
between	substrates:	U=untreated	ePTFE,	D=double	side	treated	ePTFE,	S=single	side	treated	
ePTFE,	P=PET	membrane.	Raw	p	values	from	the	ANCOVA	post-hoc	contrast	tests	are	
displayed.	Only	p	values	statistically	significant	following	correction	by	Holm-Bonferroni	for	
multiple	testing	hypotheses	are	displayed.			
	
3.5.2	 Cell	density	and	morphology	of	primary	cell	cultures	on	double	side	
ammonia	plasma	treated	ePTFE	and	PET	membrane	
Primary	cells	from	a	single	donor	(donor	10)	were	expanded	and	seeded	at	1x105/cm2	
on	ammonia	plasma	treated	ePTFE	(double	side	treated)	and	PET	membrane	(positive	
control)	in	triplicate.	The	cell	density	expanded	up	to	14	days	in	culture,	after	which	a	
decline	occurred	(Figure	61).	At	all	time	points	studied,	the	cell	density	on	PET	
membrane	was	more	than	double	that	found	on	ePTFE.	This	was	in	keeping	with	the	
qualitative	appearance	of	nuclear	staining	density	observed	in	DAPI	stained	samples	
(Figure	62).	Morphologically	however,	the	cells	appeared	larger	in	cultures	developed	
on	ePTFE	than	PET	membrane	at	day	14	giving	the	impression	of	a	similar	degree	of	cell	
confluence	despite	a	lower	cell	density	on	the	ePTFE	substrate	(Figures	61	and	62).	
Other	notable	morphological	features	include	greater	variation	in	nuclear	size	and	
shape	in	cells	developed	on	ePTFE	substrate	in	comparison	those	on	PET	membranes	at	
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day	14.	F-actin	staining	of	cells	on	both	substrates	demonstrated	that	cells	appeared	
more	elongated	with	cell	processes	visible	on	day	14	which	were	no	longer	present	at	
day	28	when	cells	appeared	sparse	with	a	more	‘rounded’	appearance	on	both	
substrates.		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	61:	Histogram	to	show	number	of	cells	per	cm2	with	advancing	time	in	culture	on	double	
side	ammonia	plasma	treated	ePTFE	(both	sides	exposed	to	plasma)	and	PET	membrane.	
Primary	cells	used	in	this	experiment	were	from	a	single	donor	and	were	seeded	at	1x105/cm2.	
Scale	bars	+/-	SD.		
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Figure	62:	Representative	photomicrographs	of	primary	conjunctival	cells	on	double	side	
ammonia	plasma	treated	ePTFE	(D)	and	PET	(P)	membrane	at	after	14	and	28	days	in	culture.	
Scale	bars	50μM.	Phalloidin	(f-actin	staining):	red.	DAPI	(nuclear	staining):	blue.	
	
	
3.5.3	 Phenotype	of	primary	cells	expanded	on	double	side	plasma	treated	
ePTFE	and	PET	membrane	by	flow	cytometry	
The	conjunctival	epithelial	cells	used	in	this	experiment	were	derived	from	explants	
from	three	separate	tissue	donors	(tissue	donors	4,	8	and	12:	Table	7).	The	majority	of	
cells	(≥97%)	expressed	cytokeratin	19	(Figure	63).	No	significant	effect	was	found	either	
with	respect	to	time	in	culture	(day	14	versus	day	28)	or	the	substrate	on	which	cells	
were	grown	(double	side	ammonia	treated	ePTFE	or	PET	substrate);	p=0.079,	p=0.123	
respectively.	Similarly,	no	statistically	significant	differences	could	be	found	in	CK7,	CK4,	
UAE-1	lectin	or	co-expression	of	CK7/UAE-1	lectin	with	respect	to	advancing	time	or	
substrate	(Figures	64-67).	The	histograms	of	CK7	expression	alone	and	CK7	and	UAE-1	
lectin	co-expression	were	quantitatively	similar	(Figures	65	and	67).	UAE-1	lectin	
expression	alone,	however,	was	greater	than	CK7	expression	alone	(Figure	66).	The	
expression	of	both	MUC5AC	and	UAE-1	lectin	were	on	average	higher	at	28	days	than	
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14	days	in	culture,	however,	this	was	not	statistically	significant;	p=0.12,	p=0.51	
respectively	(Figures	66	and	68).	No	significant	differences	could	be	could	be	
demonstrated	in	MUC5AC	or	UAE-1	lectin	expression	between	cells	cultured	on	PET	
and	ePTFE	substrates;	p=0.46,	p=0.26	respectively.	
No	statistically	significant	differences	in	ΔNp63,	ABGC2	expression	or	co-expression	of	
ΔNp63	and	ABGC2	were	demonstrated	with	advancing	time	in	culture	or	between	
substrates	(Figures	69-71).	The	proportion	of	cells	expressing	either	ABCG2	or	ΔNp63,	
however,	less	than	halved	between	day	14	and	day	28,	and	the	proportion	of	cells	co-
expressing	ABCG2	and	ΔNp63	also	diminished	markedly.	It	should	be	noted	that	
variance	in	the	test	samples	was	relatively	high.	Similarly,	caspase-3	expression	
appeared	to	more	than	double	with	advancing	time	and	higher	levels	were	found	on	
ammonia	plasma	treated	ePTFE	(Figure	72).	The	variance,	again,	was	high	and	
therefore	no	statistically	significant	differences	with	respect	to	advancing	time	in	
culture	or	substrate	were	demonstrated.	PCNA	expression	declined	with	advancing	
time	in	culture	and	was	found	to	be	statistically	significant	following	Holm-Bonferroni	
correction;	p=0.003	(Figure	73).	Levels	of	PCNA	expression	were	similar	between	
double	side	ammonia	plasma	treated	ePTFE	and	PET	membrane.		
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Figure	63:	Histogram	to	show	percentage	expression	of	CK19	in	primary	cells	cultured	on	
double	side	ammonia	plasma	treated	ePTFE	and	PET	membrane	after	14	and	28	days.	ANCOVA	
time	p=0.079;	substrate	p=0.123.	Error	bars	+/-SD.		
	
	
	
	
	
	
	
	
	
	
	
Figure	64:	Histogram	to	show	percentage	expression	of	CK4	in	primary	cells	cultured	on	double	
side	ammonia	plasma	treated	ePTFE	and	PET	membrane	after	14	and	28	days.	ANCOVA	time	
0.52;	substrate	0.753.	Error	bars	+/-SD.	
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Figure	65:	Histogram	to	show	percentage	expression	of	CK7	in	primary	cells	cultured	on	double	
side	ammonia	plasma	treated	ePTFE	and	PET	membrane	after	14	and	28	days.	ANCOVA	time	
0.647;	substrate	p=0.25.	Error	bars	+/-SD.	Error	bars	+/-SD.	
	
	
	
	 	
	
	
	
	
	
	
Figure	66:	Histogram	to	show	percentage	expression	of	UAE-1	lectin	in	primary	cells	cultured	
on	double	side	ammonia	plasma	treated	ePTFE	and	PET	membrane	after	14	and	28	days.	
ANCOVA	time	0.39;	substrate	p=0.712.		Error	bars	+/-SD.	
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Figure	67:	Histogram	to	show	percentage	expression	of	UAE-1	lectin	and	CK7	in	primary	cells	
cultured	on	double	side	ammonia	plasma	treated	ePTFE	and	PET	membrane	after	14	and	28	
days.	ANCOVA	time	p=0.505;	substrate	p=0.263.		Error	bars	+/-SD.	
	
	
	
	
	
	
	
	
	
Figure	68:	Histogram	to	show	percentage	expression	of	MUC5AC	in	primary	cells	cultured	on	
double	side	ammonia	plasma	treated	ePTFE	and	PET	membrane	after	14	and	28	days.	ANCOVA	
time	p=0.124;	substrate	p=0.456.	Error	bars	+/-SD.	
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Figure	69:	Histogram	to	show	percentage	expression	of	ΔNp63	in	primary	cells	cultured	on	
double	side	ammonia	plasma	treated	ePTFE	and	PET	membrane	after	14	and	28	days.	ANCOVA	
time	p=0.945;	substrate	0.537.	Error	bars	+/-SD.	
	
	
	
	
	
	
	
	
	
	
Figure	70:	Histogram	to	show	percentage	expression	of	ABCG2	in	primary	cells	cultured	on	
double	side	ammonia	plasma	treated	ePTFE	and	PET	membrane	after	14	and	28	days.	ANCOVA	
time	p=0.753;	substrate	p=0.611.	Error	bars	+/-SD.	
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Figure	71:	Histogram	to	show	percentage	expression	of	ΔNp63	and	ABCG2	in	primary	cells	
cultured	on	double	side	ammonia	plasma	treated	ePTFE	and	PET	membrane	after	14	and	28	
days.	ANCOVA	time	p=0.328;	substrate	p=0.787.		Error	bars	+/-SD.	
	
	
	
	
	
	
	
	
	
	
Figure	72:	Histogram	to	show	percentage	expression	of	caspase-3	in	primary	cells	cultured	on	
double	side	ammonia	plasma	treated	ePTFE	and	PET	membrane	after	14	and	28	days.	ANCOVA	
time	p=0.138;	substrate	p=0.134.		Error	bars	+/-SD.	
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Figure	73:	Histogram	to	show	percentage	expression	of	PCNA	in	primary	cells	cultured	on	
double	side	ammonia	plasma	treated	ePTFE	and	PET	membrane	after	14	and	28	days.	ANCOVA	
time	p=0.003;	substrate	p=0.04.		Error	bars	+/-SD.	
	
3.6	 Decellularisation	of	human	conjunctiva	and	its	characterisation		
3.6.1	 DNA	quantification	of	decellularised	conjunctiva	
A	commercially	available	kit	was	used	to	degrade	conjunctival	tissue	and	isolate	double	
stranded	DNA	so	that	it	was	present	in	solution	for	quantification	with	a	fluorescent	
nucleic	acid	stain.	Calf	thymus	DNA	standards	were	used	in	known	serial	dilutions	to	
enable	the	acquisition	of	a	standard	curve	(Figure	74).	The	standard	curve	displays	the	
relationship	between	the	measured	absorbance	values	and	known	concentrations	of	
DNA.	This	enabled	calculation	of	the	gradient	and	intercept	from	the	equation	y=mx+c	
so	that	DNA	could	be	quantified	from	each	test	sample	from	the	measured	absorbance	
value.		
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The	effective	decellularisation	of	tissues	was	demonstrated	in	all	treatment	groups	
defined	by	SDS	dilution	in	the	decellularisation	process	(p<0.001).	No	difference	could	
be	demonstrated	between	SDS	treatment	groups	in	Bonferroni	post-hoc	tests	(p>0.1)	
indicating	there	was	no	difference	in	efficacy	with	variation	in	dilution	of	SDS	(Table	
12).	The	reproducibility	of	decellularisation	using	the	0.05%	SDS	(w/v)	concentration	
(p<0.001)	was	confirmed	by	no	significant	difference	in	DNA	levels	detected	between	
tissues	obtained	from	3	separate	donors	(Table	13).	In	all	treatment	groups,	98.9%	
(mean	99.1%)	or	greater	DNA	removal	was	achieved.	Effective	decellularisation	was	
also	indicated	by	the	absence	of	fluorescent	nuclear	staining,	otherwise	detectable	by	
DAPI	(4',	6-diamidino-2-phenylindole,	dihydrochloride)	in	decellularised	tissue	(Figure	
75).	In	contrast,	abundant	blue	fluorescent	staining	of	nuclei	was	demonstrated	in	the	
cellular	(control)	tissue	samples.		
	
	
	
	
	
	
	
	
	
	
	
	
Figure	74:	Standard	curve	of	fluorescence	absorbance	values	with	increasing	DNA	
concentration	in	control	samples	(known	dilutions	of	calf	thymus	DNA).		The	standard	curve	
shown	enabled	calculation	of	the	gradient	and	y	intercept	in	the	equation	y=mx+c	to	determine	
the	DNA	content	in	experimental	samples.		
	
Absorbance	
DNA	concentration	ng/ml	
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Treatment	group	 DNA	ng/mg	(SD)	 Percentage	DNA	removal		
Cellular	control	 54.5	 (10.4)	 -	
0.05%	 		0.4	 		(0.2)	 99.3	
0.1%	 		0.2		 		(0.1)	 99.7	
0.5%	SDS	 		0.3	 		(0.3)	 99.4	
	
	
Table	12:	Table	to	show	DNA	content	of	cellular	tissues	and	decellularised	tissues	using	SDS	of	
varying	concentration.	The	overall	ANOVA	model	was	significant;	p<0.001.	Data	was	log	
transformed	to	enable	parametric	data	analysis	and	ANOVA	model	was	satisfied	following	
Levene’s	test	of	equality	of	variance	(p=0.1).	Bonferroni	post	hoc	tests	between	
0.05%/0.1/0.5%	SDS	(w/v)	treatment	groups;	p≥0.1.	
	
	
	
Tissue		 DNA	ng/ml	(SD)	 Percentage	DNA	removal	
Cellular	control		 42.3						(7.4)	 -	
Donor	a	 		0.4	 	(0.2)	 98.9	
Donor	b		 		0.3	 	(0.1)	 99.2	
Donor	c	 		0.3	 	(0.1)	 99.3	
	
	
Table	13:	Table	to	show	DNA	content	of	cellular	tissues	and	donor	tissues	decellularised	with	
0.05%	SDS	(w/v).	Overall	ANOVA	model	was	significant	p<0.001.	Data	log	was	transformed	to	
enable	parametric	data	analysis	and	ANOVA	model	satisfied	following	Levene’s	test	of	equality	
of	variance	(p=0.28).	Bonferroni	post	hoc	tests	between	donor	a/b/c;	p≥0.1.	
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Figure	75:	Representative	photomicrographs	of	deparrafinised	tissue	sections	stained	with	
DAPI.	Bright	fluorescent	blue	staining	indicates	the	presence	of	DNA/nuclei	a)	cellular	
conjunctival	cellular	tissue:	b)	conjunctival	tissue	decellularised	with	0.05%	SDS	(w/v).		
	
	
3.6.2	 Contact	cytotoxicity	of	decellularised	conjunctival	tissue		
Photomicrographs	taken	of	fixed	Giemsa	stained	cultures	demonstrated	both	HCjE-Gi	
cells	and	primary	human	skin	fibroblasts	were	present	in	close	proximity,	seen	within	
and	around	decellularised	tissue	in	the	absence	of	a	zone	of	inhibition	or	any	cellular	
debris	that	would	have	indicated	the	presence	of	non-viable	cells	(Figure	76).	In	
contrast,	cellular	debris	indicating	non-viable	cells	were	demonstrated	surrounding	the	
cyanoacrylate	glue	sample	that	served	the	role	of	a	positive	(cytotoxic)	control	in	this	
experiment.	A	large	zone	of	inhibition	was	found	when	primary	human	fibroblasts	were	
cultured	with	cyanoacrylate	glue	(Figure	76).		
	 	
a)	 b)	
200μm	 200μm	
	 138	
	
		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	76:	Representative	photomicrographs	of	fixed	Giemsa	stained	cells	from	a	human	
conjunctival	cell	line	(HCjE-Gi	cells)	and	primary	human	skin	fibroblasts	in	culture	with	
decellularised	conjunctiva,	Steri-stripsTM	and	cyanoacrylate	glue	after	48	hours.	a)	
Decellularised	conjunctiva	with	cells	seen	in	contact	with	tissue	b)	Steri-stripsTM,	experimental	
negative	control	known	not	to	exhibit	cytotoxicity,	seen	here	with	cells	visible	in	contact	c)	
cyanoacrylate	glue,	experimental	positive	control	showing	cytotoxicity	with	cellular	debris	of	
HCjE-Gi	cells	surround	it	and	a	large	zone	on	inhibition	apparent	with	cellular	debris.		Scale	bars	
200µm.	
b)	c)	
c)	
a)	
b)	
HCjE-Gi	Cells	 Primary	human	skin	fibroblasts	
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3.6.3	 Tensile	strength	testing		
The	tensile	strength	of	cellular	and	decellularised	conjunctiva	were	tested	in	
comparison	to	ePTFE	and	cellular	and	decellularised	amniotic	membrane	(Table	14).	
The	mean	ultimate	tensile	stress	values	were	greatest	for	ePTFE;	however,	there	was	
no	significant	difference	between	ePTFE	and	cellular	or	decellularised	amniotic	
membrane.	The	ultimate	tensile	strength	was	least	for	cellular	and	decellularised	
conjunctiva	and	significant	differences	were	demonstrated	between:	conjunctiva	and	
amniotic	membrane	(p<0.0001);	and	conjunctiva	and	ePTFE	(p=0.01).		
	
Decellularised	amniotic	membrane	had	the	greatest	Young’s	modulus	(12.0	MPa),	
which	was	more	than	3-fold	higher	than	ePTFE	and	decellularised	conjunctiva,	
indicating	greater	stiffness.	Young’s	modulus	was	similar	between	ePTFE	and	
conjunctiva:	2.7	and	3.0	MPa	respectively	(p=1).	Marked	variance	in	conjunctival	and	
amniotic	membrane	tensile	stress	data	was	demonstrated	by	high	standard	deviation	
values	in	all	measured	parameters.	No	significant	difference	in	ultimate	tensile	stress	or	
Young’s	modulus	could	be	demonstrated	between	cellular	and	decellularised	
conjunctiva	or	between	cellular	and	decellularised	amniotic	membrane,	which	suggests	
no	change	in	stiffness	following	decellularisation	(Figure	77).			
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Tissue	
Ultimate	tensile	stress	
MPa	(+/-SD)	
Young’s	modulus	MPa		
(+/-SD)		
ePTFE	 1.2	(0.01)	 2.7	(0.2)	
Cellular	conjunctiva	 0.7	(0.5)	 3.9	(5.6)	
Decellularised	conjunctiva	 0.5	(0.9)	 3.0	(3.6)		
Cellular	amniotic	membrane	 1.7	(1.1)	 11.5	(6.1)	
Decellularised	amnion	 1.8	(0.7)	 12.0	(5.1)	
	
	
Table	14:	Table	of	results	from	tensile	strength	testing	of	ePTFE,	cellular	and	decellularised	
conjunctiva	and	amniotic	membrane.	Data	shown	in	this	table	was	normalised	by	log	
transformation	prior	to	ANOVA	analysis.	Overall	ANOVA	model	for	both	ultimate	tensile	
strength	and	Young’s	modulus	between	tissues;	p<0.0001.	No	significant	differences	were	
found	in	both	parameters	studied	between	cellular	and	decellularised	tissues;	p=0.354	ultimate	
tensile	strength;	p=0.561	Young’s	modulus.		
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Figure	77:	Representative	histograms	of	load	(N)	against	advancing	time	(seconds)	during	the	
tensile	strength	test:	a)	conjunctiva	b)	amniotic	membrane	c)	ePTFE.	Each	histogram	also	
demonstrates	the	section	of	the	curve	from	which	the	gradient	for	the	greatest	slope	was	
determined	(see	‘Greatest	slope’	marked	on	each	graph	by	the	red	arrows).		
	
Conjunctiva	
a)	
c)	
b)	
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3.6.4	 Collagen	Denaturation	Assay		
A	standard	curve	from	the	measured	absorbance	values	of	known	concentrations	of	a	
hydroxyproline	standard	enabled	the	determination	of	the	gradient	and	intercept	from	
the	equation	y=mx+c	(Figure	78).	These	values	allowed	hydroxyproline	quantification	
from	test	samples.	Minimal	collagen	denaturation	was	observed	in	all	tissue	samples	
studied	demonstrated	by	low	hydroxyproline	values	(range	3.12-6.24	hydroxyproline	
ng/mg).	The	negative	control	values	were	2.82	hydroxyproline	ng/mg.	No	difference	in	
hydroxyproline	was	found	between	paired	samples	of	cellular	and	decellularised	
conjunctival	tissue	suggesting	collagen	was	not	denatured	by	decellularisation	(p=0.74,	
paired	t-test).	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	78:	Standard	curve	of	colorimetric	absorbance	values	with	increasing	hydroxyproline	
concentration	from	known	concentrations	of	the	control	standard.		The	standard	curve	shown	
enabled	calculation	of	the	gradient	and	y	intercept	in	the	equation	y=mx+c	to	determine	the	
hydroxyproline	content	of	each	of	the	experimental	samples.		
	
Absorbance		
Hydroxyproline	ng/mg	tissue		
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	 Hydroxyproline	ng/mg	 SD	
Positive	control	 																196.8	 																					31.9	
Negative	control	 2.8	 0.9	
Cellular	tissue	donor	a		 3.1	 0.9	
Decellularised	tissue	donor	a	 4.0	 1.1	
Cellular	tissue	donor	b	 4.2	 1.2	
Decellularised	tissue	donor	b	 3.6	 0.8	
Cellular	tissue	donor	c	 6.2	 4.6	
Decellularised	tissue	donor	c	 5.2	 1.6	
	
Table	15:	Table	to	show	hydroxyproline	(ng/mg)	found	in	assays	of	paired	samples	of	cellular	
and	decellularised	tissue.	P=0.74:	paired	samples	t-test	between	cellular	and	decellularised	
donor	tissue	(n=3	in	each	group).	
	
	
3.6.5	 Histology	of	decellularised	conjunctiva		
Haematoxylin	and	Eosin	(H&E)	staining	of	cellular	and	decellularised	tissues	
demonstrated	marked	similarities	in	the	Eosin	staining	patterns	and	the	notable	
absence	of	basophilic	Haematoxylin	staining	in	keeping	with	the	absence	of	nuclei	in	
decellularised	tissue	(Figure	79).	Van	Gieson’s	stain	demonstrated	the	absence	of	
brown	staining	in	decellularised	tissue	indicating	the	absence	of	nuclear	material	and	
preserved	collagen	extracellular	matrix	architecture,	as	shown	by	the	red-purple	
staining	(Figure	80).	
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Figure	79:	Representative	photomicrographs	of	Haematoxylin	and	Eosin	stained	paraffin	
embedded	tissue	sections:	a)	decellularised	tissue;	b)	cellular	tissue.	Scale	bars	200µm.		
	
	
	
	
Figure	80:	Representative	photomicrographs	of	conjunctiva	tissue	stained	with	Van	Gieson’s	
stain:	a)	decellularised	tissue;	b)	cellular	tissue.	Scale	bars	100µm.	
	
	
	 	
a)	
a)	 b)	b)	
b)	a)	 b)	
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3.7	 Culture	of	primary	human	conjunctival	epithelial	cells	on	
decellularised	conjunctiva	
3.7.1	 Cell	culture	on	decellularised	tissue	substrates	with	primary	conjunctival	
epithelial	cells	using	explant	and	suspension	cultures	
The	conjunctival	explants	used	for	this	experiment	were	taken	from	donor	eye	5.	The	
isolated	cells	cultured	on	amniotic	membrane	were	sparse	and	grew	in	concentrated	
areas	in	comparison	to	explant	cultures	in	which	a	more	confluent	cell	culture	
developed	(Figure	81).	Similar	results	were	obtained	using	decellularised	conjunctiva	in	
which	explant	cultures	resulted	in	a	qualitatively	higher	cell	density	in	comparison	to	
the	culture	of	an	isolated	cell	suspension	using	cells	from	the	same	donor.	This	
difference	was	more	notable	on	amniotic	membrane	whereby	cells	were	also	
qualitatively	found	in	greater	density	than	on	conjunctiva	overall.	The	basement	
membrane,	however,	in	the	decellularised	tissue	appeared	to	be	absent	based	on	the	
H&E	staining	in	these	photomicrographs.	
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Figure	81:	Representative	photomicrographs	of	decellularised	amniotic	membrane	and	
conjunctival	tissue	sections	recellularised	with	conjunctival	epithelial	cells.		Greater	cell	density	
was	evident	qualitatively	following	explant	culture	(b	and	d)	than	that	following	suspension	
culture	(a	and	c).	Scale	bars	100µm.	Arrows	point	to	purple	nuclei	in	cells.		
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3.7.2	 Explant	culture	with	attention	to	conjunctival	basement	membrane	
orientation		
Confluent	cell	growth	was	demonstrated	with	qualitatively	greater	cell	density	from	
explant	cell	culture	following	the	confirmation	and	orientation	of	the	basement	
membrane	in	comparison	to	tissue	in	which	the	basement	membrane	could	not	be	
identified	(Figure	82).		The	explant	cultures	used	in	this	experiment	were	taken	from	
donor	eye	7.		
	
	
		
Figure	82:	Representative	photomicrographs	of	explant	cultures	grown	on	decellularised	tissue:	
a)	basement	membrane	not	present	b)	basement	membrane	present.	Arrows	are	pointing	to	
nuclei	(purple).	Scale	bars	100µm.		
	 	
a)	
a)	 b)	
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3.7.3	 Comparison	of	conjunctival	epithelial	cultures	using	tissue	from	
different	donors	for	explants	and	decellularised	substrates	
Conjunctival	tissues	from	donor	eyes	9,	5	and	13	were	decellularised	for	use	in	this	
experiment.	The	explants	cultured	on	these	substrates	were	taken	from	tissue	donor	
eyes	15,	17	and	19.	Results	from	these	experiments	showed	that	growth	was	sparse	
from	all	three	explant	donors.	The	best	results	qualitatively	based	upon	confluence	and	
the	apparent	density	of	cells	was	demonstrated	using	decellularised	tissue	from	donor	
13	and	explants	from	donor	19	(Figure	83-86).	Consistent	cellular	expansion	from	
explant	donor	19	however	was	not	evident	across	all	decellularised	tissue	samples.	
Donor	19,	however,	also	produced	the	greatest	density	of	cells	qualitatively	on	the	
amniotic	membrane	control	tissue	(Figure	86).	In	some	tissue	sections,	the	explant	
itself	was	visible	with	minimal	outgrowth	from	its	edge.	
	
	
											Tissue	donor	9																																		Tissue	donor	5																																			Tissue	donor	13			
	
Figure	83:	Representative	H&E	stained	photomicrographs	of	explants	from	donor	15	cultured	
on	decellularised	conjunctiva	from	tissue	donors	9/5/13.	The	photomicrograph	of	
decellularised	tissue	donor	5	has	captured	the	presence	of	explant	(solid	arrow)	with	
conjunctival	epithelium	that	had	developed	on	the	left	hand	side	of	this	photomicrograph	
(dashed	arrow).	In	contrast	minimal	and	no	nuclei	were	visible	in	photos	from	decellularised	
tissue	donors	9	and	13.	Scale	bars	200µm.	
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											Tissue	donor	9																																	Tissue	donor	5																															Tissue	donor	13	
	
Figure	84:	Representative	H&E	stained	photomicrographs	of	explants	from	donor	17	cultured	
on	decellularised	conjunctiva	from	tissue	donors	9/5/13.	No	cells	are	evident	from	on	tissue	
sections	derived	from	decellularised	tissue	donor	13.	Occasional	areas	of	epithelial	growth	
were	demonstrated	on	decellularised	tissues	from	donor	9	and	5.	In	the	centre	photo	from	
decellularised	tissue	donor	5	an	explant	(solid	arrow)	can	be	seen	with	cellular	outgrowth	
(dashed	arrow).	Scale	bars	200µm.	
	
	
	
												Tissue	donor	9																																Tissue	donor	5																														Tissue	donor	13			
	
Figure	85:	Representative	H&E	stained	photomicrographs	of	explants	from	donor	19	cultured	
on	decellularised	conjunctiva	from	tissue	donors	9/5/13.	No	cells	were	evident	from	on	tissue	
sections	derived	from	decellularised	tissue	donors	9	or	5	(donor	tissue	5	shows	only	the	explant	
with	no	outgrowth;	solid	arrow).	Cellular	growth	was	observed	in	most	tissue	sections	derived	
from	explant	culture	on	decellularised	tissue	donor	13	(dashed	arrow).	Scale	bars	200µm.	
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									Explant	donor	15																													Explant	donor	17																										Explant	donor	19	
	
Figure	86:	Representative	H&E	stained	photomicrographs	of	explants	from	donors	15/17/19	
cultured	on	a	decellularised	amniotic	membrane	substrate	(same	donor).	Cellular	growth	is	
evident	from	all	the	explants;	however,	qualitatively	the	greatest	density	of	cells	was	evident	
from	explants	derived	from	donor	19.	Scale	bars	200µm.	
	
3.7.4	 Further	conjunctival	explant	cultures	on	freshly	decellularised	tissues	
Further	conjunctival	explant	cultures	were	undertaken	using	decellularised	tissues	
stored	in	phosphate	buffered	saline	supplemented	with	1%	penicillin/streptomycin,	
used	within	one	week	of	decellularisation.	In	previous	experiments,	decellularised	
conjunctival	tissues	were	stored	at	-40oC	and	allowed	to	thaw	prior	to	use.	The	
decellularised	tissues	from	the	same	donor	(21)	were	seeded	with	explants	acquired	
within	hours	of	tissue	retrieval.	This	was	undertaken	twice	using	two	separate	donors	
(23	and	25).	Both	these	experimental	runs	resulted	in	more	confluent	growth	of	
conjunctival	epithelium	across	the	entire	sectioned	tissue	samples	on	both	
decellularised	conjunctiva	and	the	amniotic	membrane.	The	formation	of	a	multi-
layered	epithelium	was	also	evident	on	the	decellularised	conjunctiva	but	not	on	the	
amniotic	membrane	(Figure	87).	
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		Decellularised	amniotic	membrane																		Decellularised	conjunctiva	
	
Figure	87:	Representative	photomicrographs	of	stained	tissue	sections	following	conjunctival	
explant	culture	using	donor	23	(a)	and	25	(b)	on	decellularised	conjunctiva	(from	donor	21)	and	
amniotic	membrane.	Stratified	cells	were	demonstrated	on	decellularised	conjunctiva	in	
contrast	to	monolayer	formation	on	amniotic	membrane.	Qualitatively,	the	cell	density	and	
morphology	of	the	epithelium	appeared	similar	between	the	donors	(23	and	25)	on	both	tissue	
substrates.	Scale	bars	100μm.	
	
3.7.5	 Characterisation	of	the	cellular	phenotype	of	conjunctival	epithelium	
cultured	on	decellularised	conjunctiva	
An	embedded	tissue	wax	block	from	the	previous	experiment;	donor	21	with	explants	
from	donor	23	was	further	sectioned	to	allow	immunohistochemical	identification	of	
markers	associated	with	conjunctival	epithelial	cells.	Figure	89	demonstrates	abundant	
expression	of	CK19	throughout	the	tissue	sample.	In	contrast,	CK7	and	CK4	were	
a)	
b)	
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expressed	in	a	qualitatively	lower	proportion	of	cells.	MUC5AC	expression	was	
qualitatively	sparse,	however	detectable,	within	the	tissue	sections	examined.	Markers	
of	progenitor	cells	ΔNp63	and	ABCG2	were	also	present	in	lesser	frequency,	and	ABGC2	
expression	appeared	less	abundant	than	ΔNp63	(Figure	90).	Levels	of	PCNA	expression	
appeared	similar	to	that	of	ΔNp63.	Caspase	3,	a	marker	of	apoptotic	cells	was	also	
present	and	appeared	to	be	expressed	in	apical	rather	than	basal	cells,	in	contrast	to	
the	other	cell	markers	studied	which	appeared	more	evenly	distributed.		
	
	
	
	
Figure	88:	Representative	photomicrographs	of	tissue	sections	of	conjunctival	tissue	(a)	mouse	
IgG	isotype	control,	(b)	rabbit	IgG	isotype	control	stained	with	Mayers	haematoxylin	only.	
These	representative	images	display	the	level	of	background	staining	detected	for	
immunohistochemistry	samples	in	this	section	and	are	the	negative	controls.	Scale	bars	100μm.	
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Figure	89:	Representative	photomicrographs	of	immunohistochemical	staining	of	tissue	
sections	of	decellularised	conjunctiva	21	recellularised	using	explants	from	donor	23.	All	brown	
staining	represents	positive	immunolocalisation	of	the	respective	marker	studied.	Scale	bars	
100µm.		
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Figure	90:	Representative	photomicrographs	of	immunohistochemical	staining	of	tissue	
sections	of	decellularised	conjunctiva	21	recellularised	using	explants	from	donor	23.	All	brown	
staining	represents	positive	immunolocalisation	of	the	respective	marker	studied.	Scale	bars	
100µm.			 	
ABCG2	 Caspase-3	
PCNA	 ΔNp63	
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3.8	 Identification	and	characterisation	of	basement	membranes	of	
human	conjunctiva	and	amniotic	membrane		
3.8.1	 Characterisation	of	basement	membrane	with	PAS	
Conjunctiva	from	three	tissue	donors	and	amniotic	membrane	from	three	tissue	donors	
were	stained	with	periodic	acid	Schiff	(PAS)	stain	to	identify	glycoproteins	within	
basement	membranes.	PAS	also	stains	transmembrane	and	goblet	cell	associated	
mucins	in	conjunctival	epithelium.	The	thickness	of	the	basement	membrane	and	
intensity	of	staining	were	qualitatively	similar	between	paired	samples	(cellular	and	
decellularised	tissue)	of	both	amniotic	membrane	and	conjunctiva	(Figure	91	and	92).	
The	outline	of	cells	were	also	visualised	and	demonstrated	on	cellular	tissue	samples	of	
both	conjunctiva	and	amniotic	membrane.	This	was	notably	absent	in	decellularised	
tissue	samples.	Representative	photomicrographs	taken	from	the	centre	of	the	slide	
mounted	stained	tissue	section	are	shown	(Figures	91	and	92).		
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Figure	91:	Representative	photomicrographs	tissue	sections	of	cellular	(a)	and	decellularised	
amniotic	membrane	(b)	from	three	tissue	donors	stained	with	PAS.	The	basement	membrane	
tissues	appear	stained	and	similar	between	cellular	and	decellularised	tissue	sections	
suggesting	it	was	preserved	following	decellularisation.		Scale	bars	100µm.		
	
	 	
	
a)	
b)	
a)	
Donor	1	 Donor	2	 Donor	3	
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Figure	92:	Representative	photomicrographs	tissue	sections	of	cellular	(a)	and	decellularised	
conjunctiva	(b)	from	three	tissue	donors	stained	with	PAS.	The	basement	membrane	PAS	
staining	in	all	the	cellular	and	decellularised	tissues	appeared	similar	between	tissue	sections	
suggesting	it	was	preserved	following	decellularisation.	Scale	bars	100µm.		 	
a)	
b)	
Donor	1	 Donor	2	 Donor	3	
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3.8.2	 Characterisation	of	cellular	and	decellularised	tissue	with	laminin,	
collagen	IV	and	fibronectin	
Deparaffinised	tissue	sections	from	three	conjunctival	epithelial	donors	and	three	
amniotic	membrane	donors	were	characterised	for	collagen	IV,	fibronectin	and	laminin	
by	immunohistochemical	staining.	Both	cellular	and	decellularised	tissues	were	stained	
to	ascertain	whether	decellularisation	qualitatively	affected	the	immunohistochemical	
detection	of	extracellular	proteins.	Three	different	donors	have	been	studied	for	each	
tissue	type.	The	images	(Figures	93-99)	demonstrate	that	collagen	IV,	laminin	and	
fibronectin	were	detectable	in	the	epithelial	tissue	basement	membranes	and	stromal	
tissue.	The	strongest	staining,	qualitatively,	was	present	in	the	basement	membranes.	
Overall,	there	did	not	appear	to	be	any	significant	difference	in	the	detection	of	these	
proteins	between	donors.	Furthermore,	decellularisation	did	not	reduce	the	intensity	
or	distribution	of	staining	by	qualitative	observation.	The	gross	morphology	of	the	
tissue,	specifically	the	thickness	and	appearance	of	underlying	stromal	tissue,	however,	
appeared	to	differ	more	significantly	between	the	conjunctival	donor	tissues	(Figure	
97-99)	than	the	amniotic	membrane	tissues	(Figure	94-96).	
	
	
	
	
	
	
	
	
Figure	93:	Representative	photomicrographs	of	tissue	sections	of	conjunctival	tissue	(a)	and	
amniotic	membrane	(b)	incubated	with	isotype	controls	and	stained	with	Mayer’s	haematoxylin	
only.	These	representative	images	display	the	level	of	background	staining	detected	for	
immunohistochemistry	samples	in	this	section.	All	primary	antibodies	were	raised	in	rabbit.	
Scale	bars	100μm.	
a)	 b)	
a)	 b)	
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Figure	94:	Representative	photomicrographs	of	cellular	(a)	and	decellularised	(b)	amniotic	
membrane	tissue	sections	from	three	separate	donors	examined	for	laminin	by	
immunohistochemistry.	All	brown	staining	represents	positive	immunolocalisation	of	laminin.	
Scale	bars	100μm.			 	
Donor	1	 Donor	2	 Donor	3	
a)	
b)	
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Figure	95:	Representative	photomicrographs	of	cellular	(a)	and	decellularised	(b)	amniotic	
membrane	tissue	sections	from	three	separate	donors	examined	for	fibronectin	by	
immunohistochemistry.	All	brown	staining	represents	positive	immunolocalisation	of	
fibronectin.	Scale	bars	100μm.		 	
Donor	1	 Donor	2	 Donor	3	
a)	
b)	
	 161	
	
	
	
Figure	96:	Representative	photomicrographs	of	cellular	(a)	and	decellularised	(b)	amniotic	
membrane	tissue	sections	from	three	separate	donors	examined	for	collagen	IV	by	
immunohistochemistry.	All	brown	staining	represents	positive	immunolocalisation	of	collagen	
IV.	Scale	bars	100μm.		 	
Donor	1	 Donor	2	 Donor	3	
a)	
b)	
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Figure	97:	Representative	photomicrographs	of	cellular	(a)	and	decellularised	(b)	conjunctival	
tissue	sections	from	three	separate	donors	examined	for	laminin	by	immunohistochemistry.	All	
brown	staining	represents	positive	immunolocalisation	of	laminin.	Scale	bars	100μm.	
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Figure	98:	Representative	photomicrographs	of	cellular	(a)	and	decellularised	(b)	conjunctival	
tissue	sections	from	three	separate	donors	examined	for	fibronectin	by	immunohistochemistry.	
All	brown	staining	represents	positive	immunolocalisation	of	fibronectin.	Scale	bars	100μm.	
	 	
Donor	1	 Donor	2	 Donor	3	
b)	
a)	
	 164	
	
	
Figure	99:	Representative	photomicrographs	of	cellular	(a)	and	decellularised	(b)	conjunctival	
tissue	sections	from	three	separate	donors	examined	for	collagen	IV	by	immunohistochemistry.	
All	brown	staining	represents	positive	immunolocalisation	of	collagen	IV.	Scale	bars	100μm.	
	
3.9	 Characterisation	of	patients	with	ocular	MMP	
Five	patients	were	examined	and	are	described	in	this	section.	Two	of	five	patients	
examined	had	visual	acuities	of	6/9	Snellen	acuity	or	lower	in	one	or	both	eyes.	In	both	
cases	there	was	co-existing	ocular	pathology	that	accounted	for	the	visual	impairment.	
Patient	1	had	normal	tension	glaucoma	and	visual	acuity	of	6/18	and	6/9	right	and	left	
eyes	respectively.	Patient	2	had	age	related	macular	degeneration	with	geographic	
atrophy	and	visual	acuity	of	6/12	and	6/60	right	and	left	eye	respectively.	Four	patients	
had	an	inflammatory	score	≥5	in	one	or	both	eyes.	The	score	“0”	and	“1”	were	difficult	
to	differentiate	when	assessed	at	slit	lamp	examination.	All	patients	had	one	or	both	
Donor	1	 Donor	2	 Donor	3	
b)	
a)	
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eyes	grade	III	involvement	by	Foster.(153)	Assessment	by	Tauber	grading	found	only	1/10	
eyes	had	no	involvement	and	this	was	in	keeping	with	the	Tauber-Liverpool	score.(154,	
156)	All	patients	had	in	one	or	both	eyes	≥60%	vertical	involvement	and	≥50%	horizontal	
involvement.	Four	patients	had	a	Rowsey	score	≤50%	of	the	total	score.(155)	All	patients	
had	grade	II	or	less	oxford	grading	score	(mild).	No	eyes	had	corneal	involvement	
exceeding	grade	1	on	any	of	the	measured	parameters	(conjunctivalisation/	
neovascularisation	/opacification).	No	eyes	had	lagophthalmos	or	any	upper	lid	
deformity.	Only	one	patient	had	a	lower	lid	deformity,	which	was	a	grade	1	lateral	and	
medial	entropion	that	was	in	keeping	with	the	degree	of	their	bilateral	conjunctival	
cicatrisation.	Eight	of	ten	eyes	had	trichiasis	of	any	degree.		
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Patient	number	 1;	OD	and	
OS		
2;	OD	and	
OS	
3;	OD	and	
OS	
4;	OD	and	
OS	
5;	OD	and	
OS	
Conjunctiva	 	 	 	 	 	
Inflammatory	score	
totals	(limbitis)	
5;	7	
(n;	n)	
5;	5	
(n;	n)	
4;	2		
(n;	n)	
4;	10	
(n;	n)	
7;	2		
(n;	n)	
Tauber	score	 IIcIIIb;	IIcIIIb	 IIdIIId;	
IIdIIId	
IIcIIIb;	
IIbIIIa	
IIdIIId;	
IIbIIIb	
IIcIIIb;		
IIaIIIa(nil)	
Tauber-Liverpool	(%	
II/III)	
65/30;		
70/35	
75/100;	
75/83	
60/25;	
50/13	
85/83;	
50/25	
70/46;	
0/0	
Rowsey	(score/45)	 22;	24	 16;	19	 29;	36	 14;	29	 28;	45	
Foster	 III;	III	 III/III	 III/III	 III/III	 III/0	
Fornix	upper/lower	
(mm)	
6/3;		
6/4	
5/0.5;	
6/0.5	
6/2;		
6/3	
0/6;		
8/4	
6/2;		
8/5	
Cornea	 	 	 	 	 	
Oxford	dryness	score	 2;	2		 1;	1	 2;	2	 2;	1		 1;	2	
Conjunctivalisation/	
neovascularisation	
1/1;	1/0	 1/0;	1/0	 0/0;	1;0	 1/1;	0/0	 1/0;	0/0	
Opacification	
peripheral/central	
0/0;	0;0	 0/0;	0/0	 0/0;	0/0	 1/0;	0/0	 1/0;	0/0	
LIDS	 	 	 	 	 	
Lagophthalmos	 n;	n	 n;	n	 n;	n	 n;	n	 n;	n	
Lashes	 T;	T	 T;	n	 T;		T	 T;	T	 T;	n	
Upper	lid	deformity	
and	grade	
n;	n	 n;	n	 n;		n	 n;	n	 n;	n	
Lower	lid	deformity	
and	grade	
n;	n	
(laxity	but	
grade	0)	
Entrop	G1	
L+M;		
Entrop	G1	
L+M	
n;		n	 n;	n	 n;	n	
Table	16:	Table	displaying	conjunctival,	corneal	and	lid	involvement	in	ocular	MMP	patients	
examined	using	the	new	pro	forma:	OD=right	eye,	OS=left	eye,	n=	none/no	involvement,	T=	trichiasis	
(any	degree),	Entrop=	entropion;	G=grade	L=lateral,	M=medial.	See	appendix	1	for	full	details	of	
grading.	
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Figure	100:	Photographs	of	the	right	eye	of	patient	4.	The	extent	of	horizontal	symblepharon	
involvement	was	20mm	extending	medially	from	the	lateral	canthus:	a)	lower	lid	held	at	
tension	b)	upper	lid	held	at	tension.	The	distance	between	the	inferior	limbus	at	the	midline	to	
the	edge	of	the	subconjunctival	fibrosis	was	1.5mm.	The	fornix	ruler	could	not	be	inserted	into	
the	inferior	conjunctival	fornix.		
	
	
a)	 b)	
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4	 Discussion		
4.1	 Overview		
The	conjunctiva	is	a	mucous	membrane	that	is	an	important	component	of	the	ocular	
surface.	In	a	range	of	conjunctival	diseases	leading	to	cicatrisation,	it	may	become	
irreversibly	damaged.	This	leads	to	dryness	and	desiccation	of	the	ocular	surface	and	
may	ultimately	lead	to	corneal	blindness.	To	restore	vision,	any	potential	corneal	or	
limbal	stem	cell	transplant	is	likely	to	fail	in	the	presence	of	significant	conjunctival	
disease.	This	study	sought	to	develop	novel	substrates	on	which	conjunctival	
epithelium	could	be	expanded	for	use	as	conjunctival	grafts.		
	
Two	novel	substrates	have	been	developed,	each	with	differing	properties	to	suit	a	
different	range	of	clinical	indications.	A	conjunctival	construct	developed	from	the	ex	
vivo	expansion	of	conjunctival	epithelium	on	a	decellularised	conjunctival	substrate	is	
degradable	and	therefore	may	suit	indications	where	smaller	grafts	are	required.	This	is	
in	contrast	to	a	conjunctival	construct	developed	from	the	expansion	of	conjunctival	
epithelium	on	ePTFE,	which	is	non-degradable	and	available	in	large	quantities	to	suit	
indications	where	a	larger	graft	is	required.	In	particular,	this	may	suit	forniceal	
reconstruction	whereby	the	substrate	would	remain	in	situ	to	prevent	recurrent	
forniceal	loss.		
	
Described	in	the	following	sections	is	the	process	whereby	ePTFE	and	decellularised	
conjunctival	substrates	have	been	developed	as	culture	substrates.	Ammonia	gas	
plasma	modification	of	ePTFE	and	its	effect	on	hydrophilicity	is	described	along	with	an	
exploration	of	the	optimal	culture	media	for	the	growth	of	conjunctival	cells.	The	cell	
density	of	cultured	cells	has	also	been	compared	when	ePTFE	is	treated	on	one	or	both	
surfaces	(surface	and	underside).	Finally,	the	phenotype	of	conjunctival	cells	developed	
on	plasma	treated	ePTFE	is	compared	with	untreated	ePTFE	and	an	established	cell	
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culture	material,	Thincert,	in	which	the	cell	culture	surface	is	a	chemically	modified	PET	
membrane.	In	all	experiments,	PET	membrane	is	used	as	a	positive	control	given	that	it	
is	an	established	product	designed	for	cell	culture.	Chemically	modified	PET	is	
sucessfully	utilised	in	medical	applications	such	as	capillary	membranes	for	dialysis	and	
implantable	medical	devices	such	as	vascular	stents.(175)	It	would	not	serve	as	a	
potential	substrate	for	conjunctival	transplantation,	however,	due	to	its	rigidity.	In	
contrast,	ePTFE	can	be	manufactured	into	thin	and	durable	sheets	with	a	high	degree	
of	elasticity	and	making	it	ideally	suited	to	soft	biological	tissue	applications	with	
demonstratrable	superiority	to	other	polymers.(175,	176)	PET	membrane	is	therefore	
utilised	as	a	positive	control	in	this	study	rather	than	being	investigated	as	an	
alternative	substrate	for	conjunctival	epithelial	expansion.		
	
The	decellularisation	of	human	conjunctiva	has	not	been	previously	reported.	
Described	within	the	following	sections	are	the	development	of	a	suitable	protocol	for	
the	decellularisation	of	human	conjunctiva	and	its	characterisation	in	terms	of	DNA	
content,	collagen	degradation,	tensile	strength,	basement	membrane	composition	and	
contact	cytotoxicity.	Several	attempts	have	also	been	made	to	develop	conjunctival	
cultures	on	the	decellularised	substrate	with	some	success	when	the	explant	cultures	
are	developed	on	decellularised	tissue	with	an	intact	basement	membrane.	The	
expression	of	a	range	of	conjunctival	markers	in	the	developed	conjunctival	construct	is	
also	described.			
	
	
4.2	 Ammonia	gas	plasma	treatment	increases	the	hydrophilicity	of	
ePTFE		
Expanded	polytetrafluoroethylene	(ePTFE)	is	a	relatively	hydrophobic	material.	
Ammonia	gas	plasma	was	used	as	a	treatment	in	this	study	to	increase	the	
hydrophilicity	of	ePTFE	to	improve	its	ability	to	support	cell	adhesion	and	proliferation.	
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Indeed,	ammonia	gas	plasma	has	been	previously	shown	to	increase	the	surface	
wettability	of	a	range	of	polymers	including	PTFE	and	PDMS.(108,	177)	The	results	from	
this	study	confirm	that	radio-frequency	glow	discharge	(RFGD,	also	referred	to	as	gas	
plasma)	followed	by	the	post-treatment	modification	in	distilled	water	resulted	in	a	
significant	reduction	contact	angle	to	71o,	which	is	54%	of	the	original	static	contact	
angle	of	untreated	ePTFE.	These	contact	angle	measurements	are	in	keeping	with	
previous	studies	on	the	ammonia	plasma	treatment	of	ePTFE,	which	also	demonstrated	
that	the	substrate	supported	the	growth	of	functional	retinal	pigment	epithelium.(107)	In	
general,	contact	angles	<90o	are	considered	highly	wettable	surfaces	in	which	
significant	spread	of	a	droplet	of	water	can	be	observed,	whereas	those	with	contact	
angles	>90o	are	considered	to	be	less	wettable.(109)	
	
A	potential	limitation	in	this	study	is	the	use	of	static	contact	angle	measurements	
rather	than	dynamic	contact	angle	measurements.	Potential	advantages	of	the	dynamic	
contact	angles	are	the	assessment	of	both	advancing	and	receding	measurements	of	
the	contact	angle.	These	act	as	surrogate	measures	of	hydrophobicity	and	
hydrophilicity	respectively.(109)	This	allows	additional	information	on	the	hysteresis	and	
therefore	the	roughness	of	the	material.(109)	Dynamic	contact	angle	measurements	
have	however,	been	obtained	previously	for	ammonia	gas	plasma	modified	ePTFE	in	an	
earlier	study.(178)	The	main	remit	of	contact	angle	measurement	in	the	present	study	
was	to	ensure	that	the	treatment	had	the	desired	effect	on	hydrophilicity.	Features	to	
optimise	reliability	of	static	contact	angle	measurement	in	the	present	study	included	a	
motorised	drop	dispenser	to	ensure	a	droplet	was	dispensed	in	a	controlled	rate	and	
volume,	an	enclosed	chamber	to	reduce	airborne	contamination,	optical	measurement	
based	upon	an	image	taken	by	an	in-built	camera	and	automated	process	to	reduce	
problems	with	observer	determined	tangent	lines.(109)	
	
The	RFGD	followed	by	the	post-treatment	modification	in	distilled	water	has	been	
demontrated	by	x-ray	photoelectron	spectroscopy	to	result	in	breakage	of	the	carbon-
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fluorine	bonds	which	are	replaced	by	hydroxyl	groups	(OH).(179)	Defluorination	has	also	
been	shown	to	result	in	the	addition	of	other	nitrogen	and	oxygen	containing	moieties,	
which	also	result	in	an	increase	in	surface	wettability	though	ammonia	gas	plasma.(108,	
171,	172,	180)		
	
The	specific	chemical	composition	of	the	polymer,	including	the	‘functional’	groups	
present	on	its	surface	as	a	result	of	plasma	treatment	and	the	resulting	wettability	
greatly	influence	the	nature	of	interactions	with	both	cells	and	proteins.	(108)	Studies	
have	shown	that	materials	with	terminal	functionalities	including	hydroxyl		
(-OH)	groups	and	substrates	with	increased	wettability,	in	general,	adsorb	peptides	to	
the	material	surface	more	easily	and	positively	influence	cell	attachment	and	
proliferation.(181,	182)	Alternative	gas	plasma	modifications	include	modification	with	
oxygen	and	air.(108)	These	were	not	explored	in	this	study	as	ammonia	gas	plasma	
modification	was	shown	to	be	successful	in	supporting	retinal	pigment	epithelium.(178)	
Given	that	ammonia	gas	plasma	treatment	also	increased	the	cell	density	of	cultured	
conjunctival	epithelium,	further	modifications	were	not	attempted.	Investigation	of	
alterative	gas	plasmas	however	may	warrant	consideration	in	future	work.	
	
An	ideal	synthetic	substrate	should	allow	the	adherence	of	cells	and	support	cell	
proliferation	and	differentiation	along	an	appropriate	lineage.	To	this	end,	a	multitude	
of	factors	are	responsible	for	optimal	cell	culture	in	vitro	including	media	and	its	
supplements,	the	surface	topology,	roughness	and	stiffness	of	the	substrate,	porosity	
and	surface	chemistry.(77,	183-185)	Scanning	electron	microscopy	of	ePTFE,	suggested	that	
RFGD	may	result	in	a	mild	degree	of	surface	etching	of	the	surface	ridges	that	was	not	
apparent	on	ePTFE	when	examined	as-received.(108,	171,	172,	180)	The	effect	of	this	
together	with	other	surface	topology	features	warrant	consideration.		
	
Other	modifications	to	consider	in	future	work	include	the	immobilisation	and	
adsorption	of	extracellular	matrix	proteins	on	the	material	surface	to	mimic	native	
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basement	membranes.(183)	To	this	end,	differential	signalling	in	conjunctival	epithelial	
cells	have	been	determined	when	adherent	to	different	isoforms	of	laminin.(186)	This	
therefore	confirms	the	potential	for	cell-matrix	interactions	of	conjunctival	epithelial	
cells	and	their	influence	on	cellular	phenotype	and	behaviour.(187)	
	
The	production	of	a	basement	membrane	has	been	reported	in	mature	endothelial	cell	
cultures	in	vascular	grafts	developed	from	synthetic	substrates.(185,	188)	It	has	been	
proposed	that	basement	membrane	deposition	would	occur	from	most	cell	types	when	
cultured	on	synthetic	substrates.(189)	Although	beyond	the	remit	of	the	present	study,	it	
would	be	of	interest	to	determine	the	timescale	required	for	the	development	of	a	
basement	membrane	from	conjunctival	epithelium	on	ePTFE	and	to	explore	the	specific	
components	deposited	in	comparison	to	conjunctival	basement	membrane.		
	
	
4.3	 Experimental	use	of	the	HCjE-Gi	Cell	line		
4.3.1	 Characteristics	of	the	HCjE-Gi	cell	line	
The	HCjE-Gi	cell	line	was	chosen	for	this	study	given	its	similarity	to	primary	human	
conjunctiva	in	terms	of	its	keratin	repertoire	and	mucin	gene	expression	including	
goblet	cell	specific	MUC5AC.(190)	Alternatives	such	as	the	IOB-NHC	cell	line	and	Chang	
cell	line	were	excluded	as	there	were	concerns	that	the	IOB-NHC	was	showing	signs	of	
senescence	(personal	communications	with	Dr.	Diebold)	and	the	Chang	cell	line	was	
recognised	to	have	HeLa	cell	contaminants	displaying	a	more	fibroblastic	phenotype.	
Characterisation	studies	by	the	Gipson	group	acknowledged	that	HCjE-Gi	epithelia	were	
similar	to	native	conjunctiva,	but	they	did	not	achieve	the	normal	morphologic	
differentiation	observed	in	native	conjunctiva.	A	small	subpopulation	of	HCjE-Gi	cells	
expressed	MUC5AC	mRNA	when	developed	on	type	1	collagen	and	fibroblast	co-
culture,	however,	there	was	no	morphological	evidence	of	goblet	cell	presence	or	
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secreted	mucin	within	cultures.	Despite	the	culture	of	HCjE-Gi	cells	under	the	kidney	
capsule	of	SCID	mice,	the	cell	line	still	did	not	develop	mature	goblet	cells.	The	Gipson	
group	suggested	that	it	was	likely	that	the	differentiation	pathway	had	been	
deleteriously	altered	such	that	goblet	cell	differentiation	would	not	take	place,	in	
keeping	with	other	reports	on	the	phenotypic	outcome	of	cell	transformation.	(191)		
	
Similar	to	the	present	study,	the	HCjE-Gi	cell	line	has	also	been	used	in	studies	of	
substrate	development	for	conjunctival	expansion	and	in	studies	of	mucin	gene	
expression.(190)	Despite	evidence	that	the	cell	line	may	not	fully	differentiate,	the	HCjE-
Gi	cell	line	was	used	for	the	present	study	as	the	upregulation	and	therefore	the	
relative	increase/decrease	in	conjunctival	epithelial	markers	may	serve	as	the	best	
available	indication	of	the	expected	response	in	primary	conjunctival	epithelium.	In	this	
study,	consistency	and	repeatability	of	cellular	response	was	of	particular	importance	
given	that	numerous	substrates	and	experimental	repeats	were	required	for	
experiments.	The	alternative	of	using	primary	conjunctival	epithelial	cells	from	a	single	
donor	would	have	been	insufficient.	The	detection	of	MUC5AC	by	flow	cytometry	had	
not	been	previously	reported	in	the	HCjE-Gi	cell	line	and	was	therefore	also	
investigated.		
	
4.3.2	 Surface	modified	ePTFE	allows	human	conjunctival	cell	attachment	and	
proliferation	with	an	appropriate	cell	seeding	density	and	cell	culture	media	
4.3.2.1		 Determination	of	the	optimal	cell	seeding	density		
Determination	of	an	optimal	cell	seeding	density	is	crucial	in	the	context	of	
repopulating	synthetic	scaffolds	with	cells.	Studies	on	the	cell	seeding	density	of	
primary	endothelial	cells	found	that	between	20-70%	of	cells	that	initially	adhered	to	
synthetic	materials	were	lost	after	one	hour.(192)	This	is	likely	to	occur	in	most	cell	types	
and	depends	upon	the	substrate	used	for	culture.(185)	The	residual	cells	may	partially	
replace	cell	loss	by	proliferation	and	migration	but	this	would	depend	on	the	density	of	
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residual	cells.(185)	It	follows	therefore,	that	initial	cell	seeding	experiments	enable	the	
development	of	cultures	within	a	suitable	time	frame	and	rate	but	importantly,	ensure	
that	the	development	of	confluent	cell	growth	is	possible.		
	
In	the	present	report,	it	was	noted	that	the	cell	seeding	density	was	more	crucial	for	
cultures	seeded	on	ammonia	plasma	treated	ePTFE	than	those	on	PET	membrane	
(polyethylene	terephthalate;	Thincert).	A	cell	seeding	density	of	1x104cells/cm2	versus	
1x105cells/cm2	on	plasma	treated	ePTFE	led	to	a	more	than	3-fold	difference	in	cell	
density	after	7	days	in	culture.	This	contrasts	with	PET	membrane	in	which	the	
difference	in	cell	density	at	7	days	after	seeding	at	1x104cells/cm2	was	approximately	
30%	less	than	an	initial	seeding	density	of	1x105cells/cm2.	The	observed	differences	
suggest	a	superior	ability	of	PET	to	support	greater	cell	adherence	following	seeding.		
	
In	models	of	bone	regeneration,	the	cell	seeding	density	was	regarded	as	a	critical	
factor	to	the	synthesis	of	extracellular	matrix	and	subsequent	induction	of	new	
bone.(193)	The	role	of	cell	seeding	density	has	also	been	shown	to	influence	the	
differentiation	of	pluripotent	stem	cells	and	in	particular,	the	expression	of	tight	
junctional	proteins.(194)	It	seems	likely	therefore,	that	the	cell	density	is	of	critical	
importance	to	ensure	cell-cell	contact	and	signalling.(185)	This	was	proven	by	Chen	and	
colleagues,	who	demonstrated	that	proliferation	of	cells	in	culture	was	dependent	
upon	cell-cell	contact,	and	not	just	soluble	factors	within	media.	This	was	
demonstrated	through	experiments	designed	to	control	the	space	and	contact	
between	pairs	of	cells.(195)		
	
4.3.2.2		 Determination	of	the	optimal	culture	media		
The	original	protocol	for	culture	of	the	human	conjunctival	cell	line	HCjE-Gi	had	
described	the	use	of	‘early’	and	‘late’	grow	media	formulae,	which	were	replicated	in	
the	present	study.(190)	The	purpose	of	testing	a	change	in	media	from	the	‘early’	to	
‘late’	formula	after	3	days	(protocol	C)	and	7	days	(protocol	B)	in	culture	were	to	
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ascertain	which	protocol	would	lead	to	a	greater	cell	density.	Furthermore,	it	was	also	
of	interest	to	quantify	cell	density	using	the	‘late	grow’	media	alone	to	determine	
whether	the	initial	early	grow	media	was	required.	A	further	cohort	also	included	the	
‘early	grow’	media	with	1%	BSA	(w/v)	in	the	place	of	bovine	pituitary	extract	and	
epidermal	growth	factor.	The	1%	BSA	cohort	(protocol	D)	was	included	to	determine	its	
effect	on	cell	density	since	to	the	best	of	my	knowledge,	it	has	not	been	previously	
reported	as	a	media	constituent	used	in	the	culture	of	epithelial	cells.		
	
Gipson	and	colleagues	had	described	a	protocol	in	which	the	‘early	grow’	media	was	
changed	to	the	‘late	grow’	formula	when	HCjE-Gi	cells	were	70-100%	confluent.(190)	As	
the	ePTFE	substrate	is	opaque,	phase	microscopy	could	not	be	used	when	an	
experiment	is	in	progress	to	determine	cellular	confluence.	The	use	of	media	protocols	
A	and	D	led	to	an	overall	decline	in	cell	density	in	contrast	to	protocols	B	and	C,	in	
which	the	cell	density	increased	with	advancing	time	in	culture.	In	protocols	B	and	C,	
the	media	was	changed	from	‘early’	to	the	‘late	grow’	media	after	7	and	3	days	
respectively.	The	experiment	determined	that	the	greatest	cell	density	can	be	achieved	
if	the	media	is	changed	from	an	‘early	grow’	to	the	‘late	grow’	formula	on	day	7	
(protocol	B)	when	cells	are	seeded	at	1x105	cells/cm2.	This	was	in	keeping	with	existing	
protocols	for	the	culture	of	the	HCjE-Gi	cell	line	in	which	the	late	grow	formula	was	
used	once	cells	were	70-100%	confluent.(190)	This	was	evident	and	in	keeping	with	the	
cell	density	and	spacing	demonstrated	on	DAPI	stained	photomicrographs,	which	
demonstrate	confluent	cultures	on	treated	ePTFE	and	PET	membrane	but	sparse	cell	
growth	on	untreated	ePTFE.	Interestingly,	even	untreated	ePTFE	supported	a	slowly	
increasing	population	of	HCjE-Gi	cells	in	culture	with	media	protocol	B.	This	was	in	
contrast	to	culture	in	media	protocol	C,	in	which	a	decline	in	cell	density	was	
demonstrated	after	7	days	in	culture.	The	PET	membrane	was	demonstrated	to	support	
a	steady	cell	density	with	media	protocol	A	in	comparison	to	ePTFE	substrates	in	which	
a	more	obvious	decline	is	notable	with	advancing	time.	It	follows	therefore,	that	the	
PET	membrane	may	be	supplying	factors	that	enable	a	higher	rate	of	initial	cell	
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adherence	and	maintenance	of	a	higher	cell	density	in	comparison	to	cultures	
developed	on	ePTFE.	These	data	also	demonstrate	that	untreated	ePTFE	supports	a	
very	limited	population	of	cells	and	the	resulting	cell	density	is	influenced	by	factors	in	
the	culture	media.	It	is	unlikely	that	untreated	ePTFE	would	serve	as	a	useful	substrate	
in	cell	culture	applications	given	the	sparse	cell	density	of	cells	after	14	days	in	culture.		
	
For	optimal	cell	growth	in	vitro,	the	osmolality	and	pH	of	the	media	must	be	tightly	
controlled.	In	addition,	the	media	must	contain	sugars,	salts,	amino	acids,	growth	
factors	and	hormones	specific	to	the	cell	type	being	cultured.(185)	In	a	variety	of	media,	
growth	factors	and	hormones	are	supplied	through	the	addition	of	foetal	calf	serum	to	
constitute	10%	of	the	media.(185)	Disadvantages	of	this	approach	are	the	potential	for	
the	transmission	of	infection	and	the	potential	variability	in	batches	of	serum.(185)	
Bovine	serum	albumin	(BSA)	is	commonly	used	in	media	studies	of	gametes	including	
the	ovine	oocytes	model	(0.04%	w/v)	and	spermatogonal	stem	cells.(196,	197)		Media	
used	in	the	culture	of	spermatogonal	stem	cells	contains	0.2%BSA	and	a	number	of	
cytokine	constituents	have	been	identified	including	fibroblast	growth	factor-2,	glial	
cell-line	derived	neurotrophic	factor	and	GDNF	family	receptor	alpha	1.(198,	199)	Indeed	
other	media	designed	for	stem	cell	culture	have	been	developed	for	haemopoietic	
stem	cell	culture	which	include	0.5%	BSA	in	StemPro34-SFM	media,	but	this	also	
contains	1%	foetal	calf	serum.(200)		
	
Given	the	above	examples	of	the	use	of	BSA	in	media,	it	seems	to	have	greater	utility	in	
the	context	of	maintaining	undifferentiated	cells	and	therefore	its	use	in	the	promotion	
of	proliferation	and	differentiation	of	epithelia	may	be	limited.	In	other	experimental	
models	BSA	underwent	a	reaction	with	glucose	to	produce	advanced	glycation	end	
products,	which	were	found	to	drive	lymphocytes	towards	a	pro-inflammatory	
response.(201)	Indeed	in	the	present	report,	in	contrast	to	the	other	media	protocols	
tested,	the	cell	density	with	use	of	media	protocol	D	resulted	in	a	decline	in	cell	density	
across	all	substrates	with	advancing	time.	The	cell	density	on	treated	and	untreated	
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ePTFE	was	similar	but	four-fold	greater	on	PET	membrane	suggesting	far	greater	initial	
adherence	on	PET	membrane.	It	would	be	of	benefit	to	ascertain	the	nature	of	the	
surface	chemistry	on	the	Thincert	PET	membrane	however	this	has	been	protected	
from	the	public	domain	given	that	it	is	a	commercial	cell	culture	product.		
	
The	initial	cell	density	is	similar	on	PET	membrane	regardless	of	the	media	used	
suggesting	that	the	initial	adherence	is	superior	due	to	its	surface	modification	rather	
than	media	factors.	This	study	also	confirmed	that	cell	density	is	greater	on	ammonia	
plasma	treated	than	untreated	ePTFE	regardless	of	the	media	used	suggesting	that	
superior	adherence	occurs	on	treated	ePTFE	in	comparison	to	untreated	ePTFE.	These	
differences	in	cell	density	became	increasingly	marked	with	advancing	time	in	culture.		
	
Epithelia	are	arranged	as	a	sheet	of	cells	on	a	basement	membrane.	In	general	epithelia	
are	recognised	to	be	relatively	short	in	vertical	height	whereas	they	are	relatively	wide	
and	therefore	flat	in	shape.(185)	The	cell	morphology	demonstrated	following	culture	in	
media	protocol	B	on	treated	ePTFE	and	PET	was	therefore	in	keeping	with	the	expected	
appearance	of	epithelial	cells	in	contrast	to	cells	imaged	on	untreated	ePTFE,	which	
were	sparse.	The	phalloidin	staining,	however,	was	poor	with	diffuse	staining	of	cells	
cultured	on	the	PET	membrane.	It	may	be	that	there	is	an	unknown	chemical	
component,	which	prevents	effective	phalloidin	staining	or	that	the	chemical	
composition	of	the	membrane	itself	results	in	a	high	degree	of	background	staining.	
This	may	be	due	to	the	presence	of	proteins	on	the	polymer	surface	as	part	of	the	
surface	modification	process.	The	cell	morphology	on	both	treated	ePTFE	and	PET	
membrane	demonstrated	cellular	confluence.	A	notable	difference	however	was	the	
size	of	both	the	nuclei	and	the	size	of	the	cells	overall	whereby	HCjE-Gi	cells	cultured	on	
treated	ePTFE	were	considerably	larger.		
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4.3.2.3		 Summary	of	the	optimisation	experiments	for	the	culture	of	
conjunctival	epithelium	on	ePTFE	
In	summary,	these	experiments	determined	that	the	greatest	cell	density	could	be	
achieved	at	14	days	in	culture	with	the	use	of	media	protocol	B	and	a	cell	seeding	
density	of	1x105/cm2.	A	further	advantage	of	cell	culture	protocol	B	is	that	it	is	similar	
to	that	that	defined	in	other	studies	used	for	primary	conjunctival	epithelial	cells.(97,	111,	
115)		
	
4.3.3	 Consistency	of	marker	expression	between	passages	and	demonstration	
of	caspase-3	upregulation	in	HCjE-Gi	cells		
4.3.3.1		 The	HCjE-Gi	cell	line	is	consistent	in	the	expression	of	the	range	of	
tested	markers	between	passages	2-28	
The	HCjE-Gi	cell	line	was	used	at	several	passages	in	this	study.	Passages	2	and	28	(from	
arrival	of	the	donated	cell	line)	were	developed	under	the	same	experimental	
conditions	and	the	phenotype	analysed	through	flow	cytometry.	This	was	undertaken	
to	ensure	that	there	would	be	consistency	in	expression	of	the	range	of	phenotypic	
markers	used	in	this	study	between	passages.		
	
There	are	many	reports	of	phenotypically	stable	cell	lines	with	advancing	serial	
passage,	which	can	be	propagated	indefinitely.	This	enables	us	to	exploit	the	
consistency	and	proliferative	capacity	of	cell	lines	in	experimental	work.	This	was	of	
particular	importance	in	the	present	study	in	which	it	was	not	possible	to	derive	large	
cell	numbers	from	the	same	primary	cell	source,	especially	as	numerous	replicates	and	
variables	were	required.		There	are	also	reports	of	cell	lines	such	as	a	human	bronchial	
epithelial	cell	line,	which	became	spontaneously	tumorigenic	at	passage	184	in	vitro-
culture.(202)	Furthermore,	other	than	a	marked	transformation,	more	subtle	differences	
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in	phenotype	including	those	due	to	epigenetic	changes	(e.g.	architecture	of	chromatin)	
are	recognised	caveats	of	the	use	of	cell	lines	in	experimental	conditions.(203)		
	
An	alteration	in	telomerase	activity	is	regarded	as	a	key	component	in	establishing	
immortality	in	cells	lines.(204)	Indeed,	the	HCjE-Gi	cell	line	was	telomerase	transformed	
with	hTERT,	a	telomerase	holoenzyme	reported	to	induce	replicative	immortality	
without	shortening	telomeres	and	without	loss	of	potential	to	differentiate.(190,	204,	205)	
Gipson	and	colleagues	developed	the	HCjE-Gi	cell	line	and	confirmed	the	expression	of	
cytokeratins,	membrane	associated	mucins	and	MUC5AC	mRNA	determining	that	this	
cell	line	could	be	useful	in	studies	of	conjunctival	mucin	gene	repertoire.(190)		
The	cytokeratin	markers,	together	with	progenitor	cell	markers,	MUC5AC,	PCNA	and	
caspase-3	had	not	been	characterised	in	the	HCjE-Gi	cell	line.	These	preliminary	
experiments	therefore	sought	to	determine	the	‘baseline’	level	of	expression	of	these	
markers	after	14	days	in	culture	and	the	proportion	of	cells	expressing	these	markers	
with	advancing	passage.	The	expression	of	a	range	of	markers	associated	with	
proliferation	(PCNA),	apoptosis	(Caspase-3),	progenitor	cell	markers	(ΔN-p63	and	
ABCG2),	cytokeratins	19/7/4	and	the	goblet	cell	marker	MUC5AC	were	tested	in	cells	of	
passage	2	and	28	to	ensure	consistency.	Indeed,	no	significant	difference	between	cells	
of	passage	2	and	passage	28	were	demonstrated.	It	was	therefore	determined	that	all	
subsequent	work	could	be	undertaken	with	the	HCjE-Gi	cell	line	within	this	range	of	
passage	without	concerns	relating	to	phenotypic	change.		
	
4.3.3.2		 Caspase-3	expression	increases	in	response	to	environmental	stress	
Caspase-3	is	involved	in	the	apoptotic	pathway	and	can	be	found	in	the	cytoplasm	of	
cells	destined	for	apoptosis.(136)	The	downregulation	of	caspase-3	has	been	reported	in	
the	context	of	cancer	including	breast	carcinoma.(206)	Caspase-3	has	been	used	as	
marker	of	apoptosis	in	in	a	variety	of	cells	including	cell	lines.(207,	208)	Nevertheless,	since	
the	use	of	caspase-3	as	a	marker	of	apoptosis	had	not	been	previously	reported	in	the	
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HCjE-Gi	cell	line,	this	experiment	sought	to	characterise	its	expression	prior	to	use	in	
subsequent	experimental	work.	
	
To	ensure	that	caspase-3	would	be	a	useful	marker	to	assess	the	viability	of	HCjE-Gi	
cultures,	staining	was	compared	in	healthy	cells	with	those	exposed	to	environmental	
stress	to	ensure	that	caspase-3	was	up	regulated.(209)	The	findings	of	this	experiment	
determined	a	100-fold	increase	in	expression	of	caspase-3	with	environmental	stress.	
This	marker	was	therefore	appropriately	upregulated	in	the	cell	line	and	was	used	as	a	
marker	of	apoptosis	in	subsequent	experiments.			
	
	
4.4	 Culture	of	HCjE-Gi	and	primary	conjunctival	cells	on	ammonia	
plasma	treated	ePTFE	
Preliminary	experiments	determined	that	ammonia	plasma	treated	ePTFE	could	
support	a	growing	population	of	conjunctival	epithelial	cells	as	described	in	section	
4.3.2.	Initial	experiments	were	also	undertaken	to	determine	the	optimal	seeding	
density	and	media	that	would	enable	this.	The	work	described	in	this	section	describes	
how	HCjE-Gi	cell	density	can	be	influenced	by	the	exposure	of	ePTFE	to	ammonia	gas	
plasma	on	both	sides	of	the	material.		
	
4.4.1	 HCjE-Gi	cell	density	is	greater	on	ePTFE	subjected	to	ammonia	gas	
plasma	on	both	sides	
An	experiment	was	undertaken	to	determine	how	ammonia	plasma	treatment	on	one	
or	both	sides	(referred	to	here	as	single	or	double	side	treated)	of	the	ePTFE	substrate	
would	compare	with	PET	membrane	and	untreated	ePTFE	as	positive	and	negative	
controls	respectively.	This	was	undertaken	as	it	was	hypothesised	that	additional	
ammonia	gas	plasma	modification	on	the	underside	of	the	culture	surface	could	
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improve	the	passage	of	nutrients	from	media	through	the	ePTFE	membrane.	The	cell	
density	was	determined	together	with	cell	morphology	and	analysis	of	the	cellular	
phenotype	by	flow	cytometry.	The	latter	is	described	in	section	4.5.1.		
	
The	results	of	this	experiment	demonstrated	a	gradual	increase	in	cell	density	with	
advancing	time	across	all	substrates,	which	was	greatest	on	PET	membrane.	
Significantly	higher	cell	density	however	could	be	cultured	on	double-side	ammonia	
plasma	treated	ePTFE	than	single	side	ammonia	plasma	treated	ePTFE.	Another	
example	of	a	hydrophobic	polymer	treated	by	ammonia	gas	plasma	treatment	on	both	
sides	of	the	material	to	enable	cell	culture	was	poly	(L	-lactide).	A	study	investigated	
the	depth	of	plasma	treatment	such	that	it	penetrated	both	sides	of	the	material	and	
found	that	the	latter	enabled	the	proliferation	of	cells	and	promoted	proliferation	
within	the	scaffold	itself.(210)	This	may	be	more	relevant	to	this	particular	type	of	
scaffold,	which	is	biodegradable	and	therefore	cell	growth	and	infiltration	from	both	
sides	and	within	the	body	of	the	material	was	desirable.	It	was	hypothesised	in	the	
present	study,	however,	that	treatment	on	both	sides	of	the	ePTFE	material	would	
result	in	improved	transport	of	water,	solutes	and	proteins	across	the	pores	from	the	
basal	portion	of	the	ePTFE	in	contact	with	culture	media	and	the	apical	portion	
supporting	epithelia.	This	was	most	likely	to	have	an	effect	after	the	process	of	airlifting	
had	begun.	Indeed,	a	marked	difference	in	cell	density	between	single	and	double	side	
treated	ePTFE	was	apparent	but	only	after	14	days	in	culture	when	cultures	were	in	the	
airlifting	phase	of	the	culture	protocol.		
	
The	cell	cytoskeleton	comprises	intermediate	filaments,	microtubules	and	
microfilaments.(185)	The	microfilaments	are	composed	of	actin	whereas	intermediate	
filaments	represent	cytokeratins	in	epithelial	cells.(185)	The	cell	cytoskeleton	is	crucial	to	
cell	function	including	division	and	movement	and	therefore	also	influences	the	shape	
of	the	cell.	(185)	The	microfilaments	considered	the	most	abundant	protein	in	animal	
cells,	comprised	of	actin	polymers	and	are	arranged	in	different	ways	based	upon	their	
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function	e.g.	as	a	contractile	ring	in	cell	division.(185)	Phalloidin	stains	f-actin	and	was	
therefore	used	to	assess	the	cytoskeletal	structure	in	cells.	Unfortunately	the	phalloidin	
staining	on	the	PET	membrane	did	not	stain	the	cytoskeletal	fibres	as	clearly	as	those	
on	ePTFE	substrates.	Preliminary	experiments	in	the	present	study	found	UAE-1	stained	
the	HCjE-Gi	cell	line	such	that	the	cell	outline	became	clearly	visible	and	was	also	
accompanied	by	variable	intracellular	staining	on	both	ePTFE	and	PET	substrates.	It	was	
therefore	was	used	as	a	surrogate	marker	to	qualitatively	assess	cell	morphology	in	
addition	to	phalloidin	staining.		
	
The	morphology	of	cells	on	PET	membrane	show	that	cultured	cells	were	smaller	in	size	
and	assume	an	epithelioid	‘cobblestone’	morphology	after	14	days	in	culture	that	are	in	
keeping	with	typical	conjunctival	epithelium.(211)	In	earlier	time	points	when	the	density	
was	lower	cells	appear	more	‘rounded’	across	all	the	substrates.	This	would	be	
expected	given	this	was	at	a	time	when	the	cell	population	was	expanding	e.g.	day	2	in	
culture.	Indeed,	it	has	been	observed	that	mammalian	cells	become	round	and	may	
even	almost	detach	as	they	divide.(185)	The	key	morphological	differences	
demonstrated	were	the	appearance	of	larger	cells	with	proportionately	larger	nuclei	on	
ePTFE	compared	with	PET	membranes	by	qualitative	assessment	of	representative	
photomicrographs.	Larger	cells,	high	nuclear	cytoplasmic	ratio,	and	heterogeneity	in	
the	nuclear	appearance	have	been	reported	as	measures	of	squamous	metaplasia	in	
impression	cytology	specimens.	(37,	211,	212)	To	this	end,	the	cells	developed	on	ePTFE	
substrates	were	larger	and	although	this	feature	may	be	regarded	to	constitute	as	a	
feature	of	squamous	differentiation,	the	nuclear	cytoplasmic	ratios	did	not	appear	
qualitatively	greater.	Furthermore,	heterogeneity	in	nuclear	appearance	was	not	
apparent	on	ePTFE	or	PET	membrane	samples.	In	squamous	metaplasia,	the	nuclei	are	
also	considered	to	become	pathologically	altered	and	described	aberrations	include	
double	nuclei,	nuclear	fragmentation	and	‘snake	like’	chromatin.(211)	Again,	these	
features	have	not	been	noted	in	HCjE-Gi	cells	on	any	of	the	substrates.		
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All	of	the	grading	schemes	developed	to	date	are	based	upon	impression	cytology	and	
therefore	it	must	be	taken	into	account	that	the	descriptions	may	be	based	on	loosely	
adherent	cells	on	the	most	superficial	layers	of	the	conjunctival	epithelium	and	
therefore	may	not	be	representative	of	the	conjunctival	epithelium	overall.(37,	211,	212)	
There	are	no	known	grading	systems	for	the	assessment	of	the	cross	section	of	
conjunctival	epithelium	or	cytoskeletal	staining.	Nevertheless,	the	appearance	of	larger	
cells	may	represent	a	greater	degree	of	squamous	metaplasia	in	the	cultures	developed	
on	ammonia	plasma	treated	ePTFE.	To	corroborate	these	findings	it	would	be	
imperative	in	future	work	to	assess	the	expression	of	involucrin,	a	marker	of	terminal	
differentiation,	squamous	metaplasia	and	keratinisation.(213)	
	
4.4.2	 Primary	cell	culture	is	similar	on	double	side	ammonia	plasma	treated	
ePTFE	and	PET	membrane		
Through	use	of	the	HCjE-Gi	cell	line,	it	was	demonstrated	that	greater	cell	density	could	
be	found	on	ePTFE	exposed	to	gas	plasma	on	both	sides	of	the	material	rather	than	
treatment	of	the	culture	side	only.	This	was	repeated	using	primary	conjunctival	
epithelial	cells	to	determine	how	cultures	developed	on	double	side	ammonia	plasma	
treated	ePTFE	would	compare	with	the	PET	membrane.	The	phenotype	in	terms	of	a	
range	of	intracellular	conjunctival	epithelial	markers	was	also	undertaken	and	is	
described	in	section	4.5.2.	This	experiment	was	undertaken	to	demonstrate	the	
potential	of	double	side	ammonia	plasma	treated	ePTFE	as	a	cell	culture	substrate	in	
comparison	to	PET,	a	commercially	available	cell	culture	product	used	in	this	
experiment	as	a	positive	control.	A	limitation	of	this	experiment	was	the	inability	to	
include	single	side	ammonia	plasma	treated	and	untreated	ePTFE	substrate	(negative	
control)	cohorts	due	to	lack	of	available	cell	number.	Unfortunately,	only	a	limited	
number	of	cells	could	be	derived	from	a	single	donor.	Indeed	it	was	imperative	to	use	
cells	from	a	single	donor	for	consistency	and	comparability.	The	experiment	showed	
that	the	trend	in	cell	density	developed	on	treated	ePTFE	mirrored	that	of	PET	
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membrane,	in	which	both	cultures	supported	a	degree	of	proliferation	from	day	2	to	
day	14	in	culture,	following	which	a	decline	occurred.	The	primary	cells	may	therefore	
require	further	exogenous	factors	and	improved	culture	techniques	to	enhance	their	
proliferative	potential	and	maintain	a	population	of	progenitor	cells.	Possible	methods	
may	include	the	use	of	fibroblast	conditioned	media	and/or	enrichment	with	human	
serum,	both	of	which	were	shown	to	increase	cell	numbers	with	advancing	time	in	
contrast	to	EGF	enriched	media	shown	by	Garcia-Posadas	and	colleagues.(132)	
	
The	morphology	of	cultures	on	double	side	treated	ePTFE	demonstrated	cells	of	similar	
size	and	elongated	cell	processes	visible	at	day	14	that	are	no	longer	present	at	day	28	
when	cells	appear	more	rounded.	Notably,	however	there	was	greater	variation	in	
nuclear	size	and	shape	on	ePTFE	in	comparison	to	cells	on	PET	membrane.	This	
suggests	that	these	cells	were	undergoing	squamous	differentiation	based	upon	
conjunctival	cytology	grading	classifications	described	in	the	previous	section	(4.4.1).(37,	
211,	212)	Another	study	comparing	primary	human	conjunctival	cells	with	a	cell	line	
reported	the	appearance	of	elongated	shapes	to	be	in	keeping	with	a	‘fibroblastic	
morphology’.(214)	A	limitation	of	the	present	study	was	that	analysis	of	the	presence	of	
fibroblast-associated	markers	was	not	undertaken.	Given	that	flow	cytometry	
demonstrated	that	of	96%	or	greater	cells	expressed	CK19	(of	the	same	cells	in	this	
experiment:	section	4.5.2)	it	seems	unlikely	that	these	cells	represent	fibroblasts	per	se	
rather	than	conjunctival	epithelia.		
	
	
4.5	 Phenotype	of	conjunctival	epithelial	cultures	developed	on	ePTFE	
and	PET	membranes	
Flow	cytometry	was	undertaken	using	the	HCjE-Gi	and	primary	cell	cultures	developed	
on	ePTFE	and	PET	membrane	as	described	in	sections	4.4.1	and	4.4.2.	This	was	
undertaken	to	enable	quantitative	assessment	of	the	expression	of	a	range	of	
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conjunctival	intracellular	markers	to	determine	the	presence	of	goblet	and	progenitor	
cells	and	to	determine	whether	cells	were	actively	proliferating	or	undergoing	
apoptosis.	The	described	analysis	was	undertaken	with	respect	to	the	substrate	used	
and	advancing	time	in	culture.	Comparisons	have	also	been	made	with	regard	to	overall	
levels	of	expression	of	markers	between	HCjE-Gi	cells	and	primary	conjunctival	cells.	
This	was	undertaken	as	these	differences	were	unknown	prior	to	these	experiments	
and	would	be	important	for	future	work.	
	
4.5.1	 Differential	expression	of	cytokeratins,	UAE-1	lectin	and	MUC5AC	in	
HCjE-Gi	cells	and	primary	human	conjunctival	cells		
Analysis	of	primary	cell	cultures	was	limited	to	those	developed	on	double	side	
ammonia	plasma	treated	ePTFE	and	PET	membrane	whereas	the	HCjE-Gi	cell	line	was	
additionally	cultured	on	untreated	ePTFE	and	single-side	ammonia	plasma	treated	
ePTFE.	This	was	due	to	a	limitation	in	the	number	of	cells	available	for	primary	cell	
culture	since	all	cells	were	derived	from	a	single	tissue	donor.	The	experiment	was	
repeated	on	three	occasions	with	cells	from	a	different	donor.	Determination	of	the	
cell	density	and	morphology	was	undertaken	using	the	same	cohort	of	HCjE-Gi/primary	
conjunctival	cells	as	that	described	in	this	section	and	has	been	discussed	in	sections	
4.4.1	and	4.4.2.		
	
4.5.1.1		 Expression	of	cytokeratin	19	
• The	majority	of	HCjE-Gi	and	primary	conjunctival	cells	expressed	CK19		
• No	differences	in	CK19	expression	were	determined	between	substrates	or	
advancing	time	in	culture		
	
In	the	present	study,	detection	of	the	CK19	antigen	was	demonstrated	in	96%	or	
greater	of	the	gated	cell	populations	demonstrated	by	flow	cytometry	for	both	HCjE-Gi	
and	primary	conjunctival	cells	on	all	substrates.	There	was	no	significant	difference	in	
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CK19	expression	between	the	time	points	or	substrates	studied.	This	indicates	that	the	
cells	were	of	a	conjunctival	epithelial	phenotype	as	CK19	is	a	recognised	marker	of	
conjunctival	epithelia,	and	is	not	expressed	by	conjunctival	fibroblasts.(125,	132)	A	study	
of	explant	cultures	on	gelatin	sponges	found	that	CK19	was	not	expressed	by	the	basal	
layer	of	cells,	which	expressed	in	greater	frequency,	markers	associated	with	a	
progenitor	phenotype.(215)	In	contrast,	other	studies	have	found	CK19	expression	in	all	
epithelial	layers	when	developed	with	serum	on	a	3T3	feeder	layer.(49)	The	described	
differences	in	the	literature	are	likely	to	be	due	to	differences	in	culture	protocols.	
Given	that	a	small	proportion	of	cells	did	not	express	CK19	in	the	present	study,	it	may	
provide	an	explanation	for	the	less	than	100%	CK19	expression	if	it	could	be	further	
verified	that	progenitor	cells	do	not	express	CK19.	It	would	also	be	in	keeping	with	the	
proportion	of	cells	expressing	ABCG2	alone	or	ABCG2/	ΔNp63	co-expression	discussed	
in	the	next	section	of	this	thesis	(section	4.5.2).	Multichannel	flow	cytometry	may	
provide	future	opportunities	to	verify	these	observations	and	achieve	a	better	
understanding	of	conjunctival	cell	developmental	biology.		
	
4.5.1.2		 Expression	of	cytokeratin	4		
• CK4	expression	was	markedly	higher	in	primary	cell	cultures	than	HCjE-Gi	cell	
cultures	
• HCjE-Gi	expression	of	CK4	was	lower	on	double	side	treated	ePTFE	on	PET	
membrane	
• No	significant	effect	of	CK4	expression	was	found	with	respect	to	time	in	culture	
in	primary	cell	cultures	or	HCjE-Gi	cell	cultures	
	
CK4	expression	was	almost	a	10-fold	greater	in	primary	cells	in	comparison	to	HCjE-Gi	
cells	after	28	days	in	culture.	It	should	be	noted	however	that	variance	was	high	in	
primary	cell	cultures	and	no	significant	difference	was	demonstrated	with	respect	to	
substrate	or	advancing	time	in	culture.	CK4	expression	in	HCjE-Gi	cultures	was	greatest	
on	PET	membrane	and	untreated	ePTFE	and	lowest	on	single	and	double	side	ammonia	
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plasma	treated	ePTFE.	Statistically	significant	differences	were	only	demonstrated	
however	between	double	side	ammonia	plasma	treated	ePTFE,	untreated	ePTFE	and	
PET	membrane	in	post	hoc	analyses.	CK4	is	used	as	a	marker	for	non-goblet	
conjunctival	epithelia	and	is	considered	to	be	specific.(11)	There	have	however	been	
variable	reports	in	relation	to	the	patterns	of	CK4	expression	in	conjunctival	epithelium.	
Eidet	and	colleagues	found	no	immunoreactivity	to	CK4	in	primary	human	conjunctival	
cell	cultures	when	testing	a	serum	free	cryopreservation	storage	protocol.(139)	Garcia-
Posadas	and	colleagues	also	used	the	CK4	marker	in	the	characterisation	of	
conjunctival	cultures	but	did	not	comment	on	its	qualitative	or	quantitative	
detection.(132)	In	contrast,	Schrader	and	colleagues	reported	CK4	expression	through	all	
but	the	basal	epithelial	layers	in	cryopreserved	epithelial	cultures	developed	in	serum	
containing	media	on	a	growth	arrested	3T3	layer,	whereas	Qi	and	colleagues	reported	
CK4	in	superficial	layers	of	bulbar	conjunctiva.(49,	130)	Differences	in	the	frequency	of	
CK4	detection	between	the	present	study	and	that	by	Schrader	and	colleagues	may	be	
due	to	substrate	related	factors,	differences	in	media,	the	specificity	of	the	antibody	
clone	used	within	experiments	or	a	combination	of	these.	To	date,	there	has	not	been	a	
study	that	has	characterised	the	frequency	and	spatial	distribution	of	CK4	throughout	
native	conjunctival	epithelium.	Therefore,	it	is	not	possible	to	comment	on	how	the	
cultures	developed	on	substrates	in	the	present	report	compare	with	expression	
patterns	in	vivo.	Furthermore,	the	functional	relevance	of	the	proportional	of	cells	
expressing	CK4	is	unclear	from	the	existing	body	of	literature.	If	regarded	as	a	marker	
of	differentiation,	it	is	notable	that	a	significantly	greater	proportion	of	primary	cells	
express	CK4.	The	HCjE-Gi	cell	line	data	would	suggest	that	cultures	may	be	more	
differentiated	when	cultured	on	untreated	ePTFE	and	PET	membrane	than	ammonia	
plasma	treated	ePTFE.	This	is	in	keeping	with	and	is	inversely	proportional	to	the	
proportion	of	progenitor	cells	and	those	of	a	proliferating	phenotype	described	in	the	
next	section	(4.5.2).		
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4.5.1.3		 Expression	of	cytokeratin	7		
• CK7	expression	was	similar	between	HCjE-Gi	and	primary	cell	cultures		
• A	significant	increase	in	expression	of	CK7	and	CK7/UAE-1	lectin	co-expression	
was	noted	with	advancing	time	in	HCjE-Gi	cell	cultures	
	
CK7	expression	was	similar	in	primary	conjunctival	cells	and	HCjE-Gi	cells	after	28	days	
in	culture.	In	HCjE-Gi	cell	cultures,	however,	the	percentage	of	CK7	and	CK7/UAE-1	co-
expressing	cells	demonstrated	on	untreated	ePTFE	was	more	than	double	that	of	other	
substrates.	In	HCjE-Gi	cell	cultures,	but	not	primary	cell	cultures,	a	statistically	
significant	increase	in	expression	of	CK7	and	CK7/UAE-1	lectin	co-expression	was	found	
with	respect	to	advancing	time	in	culture.	The	absence	of	a	statistically	significant	
increase	with	advancing	time	in	primary	cell	cultures	may	relate	to	the	high	levels	of	
variance	as	shown	by	standard	deviation	values.	In	contrast	to	HCjE-Gi	cell	cultures,	no	
significant	difference	was	found	between	substrates	investigated	in	primary	cell	culture	
experiments.	For	both	cell	types,	a	similar	proportion	of	cells	co-expressed	UAE-1/CK7.	
Interestingly,	these	values	are	remarkably	similar	to	the	percentage	expression	of	CK7	
alone	in	both	HCjE-Gi	and	primary	cells.	This	would	suggest	that	most	CK7	positive	cells	
express	UAE-1	lectin	but	not	vice	versa.	Indeed	this	is	in	keeping	with	existing	
knowledge	that	mucin	is	present	in	all	conjunctival	epithelia	(e.g.	transmembrane	
mucins	on	epithelial	cells)	and	is	not	limited	to	goblet	cells.(17)		
	
Dartt	and	colleagues	have	localised	the	presence	of	CK7	with	Ulex	Europaeus	Lectin-1	
(UAE-1).(11)	UAE-1	is	a	glycoprotein	that	is	recognised	to	bind	with	oligosaccharides	on	
the	membranes	of	blood	group	O	erythrocytes	but	also	on	human	epithelial	cells.	Given	
the	results	by	Dartt	and	colleagues	together	with	the	present	study,	it	appears	that	CK7	
and	UAE-1	lectin	localise	to	the	same	cells	making	it	highly	likely	that	these	cells	are	of	
a	goblet	cell	phenotype.	Indeed,	Dartt	and	colleagues	hypothesise	that	CK7+/UAE-1	
negative	cells	may	represent	a	population	of	immature	and	actively	proliferating	goblet	
cells	in	their	study	of	the	migration	patterns	from	conjunctival	explant	outgrowth	and	
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differentiation.(134)	In	this	study,	the	percentage	of	conjunctival	cells	co-expressing	
CK7/UAE-1	lectin	increases	with	advancing	time	in	culture,	suggesting	the	maturation	
of	a	subset	of	goblet	cells	was	in	progress.	It	was	also	determined	that	double	side	
ammonia	plasma	treated	ePTFE	appears	to	support	a	subpopulation	of	immature	
goblet	cells	similar	to	cultures	developed	on	PET	membrane.	Improvements	in	culture	
techniques,	optimisation	of	biopsy	site	location	and	cell	purification	may	result	in	
improved	cell	density	and	the	development	of	mature	goblet	cells	on	ammonia	plasma	
treated	ePTFE	in	future	studies.	Further	application	of	multichannel	flow	cytometry	and	
cell	sorting	in	future	studies	would	also	enable	verification	and	further	analysis	of	
specific	sub	populations	of	cells	and	further	our	understanding	of	conjunctival	cell	
biology	and	the	development	of	goblet	cells	in	conjunctival	epithelial	cultures.			
	
4.5.1.4		 Expression	of	MUC5AC	
• MUC5AC	expression	was	markedly	greater	in	primary	cell	cultures	than	HCjE-Gi	
cells	
• MUC5AC	expression	was	similar	between	substrates		
• MUC5AC	expression	increased	with	advancing	time	in	HCjE-Gi	cell	cultures	
	
MUC5AC	was	expressed	in	a	20-fold	or	greater	proportion	of	primary	conjunctival	cells	
in	comparison	to	HCjE-Gi	cell	cultures	regardless	of	substrate	after	28	days	in	culture.	A	
significant	increase	in	MUC5AC	detection	in	HCjE-Gi	cells	was	found	with	advancing	
time	in	culture	but	the	substrate	did	not	have	a	statistically	significant	effect.	In	primary	
cell	cultures,	no	statistically	significant	difference	was	demonstrated	in	MUC5AC	
expression	between	substrates	or	time	points.		
	
Ang	and	colleagues	developed	an	ultrathin	poly	(ε-caprolactone)	(PCL)	membrane	and	
found	marginally	higher	goblet	cell	density	after	seeding	primary	rabbit	conjunctival	
cells	on	PCL	membrane	treated	with	sodium	hydroxide.(97)	They	suggested	that	goblet	
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cell	numbers	were	similar	to	that	developed	on	amniotic	membrane	(2-3%	of	cells),	but	
lower	than	that	observed	in	vivo	(21%).(97)	By	comparison,	the	finding	in	the	present	
study	that	15%	of	cells	developed	on	double	side	ammonia	plasma	treated	ePTFE	
express	MUC5AC,	is	the	highest	reported	goblet	cell	density	developed	on	a	synthetic	
or	biological	substrate	with	the	use	of	human	primary	conjunctival	cells.	It	should	be	
taken	into	account	however	that	the	variance	in	these	measurements	was	high,	which	
suggests	that	consistency	may	be	a	problem	associated	with	the	use	of	primary	cell	
cultures.	Given	that	variance	is	markedly	lower	in	HCjE-Gi	cells,	it	would	suggest	that	
variance	is	due	to	the	cells	themselves	rather	than	substrate	or	media	factors.	It	would	
be	of	interest	to	investigate	the	effect	of	media	constituents,	time	and	culture	
conditions	to	improve	goblet	cell	density.	Furthermore,	it	is	likely	that	the	location	of	
origin	of	the	explants	seeded	on	the	substrate	may	influence	the	resulting	goblet	cell	
density.(134)	It	is	possible	therefore	that	the	random	selection	of	explants	contributed	to	
the	high	variance	in	primary	cell	data	in	this	study.		
	
Tsai	and	colleagues	found	that	mucin	antigen	and	Periodic	Acid	Schiff	was	detected	in	
cultures	of	primary	rabbit	conjunctival	cells	developed	on	collagen	and	matrigel	but	not	
on	plastic	and	glass.(95)	The	latter	study	concluded	collagen	and	matrigel	as	permissive	
environments	for	goblet	cell	differentiation	by	demonstrating	mucin	detected	using	an	
anti-mucin	antibody	but	did	not	quantify	MUC5AC.	A	distinction	must	be	made	
between	mucins	overall	and	goblet	cell	specific	markers	to	enable	investigation	of	
goblet	cell	differentiation.	Indeed	this	is	an	area	that	needs	developing	in	future	studies	
and	investigation	into	alternative	markers	of	goblet	cells	are	warranted	given	that	
immature	goblet	cells	may	not	be	identified	using	MUC5AC.(11,	134)		
	
It	is	known	that	airway	goblet	cell	differentiation	is	influenced	by	the	transcription	
factors	SAM-pointed	domain–containing	ETS-like	factor	(SPDEF)	and	forkhead	ortholog	
A3	(FOXA3)	resulting	in	an	inflammatory	response	and	goblet	cell	hyperplasia.(216)	The	
role	of	SPDEF	in	conjunctival	goblet	cell	proliferation	has	been	partly	characterised,	
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however	its	role	in	chronic	inflammation	may	differ	to	that	observed	in	airway	epithelia	
given	that	SPDEF	mRNA	was	deficient	in	patients	with	Sjogrens	disease	in	comparison	
to	normal	subjects.(217)	In	future	studies,	investigation	of	factors	that	drive	goblet	cell	
differentiation	would	also	be	important	for	conjunctival	tissue	engineering	applications.	
	
4.5.2	 Differential	expression	of	markers	of	progenitor	cells,	proliferation	and	
apoptosis	in	the	HCjE-Gi	cell	line	and	primary	human	conjunctival	cells			
4.5.2.1		 Expression	of	ΔNp63	
• Expression	of	ΔNp63	was	markedly	greater	in	cultures	of	HCjE-Gi	cells	than	
primary	conjunctival	cells	after	28	days	in	culture	
• No	significant	effect	was	found	with	respect	to	substrate	or	advancing	time	in	
culture	
	
ΔNp63	expression	was	almost	3-fold	greater	in	HCjE-Gi	cell	cultures	than	primary	cell	
cultures	at	28	days	and	no	significant	difference	was	demonstrated	with	respect	to	
substrate	or	advancing	time	in	culture.	Similarly,	in	primary	cell	cultures,	no	significant	
differences	could	be	demonstrated	in	expression	of	ΔNp63	expression	between	
substrates	or	advancing	time	in	culture.	ΔNp63	has	been	studied	as	a	marker	of	
progenitor	cells	in	primary	cell	cultures	but	not	in	the	HCjE-Gi	cell	line	to	the	best	of	my	
knowledge.(18,	19)	The	greater	percentage	ΔNp63	expression	in	HCjE-Gi	cell	cultures	
overall	may	be	accountable	to	the	original	telomerase	transformation	in	the	production	
of	the	cell	line	and	therefore	its	upregulated	replicative	ability.		
	
Indeed,	ΔNp63	may	be	a	marker	that	can	be	identified	in	both	progenitor	cells	in	
addition	to	transiently	replicative	cells.	This	would	explain	the	markedly	higher	levels	of	
expression	in	the	cell	line	than	primary	conjunctival	cells.	Furthermore,	it	may	also	
explain	the	higher	than	expected	levels	of	ΔNp63	in	primary	conjunctival	cells	after	28	
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days	in	culture.	Indeed,	the	majority	of	tissue	donors	from	which	the	primary	cells	
originated	were	elderly	and	therefore	would	be	expected	to	have	a	lower	proportion	of	
progenitor	cells.	In	keeping	with	this,	it	has	been	shown	by	Stewart	and	colleagues	that	
the	colony	forming	efficiency	was	inversely	correlated	to	donor	age.(19)	
It	would	therefore	be	of	interest	to	further	investigate	the	appropriateness	of	ΔNp63	
alone	as	a	marker	of	progenitor	cells.	It	may	be	that	ΔNp63	must	be	used	in	
combination	with	other	markers	to	identify	with	greater	accuracy	a	true	population	of	
progenitor	cells.	In	view	of	this,	the	co-expression	of	ΔNp63	together	with	ABCG2	has	
been	described	(section	5.2.2.2).	Future	studies	using	multichannel	flow	cytometry	may	
be	used	to	determine	the	true	nature	of	ΔNp63	by	analysis	of	other	co-expressed	
markers	of	differentiation/proliferation.	This	may	also	be	confirmed	in	future	work	
through	clonal	analysis	of	individual	subgroups	of	cells	defined	by	their	marker	
expression	after	fluorescence	activated	cell	sorting.	
	
5.2.2.2		 Expression	of	ABCG2	and	co-expression	with	ΔNp63	
• ABCG2	expression	and	co-expression	with	ΔNp63	was	similar	in	HCjE-Gi	and	
primary	conjunctival	cells		
• ABCG2	expression	and	co-expression	with	ΔNp63	in	HCjE-Gi	cell	cultures	was	
highest	on	double	side	treated	ammonia	plasma	treated	ePTFE	after	28	days	in	
culture	
	
In	contrast	to	ΔNp63,	ABCG2	was	expressed	at	similar	frequency	in	both	the	HCjE-Gi	
and	primary	conjunctival	cells	at	14	and	28	days	in	culture.	No	significant	effect	of	
substrate	or	time	in	culture	could	be	determined	with	respect	to	ABCG2	expression	in	
primary	cell	cultures.	Amongst	HCjE-Gi	cell	cultures,	ABCG2	expression	was	highest	on	
double	side	ammonia	treated	ePTFE	and	statistically	significant	differences	were	found	
between	this,	untreated	ePTFE	and	single-side	ammonia	treated	ePTFE	in	post	hoc	
analyses.		In	both	cell	line	and	primary	cultures,	ABCG2/	ΔNp63	co-expression	was	
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remarkably	low	at	1%	or	less	after	28	days	in	culture.	No	statistically	significant	
difference	was	found	with	regard	to	ABCG2/	ΔNp63	co-expression	in	primary	cultures	
with	respect	to	advancing	time	or	substrate.	In	HCjE-Gi	cell	cultures	however,	the	
percentage	of	cells	co-expressing	ABCG2/	ΔNp63	was	highest	on	double-side	ammonia	
plasma	treated	ePTFE	and	statistically	significant	differences	were	found	between	this,	
untreated	ePTFE,	single	sided	ammonia	plasma	treated	ePTFE	and	PET	membrane	on	
post	hoc	analysis.	Although	this	pattern	mirrors	that	of	ABCG2	expression	alone	in	
HCjE-Gi	cells,	it	should	be	noted	that	the	proportion	of	cells	co-expressing	ABCG2	and	
ΔNp63	is	markedly	lower	than	that	expressing	ABGC2	alone	in	both	primary	and	HCjE-
Gi	cultures.	It	follows	therefore	that	not	all	ABCG2	expressing	cells	also	express	ΔNp63.	
The	results	from	our	study	would	suggest	that	the	highest	proportion	of	progenitor	
cells	developed	on	double	side	ammonia	treated	ePTFE,	however	this	was	confirmed	
only	with	cell	line	data.	Variance	is	high	in	the	primary	cell	data	and	is	likely	to	be	due	
to	differences	in	the	seeded	explants	in	terms	of	the	biopsy	site	from	which	the	explant	
originated.	Further	studies	using	greater	numbers	of	donors	and	consistency	in	the	
tissue	biopsy	site	are	warranted	to	corroborate	the	findings	of	this	experiment.	The	
optimisation	of	culture	conditions	together	with	improvements	in	techniques	to	isolate	
and	seed	a	purified	sample	of	conjunctival	epithelial	cells	may	enable	primary	cell	
cultures	in	the	future	to	be	developed	on	ammonia	plasma	treated	ePTFE	with	a	
greater	proportion	of	progenitor	cells	and	potential	for	self-renewal.		
	
ABCG2	and	ΔNp63	have	been	studied	together	in	a	study	of	the	colony	efficiency	assays	
of	conjunctival	tissues	from	various	sites.(19)	The	latter	report	demonstrated	highly	
significant	correlations	between	the	clonogenic	ability	of	conjunctival	explants	and	the	
levels	of	both	ABCG2	and	ΔNp63	expression.(19)	In	keeping	with	this,	it	has	been	
observed	in	other	studies	that	the	density	of	cells	expressing	these	markers	reduce	
with	advancing	passage.(49)	Although	there	are	no	definitive	markers	of	conjunctival	
stem	cells,	the	markers	used	here	within	the	present	studies	have	been	the	most	
extensively	studied.	As	findings	from	this	study	show,	not	all	cells	expressing	ABCG2	
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appear	to	express	ΔNp63.	The	use	of	both	markers,	however,	may	identify	with	greater	
sensitivity,	a	subpopulation	of	cells	that	represents	a	true	progenitor	cell	population.	
Furthermore,	it	also	suggests	that	ABCG2	alone	may	be	superior	to	ΔNp63	in	its	ability	
to	detect	progenitor	cells.	In	keeping	with	results	in	the	present	study,	ABCG2	
expression,	but	not	ΔNp63	has	been	shown	to	correlate	significantly	with	the	colony	
forming	efficiency	of	primary	conjunctival	epithelial	cultures	and	is	inversely	correlated	
to	donor	age.(19)	It	is	of	interest	to	note	that	the	ΔNp63	antibody	would	identify	
ΔNp63α	that	is	otherwise	considered	a	stem	cell	marker.(9)	The	results	of	the	present	
study	however	together	with	observations	by	Stewart	and	colleagues	would	suggest	
otherwise.(19)	To	investigate	stem	cell	marker	expression	and	corroborate	the	
observations	of	the	present	study,	the	clonogenic	ability	of	cultures	of	cells	in	relation	
to	the	expression	and	co-expression	of	candidate	stem	cell	markers	warrants	further	
study.	Furthermore,	the	use	of	a	more	specific	antibody	clone,	for	example	ΔNp63α	
instead	of	ΔNp63,	which	detects	all	isoforms	(α/β/γ),	should	also	be	undertaken	to	
determine	the	precise	location	and	phenotype	of	progenitor	cells	and	the	relative	
frequency	and	relevance	of	cells	of	each	of	the	ΔNp63	isoforms.		
	
4.5.2.3		 Expression	of	caspase-3	
• Caspase-3	expression	is	greater	in	primary	conjunctival	cell	cultures	
• Greater	caspase-3	expression	was	demonstrated	on	untreated	ePTFE	in	HCjE-Gi	
cultures	
	
Caspase-3	expression	was	more	than	double	in	primary	conjunctival	cells	overall	
compared	to	HCjE-Gi	cells	at	the	time	points	studied.	In	primary	conjunctival	cell	
cultures,	no	significant	effect	could	be	demonstrated	with	respect	to	advancing	time	in	
culture	or	substrate.	Similarly,	there	was	no	significant	difference	in	caspase-3	
expression	in	HCjE-Gi	cell	cultures	with	advancing	time	in	culture	but	substrate	had	a	
significant	effect	whereby	the	highest	levels	of	caspase-3	expression	were	found	on	
untreated	ePTFE.	Given	that	statistically	significant	differences	were	found	only	
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between	untreated	ePTFE	and	all	other	substrates	studied	in	post-hoc	tests	for	HCjE-Gi	
cells,	it	would	suggest	that	all	substrates	with	the	exception	of	untreated	ePTFE	were	
equally	capable	of	supporting	conjunctival	cell	cultures	without	inducing	high	levels	of	
apoptosis.		
	
A	limitation	of	this	work	is	that	the	untreated	ePTFE	substrate	was	not	tested	using	
primary	cell	cultures	owing	to	a	shortage	of	available	cells	to	use.	It	is	therefore	not	
possible	therefore	to	comment	on	the	expression	of	the	apoptosis	marker	on	primary	
cells	cultured	on	untreated	ePTFE.	These	data,	however,	suggest	that	there	was	no	
significant	difference	between	primary	conjunctival	epithelia	developed	on	treated	
ePTFE	and	the	PET	cell	culture	membrane.	This	represents	proof	of	concept	that	double	
side	ammonia	plasma	treated	ePTFE	could	be	an	effective	substrate	for	primary	
conjunctival	cell	expansion	and	warrants	further	investigation.	To	the	best	of	my	
knowledge,	there	are	no	other	reports	in	the	literature	describing	use	of	caspase-3	in	
the	development	of	conjunctival	substrates.	There	is	therefore	no	available	comparison	
to	determine	the	relative	caspase-3	expression	in	the	present	study.	A	study	of	the	
effect	of	hypoxia	and	staurosporine	on	endothelial	cells	however	also	determined	the	
levels	of	caspase-3	as	a	percentage	of	the	cell	population	by	flow	cytometry.(218)	This	
study	demonstrated	5.9%	caspase-3	expression	in	a	healthy	population,	compared	with	
9%	in	endothelial	cells	exposed	to	hypoxia	and	24%	in	cells	exposed	to	staurosporine	
(an	inhibitor	of	protein	kinases	used	as	a	research	tool	to	induce	apoptosis).	Similarly,	
in	the	present	study	around	20%	of	HCjE-Gi	cells	expressed	caspase-3	at	28	days	in	
culture	when	developed	on	untreated	ePTFE	compared	with	<5%	expressing	caspase-3	
on	treated	ePTFE	and	PET	membrane.	These	observations	would	also	suggest	that	
caspase-3	would	be	an	appropriate	marker	of	apoptosis	to	use	in	future	studies	of	
conjunctival	epithelial	cultures.			
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4.5.2.4		 Expression	of	PCNA		
• PCNA	expression	is	markedly	higher	in	HCjE-Gi	cell	cultures	at	day	28	
• PCNA	expression	declines	in	primary	conjunctival	cells	but	not	HCjE-Gi	cells	with	
advancing	time	in	culture	
	
No	significant	difference	was	found	with	respect	to	the	percentage	PCNA	expression	in	
HCjE-Gi	cell	cultures	with	advancing	time	in	culture	or	between	substrates.	Similar	
levels	of	PCNA	expression	were	found	in	primary	conjunctival	cell	cultures	developed	
on	treated	ePTFE	and	PET	substrates	after	28	days	suggesting	an	equivalent	ability	of	
double	side	treated	ePTFE	to	support	cell	proliferation.	In	contrast	to	HCjE-Gi	cells,	
however,	a	statistically	significant	difference	in	PCNA	expression	occurred	whereby	
expression	levels	approximately	halved	from	14	and	28	days	in	culture.	The	percentage	
PCNA	expression	in	HCjE-Gi	cells	was	approximately	double	that	of	primary	cell	cultures	
at	28	days	in	culture.		
	
The	observed	trend	of	PCNA	expression	in	HCjE-Gi	cells	with	advancing	time	was	similar	
to	that	of	ΔNp63.	The	reasons	of	the	observed	differences	in	the	primary	cells	and	the	
HCjE-Gi	cell	line	may	be	due	to	reasons	mentioned	in	earlier	sections.	It	would	be	of	
interest	in	future	studies	to	correlate	PCNA	expression	to	markers	associated	with	stem	
cells	to	determine	methods	to	distinguish	transiently	amplifying	cell	populations	from	
‘true’	stem	cells.		
	
Eidet	and	colleagues	described	PCNA	expression	by	immunohistochemistry	in	
conjunctival	tissue	samples	in	approximately	¾	of	cells	through	a	semi-quantitative	
analysis.(139)	This	study	was	designed	to	determine	the	effect	of	storage	free	media	
after	4	and	7	days.	It	must	be	noted	however	that	the	time	points,	media	used	and	
technique	used	(immunohistochemistry)	differs	to	the	present	study.	It	follows	
therefore	that	the	optimal	or	baseline	frequency	of	PCNA	expression	in	conjunctival	
epithelial	cell	cultures	has	yet	to	be	established	in	the	context	of	developing	substrates.	
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Nevertheless,	the	finding	of	similar	levels	of	PCNA	expression	between	double	side	
ammonia	plasma	treated	ePTFE	and	PET	membrane	even	in	primary	cell	cultures	
suggests	that	the	former	warrants	further	investigation.		
	
	
4.6	 Decellularised	human	conjunctiva	
Decellularised	tissues	have	been	used	as	scaffolds	for	the	re-population	of	cells	in	a	
variety	of	tissue	and	organ	models.	The	decellularisation	of	human	conjunctiva,	
however,	has	not	been	previously.	Described	in	this	section	is	the	developed	protocol	
for	the	decellularisation	of	human	conjunctiva	and	characterisation	of	the	resulting	
tissue	in	terms	of	its	cytotoxicity,	DNA	content,	collagen	denaturation,	basement	
membrane	and	tensile	strength.	Comparisons	have	been	made	between	the	basement	
membrane	of	amniotic	membrane	and	human	conjunctiva.	The	tensile	strength	of	
conjunctiva	is	also	compared	with	amniotic	membrane	and	ePTFE.		
	
4.6.1	 Decellularisation	and	cytotoxicity	of	human	conjunctiva		
Decellularisation	can	be	achieved	using	a	variety	of	chemical,	enzymatic	and	physical	
processes.	Sodium	dodecyl	sulphate	(SDS)	was	the	agent	of	choice	to	optimise	in	the	
present	study.	This	step	was	part	of	an	established	decellularisation	protocol	used	for	
the	decellularisation	of	amniotic	membrane.	Decellularisation	of	amniotic	membrane	
has	been	previously	described	by	physical	removal	alone	or	in	combination	with	
chemical	agents	and	detergents	including	ammonium	hydroxide,	SDS,	sonication	and	
trypsin.(219-222)	Of	these	methods,	only	SDS	achieved	high	levels	of	cellular	removal	from	
the	tissue	matrix.(77)	This	detergent	has	been	also	been	reported	to	successfully	
decellularise	other	tissues	including	porcine	heart	valves.(223)	The	lack	of	observed	cell	
mediated	or	humoral	immune	response	in	the	recipient	to	decellularised	tissue	has	
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been	proposed	to	be	due	to	the	removal	of	soluble	proteins	during	the	
decellularisation	process.(224)	
In	this	report,	the	decellularisation	protocol	that	utilised	SDS	at	a	concentration	of	
0.05%	(w/v)	removed	99%	or	greater	DNA	with	reproducibility	across	donors.	This	was	
also	confirmed	in	histology	specimens,	whereby	the	absence	of	nuclear	DAPI	staining	in	
decellularised	tissue	sections	was	demonstrated.	Adequate	decellularisation	is	of	
paramount	importance	as	the	presence	of	DNA	has	been	directly	correlated	to	adverse	
responses	in	the	recipient,	an	effect	that	is	most	notable	in	xenogeneic	
transplantation.(225,	226)	
	
Decellularised	tissue	per	se	has	not	been	strictly	defined	in	terms	of	residual	DNA	
content.		Results	from	in	vivo	studies	in	which	tissue	remodelling	has	been	
demonstrated	in	the	absence	of	an	adverse	host	immunological	response	suggest	90-
95%	decellularisation	is	adequate.(77,	173)	It	follows	therefore	that	a	decellularisation	
protocol	using	0.05%	SDS	(w/v)	to	decellularise	conjunctival	tissue	meets	these	
previously	defined	standards.(77)	Amniotic	membrane	closely	resembles	conjunctiva	
given	that	it	also	comprises	an	epithelial	cell	layer,	basement	membrane	and	a	thin	
layer	of	underlying	loose	connective	tissue.(54)	Amniotic	membrane	can	be	
decellularised	with	0.03%	SDS	which	removes	95%	of	the	DNA.(227)	This	is	comparable	
to	DNA	removal	shown	in	the	present	study.	A	limitation	of	the	present	study,	
however,	was	that	SDS	at	a	concentration	lower	than	0.05%	was	not	studied.	In	future	
work,	it	would	be	of	interest	to	test	lower	SDS	concentrations	and	correlate	the	DNA	
removal	against	additional	parameters	such	as	elastin	and	glycosaminoglycan	
quantification.		
	
In	the	present	study,	decellularisation	was	achieved	through	a	combination	of	
chemical,	detergent	and	enzymatic	steps.	In	the	first	stage	cell	lysis	was	achieved	
through	osmosis	using	a	hypotonic	buffer.	It	has	been	suggested	that	this	occurs	with	
minimal	alteration	in	the	architecture	of	the	tissue.(89)	In	the	second	stage,	dissolution	
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of	the	lipid	bilayer	of	the	cell	membrane	and	removal	of	cellular	residues	was	achieved	
through	the	use	of	SDS.	In	the	final	stage,	Benzonase	was	used	to	remove	any	residual	
nuclear	material	from	the	tissue	matrix.	Hypotonic	and	hypertonic	reagents	are	known	
to	be	effective	in	lysing	cells	but	may	leave	cellular	residues.(77)	The	removal	of	cellular	
residues	however	is	known	to	be	effected	by	SDS.(77)	It	has	been	demonstrated	to	
effectively	remove	nuclear	and	cytoplasmic	remnants	from	even	dense	tissues,	but	a	
disadvantage	is	that	it	may	damage	collagen	matrices.(77,	228)	Of	these	described	stages,	
the	SDS	is	known	to	have	the	greatest	potential	for	cellular	cytotoxicity.(77)	Indeed,	
multiple	washes	and	rinses	of	the	tissue	take	place	as	part	of	the	protocol	to	leach	as	
much	of	the	SDS	out	of	the	residual	tissue	as	possible.	The	results	from	the	contact	
cytotoxicity	experiments	in	this	study	demonstrated	that	both	primary	human	skin	
fibroblasts	and	the	human	conjunctival	cells	proliferate	in	close	contact	with	the	
decellularised	tissue	demonstrating	that	the	tissues	lack	cytotoxicity.	In	later	sections,	
this	is	also	demonstrated	by	the	culture	of	explants	on	decellularised	tissues	(section	
4.7).		
	
4.6.2	 Quantification	of	collagen	denaturation	
To	test	whether	the	decellularisation	process	would	disrupt	conjunctival	collagen	
matrices,	an	assay	to	test	collagen	denaturation	was	undertaken.	This	rationale	for	
undertaking	this	experiment	was	that	exposure	to	SDS	is	known	to	disrupt	collagen	
matrices.(77,	228)	Our	study	found	however	that	at	a	concentration	of	0.05%	(w/v)	SDS,	
there	was	no	increase	in	hydroxyproline	within	the	supernatant	in	the	collagen	
denaturation	assay.	This	indicated	that	there	was	no	disruption	of	conjunctival	collagen	
matrix	as	a	result	of	decellularisation.	Hydroxyproline	was	detectable	in	this	assay	
following	exposure	to	α–chymotrypsin,	an	enzyme	that	selectively	denatures	only	
degraded	collagen.(229)	These	data	therefore	suggest	that	an	SDS	concentration	of	
0.05%	(w/v)	may	represent	a	favourable	balance	between	decellularisation	and	tissue	
disruption	in	human	conjunctival	tissue.	This	collagen	degradation	assay	is	useful	as	it	
	 200	
provides	quantitative	data	to	support	the	qualitative	examination	of	other	extracellular	
matrix	proteins	through	histology,	described	in	later	sections	(section	4.6.4).	More	
detailed	studies	investigating	the	degradation	of	other	components	such	as	elastin	and	
glycosaminoglycan	content	are	warranted	in	future	work.	Importantly,	examinations	of	
the	ultrastructural	features	of	the	tissue	are	also	warranted	to	confirm	the	integrity	and	
examine	the	3-dimensional	architecture	following	decellularisation.	The	ultrastructure	
may	be	studied	by	scanning	electron	microscopy	in	future	work.		
	
4.6.3	 Tensile	strength	of	conjunctiva,	amniotic	membrane	and	ePTFE	
The	effect	of	decellularisation	on	the	tensile	strength	of	conjunctival	tissue	was	
determined	together	with	data	of	the	tensile	strength	of	amniotic	membrane	and	
ePTFE	for	comparison.	Tensile	strength	results	demonstrated	no	significant	difference	
in	the	ultimate	tensile	stress	(MPa)	or	Young’s	modulus	(MPa)	between	cellular	and	
decellularised	tissue	suggesting	that	biomechanical	strength	is	not	altered	by	the	
decellularisation	treatment.	This	is	in	keeping	with	other	tissue	models	comparing	
cellular	and	decellularised	tissue.(173,	230,	231)	The	tensile	strength	measurements	are	
relatively	low	for	both	conjunctiva	and	amniotic	membrane	in	terms	of	their	absolute	
values	in	comparison	to	other	characterised	tissues	such	as	dermis	and	cartilage.(173,	230,	
231)	No	other	published	work	can	be	found	in	which	the	tensile	strength	of	conjunctiva	
has	been	characterised.		
	
Stress	at	failure	measurements	have	been	previously	reported	for	amniotic	membrane	
and	were	approximately	half	the	reported	values	in	this	study.(227)	It	is	recognised	that	
differences	between	observed	values	may	be	derived	when	using	different	equipment,	
and	that	such	differences	have	not	been	entirely	explained	in	other	reports.(232)	There	
are	a	however,	a	number	of	crucial	differences	in	the	testing	method,	in	the	present	
study	compared	to	that	by	Wilshaw	et	al.	In	general,	the	methodology	for	tensile	
strength	testing	involves	the	cutting	of	dumbbell	shaped	sections	that	are	therefore	
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constant	in	length	and	also	width,	and	the	wider	portion	at	both	ends	are	inserted	into	
the	clamps.	This	method	was	not	possible	for	the	assessment	of	both	conjunctival	and	
amniotic	membrane	in	the	present	study	as	the	standard	dumbbell	shapes	were	small,	
leaving	thin	friable	sections	of	tissue	that	would	break	or	become	damaged	during	the	
process	of	insertion	into	the	test	clamps	or	would	slide	through	the	test	clamps	
altogether.	To	enable	testing	to	take	place,	larger	rectangular	sections	of	tissue	were	
divided	and	measured	for	the	test.	The	tests	in	this	report	measured	the	thickness	of	
the	amniotic	membrane	at	3	different	points	by	placing	the	tissue	flat	between	two	
glass	coverslips.	This	method	resulted	in	mean	thickness	values	for	amniotic	membrane	
of	0.055	mm	in	this	study,	which	contrasts	to	that	by	Wilshaw	and	colleagues,	who	
measured	mean	thickness	values	of	amniotic	membrane	as	0.16mm.	Although	the	
stress	measurements	would	normalise	the	effect	of	thickness,	the	method	used	to	
measure	thickness	of	the	tissues	differs	between	the	present	study	and	that	by	
Wilshaw	and	colleagues.	In	addition,	the	speed	of	tensile	test,	which	was	not	reported,	
may	have	differed	in	addition	to	other	factors	including	the	type	of	grips	used	to	hold	
the	material.	It	is	possible	that	these	factors,	in	particular	the	thickness	measurements	
of	amniotic	membrane	may	explain	the	observed	differences.		
	
The	young’s	modulus	has	not	been	previously	characterised	for	amniotic	membrane.		
Young’s	modulus	is	a	measure	of	stiffness	of	an	elastic	material.	The	stiffness	of	a	
material	itself	has	been	recognised	to	influence	the	cellular	phenotype.(233)	It	is	of	
interest	to	note	a	3-fold	greater	Young’s	modulus	of	amniotic	membrane	in	comparison	
to	conjunctiva	indicating	greater	stiffness.	Indeed	it	has	been	recognised	that	amniotic	
membrane	has	a	thick	basement	membrane,	which	may	account	for	these	
observations.(49)			
	
It	would	be	of	interest	to	undertake	further	tensile	strength	testing	to	ascertain	the	
suture	pull	out	strength.	This	may	be	of	particular	relevance	given	that	the	materials	
investigated	are	intended	for	eventual	surgical	use.	Tensile	strength	characterisation	is	
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useful	given	the	current	scientific	climate	in	which	synthetic	materials	are	also	under	
investigation	as	conjunctival	substrates.(97)	Importantly,	the	stiffness	of	materials	is	
known	to	influence	cell	attachment,	proliferation	and	differentiation.(228,	233,	234)	The	
precise	subtypes	of	extracellular	matrix	components	and	stiffness	of	the	decellularised	
conjunctiva	are	not	greatly	altered	by	decellularisation.	This	3-dimensional	scaffold	
would	otherwise	be	difficult	to	replicate	in	synthetic	materials.	It	might	be	expected	
therefore,	that	decellularised	conjunctiva	would	possess	the	greatest	potential	to	
support	conjunctival	epithelium	with	a	subpopulation	of	progenitor	and	goblet	cells	by	
providing	the	most	appropriate	niche	for	these	cells.		
	
4.6.4	 Characterisation	of	the	extracellular	matrix	components	and	basement	
membrane	of	cellular	and	decellularised	tissues		
Decellularisation	may	reduce	the	risk	of	disease	transmission	but	may	disrupt	
extracellular	matrix	components	and	the	ultrastructure	of	the	tissue.(77)	The	histology	
and	immunohistochemistry	qualitatively	demonstrate	that	there	is	no	disruption	of	the	
extracellular	matrix	as	a	result	of	the	decellularisation	process.		
Histology	of	the	tissue	sections	stained	with	H&E	and	Van	Gieson’s	stain	demonstrate	
that	there	is	preservation	of	the	architecture	of	the	tissue	including	the	major	
structural	proteins	elastin	and	collagen.	Glycosaminoglycans	were	also	strongly	
localised	to	the	basement	membranes	and	conserved	following	decellularisation.			
	
The	extracellular	matrix	components	laminin,	fibronectin	and	collagen	IV	do	not	appear	
changed	following	decellularisation.	This	is	apparent	qualitatively	in	terms	of	the	
distribution	of	laminin,	fibronectin	and	collagen	IV	staining	through	
immunohistochemistry.	The	absence	of	collagen	degradation	is	also	supported	
quantitatively	in	terms	of	the	detection	of	denatured	collagen	as	described	in	the	
previous	section	(section	4.6.2).	Laminin,	fibronectin	and	collagen	IV	was	found	in	the	
basement	membrane	zone	and	epithelium	of	conjunctival	tissues,	a	staining	pattern	
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that	has	been	previously	described	by	immunohistochemistry.(15)	The	PAS	and	H&E	
staining	also	confirmed	that	the	basement	membrane	layer	appears	unchanged	by	
decellularisation.		
	
Tissue	samples	from	three	different	donors	were	examined	for	distribution	of	collagen	
IV,	laminin	and	fibronectin	in	both	conjunctival	tissue	and	amniotic	membrane.	This	
qualitatively	demonstrated	that	there	were	no	significant	differences	in	the	distribution	
of	these	proteins	in	either	tissue	between	different	donors.	Differences	were	observed,	
however,	in	the	distribution	of	collagen	IV,	laminin	and	fibronectin	between	
conjunctiva	and	amniotic	membrane.	The	basement	membrane	of	amniotic	membrane	
had	greater	qualitatively	staining	than	the	substantia	propria	for	all	three	proteins	
studied.	All	the	investigated	proteins	were	present	in	the	basement	membrane	of	
conjunctiva;	however,	their	presence	in	the	substantia	propria	was	present	
qualitatively	to	a	greater	degree	than	amniotic	membrane.	Laminin	appears	mostly	
within	basement	membranes	of	conjunctiva	whereas	fibronectin	appears	almost	as	
abundant	within	the	basement	membrane	as	the	substantia	propria	of	conjunctiva.	The	
distribution	of	type	IV	collagen	and	laminin	isoforms	in	amniotic	membrane	have	been	
studied	and	reported	to	be	similar	to	that	of	conjunctiva	but	differ	from	corneal	
basement	membrane.(3)	It	has	therefore	been	suggested	that	amniotic	membrane	may	
therefore	act	as	a	suitable	substrate	for	conjunctival	expansion.(12)	The	latter	study	by	
Fudaka	and	colleagues	highlights	potentially	important	differences	in	extracellular	
matrix	composition	between	amniotic	membrane	and	conjunctiva.	In	particular,	the	
greater	fibronectin	composition	of	the	substantia	propria	of	the	conjunctiva	could	
serve	as	a	preferential	environment	to	the	co-culture	of	conjunctival	fibroblasts.(235)	
The	results	in	this	study	also	demonstrated	that	there	is	far	greater	variability	in	the	
tissue	thickness	and	architecture	of	the	conjunctival	samples	in	comparison	to	amniotic	
membrane	between	the	donor	samples	studied.	Ultimately,	this	may	limit	its	future	
utility	given	limitation	in	the	availability	of	large	sections	of	tissue	of	an	optimal	quality.	
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The	qualitative	methods	used	for	the	characterisation	of	extracellular	matrix	have	their	
merits	as	they	provide	information	about	the	distribution	patterns	and	microscopic	
appearance	of	tissues,	which	quantitative	assays	such	as	the	collagen	degradation	
assay	cannot	provide.	It	is	imperative	therefore	that	both	qualitative	and	quantitative	
analysis	occurs	in	parallel.	A	limitation	of	the	immunohistochemical	methods	are	the	
variability	of	staining	that	is	observed	under	the	same	experimental	conditions	and	
even	along	the	same	tissue	section.	The	grading	of	tissue	sections	for	strength	of	
staining	therefore	may	be	unreliable.	It	follows	therefore,	that	immunohistochemical	
staining	serves	more	utility	in	being	able	to	identify	the	absence	or	presence	of	staining	
in	comparison	to	a	negative	control.	It	does	however	provide	useful	information	
regarding	the	distribution	of	the	antigen	of	interest.	As	stated	previously,	a	more	
detailed	study	of	the	ultrastructure,	degradation	of	other	components	such	as	elastin,	
glycosaminoglycan	content	and	importantly,	ultrastructural	features	are	warranted.	
Furthermore,	only	the	major	groups	of	extracellular	proteins	have	been	characterised	
in	this	study.	There	are	opportunities	in	future	work	to	characterise	precise	isoforms	
e.g.	of	laminin	in	comparison	to	other	biological	substrates	and	amniotic	membrane.		
	
4.7	 Culture	of	primary	human	conjunctival	cells	on	decellularised	
conjunctiva	and	amniotic	membrane		
The	protocol	for	the	decellularisation	of	human	conjunctiva	was	developed	and	the	
resulting	tissue	characterised	(section	4.6).	The	tissue	was	not	cytotoxic	and	the	
extracellular	matrices	and	tensile	strength	were	not	significantly	altered	by	
decellularisation.	Techniques	for	the	culture	of	human	conjunctival	epithelium	on	
decellularised	conjunctiva	were	developed	in	this	study.	Experimental	findings	are	
discussed	together	with	the	limitations	of	the	study	and	opportunities	for	further	
research.	The	key	findings	from	this	study	are	summarise	overleaf.		
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• Seeding	decellularised	tissues	with	conjunctival	tissue	explants	resulted	in	
qualitatively	greater	cell	density	in	comparison	to	seeding	a	cell	suspension.	
• Confluent	epithelial	growth	occurred	when	explants	were	cultured	in	contact	
with	the	basement	membrane	of	decellularised	conjunctival	tissue.	
• There	was	marked	variability	in	the	conjunctival	epithelial	cell	growth	from	
explants	from	different	donors	and	decellularised	conjunctiva	from	different	
sources.	
• A	stratified	conjunctival	epithelium	was	developed	from	explant	culture	on	
freshly	decellularised	conjunctival	tissue.	
• The	stratified	conjunctival	epithelial	construct	was	demonstrated	to	express	
conjunctival	epithelial	markers	including	CK7,	sparse	MUC5AC	staining	and	
progenitor	cell	markers	
	
4.7.1	 Cell	culture	experiments	and	characterisation	of	the	developed	tissue	
constructs		
Preliminary	primary	cell	culture	experiments	found	that	seeding	decellularised	tissue	
with	conjunctival	explants	resulted	in	confluent	epithelial	cell	growth	whereas	seeding	
the	decellularised	tissue	with	a	cell	suspension	resulted	in	sparse	cell	growth.	Indeed,	
the	isolated	cell	suspension	had	been	initially	expanded	on	tissue	culture	plates	from	
explants.	The	cells	were	therefore	at	a	more	advanced	passage	and	seeded	after	7	days	
in	culture	in	comparison	to	explants,	which	were	seeded	within	hours	of	retrieval.	One	
of	the	reasons	that	the	explant	cultures	develop	more	successfully	than	isolated	cells	
may	be	that	any	stem	cell	‘niche’	may	have	been	preserved	in	its	native	state	and	was	
therefore	more	capable	in	supporting	proliferation	and	differentiation.	
	
The	orientation	of	tissue	was	crucial	such	that	cellular	expansion	occurred	more	
effectively	when	cells	were	cultured	in	direct	contact	with	the	basement	membrane.	In	
the	earlier	section,	the	distribution	of	laminin,	collagen	IV	and	fibronectin	was	
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described	to	localise	strongly	to	the	basement	membrane	with	less	expression	in	the	
substantia	propria	(section	4.6.4).	Cell-extracellular	matrix	interactions	are	therefore	of	
paramount	importance	for	proliferation	and	differentiation.(185)	In	keeping	with	this,	
differential	signalling	patterns	have	been	identified	in	conjunctival	epithelia	based	upon	
interactions	with	specific	isoforms	of	laminin.(187)	
	
Results	from	this	study	comparing	decellularised	tissue	from	three	donors	with	explant	
tissue	from	three	further	donors	demonstrated	variability	in	the	potential	of	explants	
to	develop	on	decellularised	conjunctiva.	The	variability	may	be	explained	by	
differences	in	the	donor	age,	post	mortem	retrieval	time,	and	location	from	which	the	
conjunctival	explants	originated.	Studies	on	biopsy	location	in	relation	to	the	colony	
forming	efficiency	have	been	undertaken	and	it	is	of	interest	to	note	that	increasing	
length	of	the	post-mortem	retrieval	time	and	advancing	donor	age	significantly	lower	
both	the	clonogenic	ability	and	expression	of	progenitor	cell	markers	in	culture.(19)	
Nevertheless,	the	majority	of	donors	used	within	this	study	were	elderly	and	given	the	
small	sample	size,	it	is	not	possible	to	determine	if	these	were	major	contributing	
factors.	It	was	however	of	interest	to	note	that	the	two	of	the	later	culture	attempts	in	
which	fresh	samples	of	decellularised	tissue	were	used	resulted	in	cultures	with	greater	
cell	density,	confluence	and	even	became	multi-layered	constructs.	A	study	
investigated	the	effect	of	freezing	prior	to	decellularisation	of	human	umbilical	cord	
and	demonstrated	that	condensation	of	the	extracellular	matrix	lead	to	greater	
residual	DNA	following	decellularisation.(236)	Reports	on	other	tissue	types	in	which	
tissue	was	frozen	following	decellularisation	could	not	be	found.	It	would	be	of	interest	
in	future	work	to	determine	whether	freezing	changes	the	ultrastructure	and	
potentially	influence	culture	potential.		
	
Immunohistochemistry	using	one	of	the	later	multi-layered	developed	conjunctival	
constructs	confirmed	that	the	resulting	stratified	epithelium	was	of	a	conjunctival	
phenotype	expressing	CK19,	CK7	and	CK4	typical	to	conjunctival	epithelium.(10,	127,	134)	
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CK7,	regarded	as	goblet	cell	marker	was	found	throughout	the	tissue	sections	
suggesting	the	presence	of	goblet	cells	with	the	potential	to	produce	mucin.(11,	134)	Dartt	
and	colleagues	hypothesise	that	CK7+/UAE-1	negative	cells	may	represent	a	population	
of	immature	goblet	cells	that	may	have	proliferative	capacity	and	potential	to	develop	
into	mature	goblet	cells	in	their	study	of	the	migration	patterns	from	conjunctival	
explant	outgrowth	and	differentiation.(134)	Unfortunately,	UAE-1	lectin	was	not	used	as	
a	marker	in	these	immunohistochemistry	studies	in	addition	to	CK7	and	MUC5AC.	
MUC5AC	is	a	gel	forming	mucin	found	exclusively	in	mature	goblet	cells.(11)	Its	
expression	was	sparse	but	detectable,	which	may	suggest	the	presence	of	immature	
goblet	cells	given	the	degree	of	CK7	staining.(133)	To	the	best	of	our	knowledge,	this	is	
the	first	conjunctival	substrate-culture	study	in	which	CK7	positive	conjunctival	cells	
have	been	demonstrated.	Furthermore,	ex	vivo	cultivated	human	conjunctival	
epithelial	grafts	on	amniotic	membrane	have	not	been	shown	to	support	mucin	
producing	conjunctiva	and	therefore	decellularised	conjunctiva	may	be	superior	
substrate	than	amniotic	membrane	for	conjunctival	expansion.(58,	68)			
	
Markers	of	progenitor	cells	ΔNp63	and	ABCG2	were	also	present	in	lesser	frequency,	
with	ABGC2	expression	less	abundant	than	ΔNp63.	This	would	be	in	keeping	with	the	
quantitative	analysis	of	conjunctival	epithelial	cell	cultures	on	synthetic	substrates	
described	in	section	5.2.2.	Levels	of	PCNA	expression	appeared	similar	to	that	of	
ΔNp63.	Caspase	3,	a	marker	of	apoptotic	cells	was	also	present	and	appeared	to	be	
expressed	in	apical	rather	than	basal	cells,	in	contrast	to	the	other	cell	markers	studied	
which	appear	to	be	more	evenly	distributed.	This	would	be	in	keeping	with	the	
assumption	that	older	cells	that	would	be	lost	are	more	apical	and	would	be	replaced	
by	basal	cells,	which	may	be	at	an	earlier	stage	of	differentiation.	Indeed	the	
distribution	of	these	markers	in	healthy	conjunctiva	is	poorly	characterised	in	the	
literature.	It	would	be	of	interest	in	future	work	therefore,	to	characterise	the	
distribution	of	the	markers	investigated	in	this	study	in	healthy	conjunctiva	and	
between	different	sites.	Furthermore,	a	quantitative	analysis	of	marker	expression	is	
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also	warranted	for	both	conjunctival	tissues	in	addition	to	constructs	expanded	from	
explants.	The	evidence	from	this	experiment,	however,	would	suggest	that	the	
conjunctival	construct	had	potential	for	self-renewal	and	supported	a	population	of	
actively	proliferating	cells.			
	
4.7.2	 Limitations	of	the	study		
One	of	the	problems	associated	with	seeding	primary	conjunctival	cells	on	
decellularised	tissue	is	the	lack	of	cell	number	when	cells	are	isolated	from	the	tissues	
prior	to	culture	and	directly	seeded.	This	was	circumvented	by	the	use	of	conjunctival	
explants	in	the	present	study.	From	the	outset	of	the	experiments,	however,	the	cell	
numbers	seeded	or	the	growth	potential	of	the	explants	(determined	by	factors	such	as	
the	anatomical	location	of	origin	from	the	conjunctiva	and	donor	age)	were	not	
controlled.	This	could	be	addressed	in	future	work	if	a	greater	sample	number	is	
available.		
	
A	limitation	of	this	study	was	that	direct	comparisons	were	not	made	between	the	
phenotype	of	conjunctival	cultures	developed	on	decellularised	conjunctiva	and	
amniotic	membrane.	The	potential	benefits	of	amniotic	membrane	cannot	be	ignored.	
The	young’s	modulus	of	amniotic	membrane	is	higher	than	that	of	conjunctiva	and	
there	is	greater	consistency	in	the	tissue	architecture	of	amniotic	membrane	than	that	
demonstrated	between	conjunctival	samples.		Given	that	conjunctiva	would	be	derived	
from	a	cadaveric	source,	most	donors	will	be	elderly	in	whom	the	effects	of	tissue	
degeneration	cannot	be	ignored.	Human	amniotic	membrane	is	thought	to	promote	
cell	adhesion	and	differentiation.(237)	It	is	also	recognised	that	the	stromal	matrix	
contains	an	abundance	of	foetal	hyaluronic	acid,	which	aids	in	the	reduction	of	scarring	
via	a	TGF-ϒ	pathway	and	also	supresses	pro-inflammatory	cytokines.(237)	It	is	yet	to	be	
determined	how	transplanted	decellularised	conjunctiva	will	compare	in	this	regard.		
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Decellularisation	may	reduce	the	risk	of	disease	transmission	but	may	disrupt	
extracellular	matrix	components,	the	ultrastructure	of	the	tissue	and	remove	soluble	
proteins	including	growth	factors.(65)	The	results	from	this	study	however	do	not	
suggest	any	alteration	in	the	distribution	of	the	major	extracellular	matrix	proteins,	
glycosaminoglycan	content	by	PAS	staining	or	denaturation	of	collagen	through	a	
quantitative	assay.	Further	analysis	of	other	extracellular	matrix	components	and	tissue	
ultrastructure	however	is	warranted.		
	
	
4.8	 Characterisation	of	patients	with	MMP	and	potential	ocular	
surface	reconstructions	strategies	
Mucous	membrane	pemphigoid	can	lead	to	painful	loss	of	vision	and	in	its	most	severe	
form	can	be	life	threatening.	The	onset	of	MMP	is	notoriously	insidious,	can	be	difficult	
to	diagnose	and	often	the	presentation	is	delayed.(36)	Treatment	involving	
immunosuppression	is	crucial	in	active	disease	and	to	prevent	or	reduce	the	risk	of	
disease	progression.	To	this	end	it	is	important	that	objective	and	robust	grading	
systems	are	developed	and	used	to	i)	identify	patients	in	need	of	treatment	ii)	monitor	
progression	and	treatment	response.	In	this	study,	a	novel	pro	forma	was	developed	as	
a	tool	for	use	in	corneal	and	external	eye	disease	clinics	to	assess	patients	with	mucous	
membrane	pemphigoid.		
	
4.8.1	 Development	of	a	pro	forma	to	assess	mucous	membrane	pemphigoid	
patients	
A	number	of	methods	have	been	described	for	the	grading	of	ocular	mucous	
membrane	pemphigoid	without	any	consensus	on	the	optimal	method	for	use.	To	
compare	the	scores	of	the	grading	systems,	all	well-known	methods	including	that	by	
Rowsey,	Mondino	and	Foster,	Tauber	and	the	Tauber-Liverpool	were	included	in	the	
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pro	forma.(46,	153-156)	It	should	be	noted	that	these	methods	grade	cicatrisation	and	
therefore	the	sequelae	of	disease	without	any	assessment	of	the	degree	of	
inflammatory	activity.	To	overcome	this,	Saw	and	colleagues	developed	a	method	for	
assessing	disease	activity	based	on	the	degree	of	conjunctival	and	limbal	
inflammation.(163,	164)	This	was	therefore	also	included	as	part	of	the	pro	forma	
developed	and	used	within	St	Pauls	Eye	Unit	in	consultation	with	the	Corneal	and	
External	Eye	Disease	team.	Also	included,	as	part	of	the	pro	forma	were	photographs,	
fornix	rule	measurements,	grading	of	lid	deformities,	presence/absence	of	trichiasis,	
presence/absence	of	lagophthalmos,	and	documentation	of	dryness	according	to	The	
Oxford	grading	scheme.	(158)	
	
The	adapted	versions	of	existing	grading	schemes	used	for	the	assessment	of	lid	
deformities	including	grading	of	ectropion,	entropion,	the	documentation	of	trichiasis	
and	lagophthalmos	as	shown	in	the	developed	pro	forma	have	not	been	validated	for	
use	as	a	measurement	tools	(Appendix).	Furthermore,	other	components	of	the	pro	
forma	such	as	documentation	with	photographs	in	addition	to	anterior	segment	
drawings	also	require	formal	validation	studies.	The	aim	of	this	process	was	to	develop	
and	pilot	a	pro	forma	that	could	be	developed	further	for	use	in	the	clinic	to	identify	
patients	that	may	benefit	from	ocular	surface	reconstruction	and	adjunctive	therapies	
to	reduce	the	risk	of	cicatrisation.	To	this	end,	it	would	be	of	interest	to	undertake	
validation	studies	in	the	future	to	assess	the	inter-rater	and	intra-rater	reliability	of	the	
grading	scales	developed	for	use	in	this	pro	forma.	In	addition,	it	would	be	of	interest	
to	formally	assess	the	time	taken	for	completion	of	the	pro	forma	and	also	the	utility	of	
anterior	segment	drawings	in	combination	with	photographic	evidence	for	the	
documentation	of	disease	activity	and	progression	in	MMP.		
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4.8.2	 Characterisation	of	the	patient	examined	using	the	novel	pro	forma	
The	patients	examined	as	part	of	this	pilot	scheme	were	opportunistically	sought	from	
corneal	and	external	eye	disease	clinics	at	St	Paul’s	eye	unit.	All	the	patients	were	
therefore	under	active	follow	up	for	ocular	mucous	membrane	pemphigoid	or	were	
being	monitored	as	they	were	receiving	immunosuppression.	None	of	the	patients	seen	
were	treated	for	any	cicatricial	disease	process	other	than	ocular	mucous	membrane	
pemphigoid.	This	would	be	in	keeping	with	the	known	incidence	of	conditions	classed	
as	cicatrising	conjunctivitis	in	which	mucous	membrane	pemphigoid	affects	the	
greatest	proportion	of	patients.(36)	Furthermore,	many	other	conditions	e.g.	ocular	
burns	undergo	an	active	period	of	follow	up	following,	which	they	may	be	discharged	if	
stable,	in	contrast	to	ocular	mucous	membrane	pemphigoid.		
	
All	the	examined	patients	were	graded	as	III	(Tauber)	in	one	or	both	eyes.	All	patients	
also	had	one	or	both	eyes	≥60%	vertical	involvement	and	≥50%	horizontal	involvement,	
and	four	out	of	five	patients	with	a	Rowsey	score	≤50%	of	the	total	score.	The	grading	
scheme	suggested	none	of	the	patients	had	significant	corneal	involvement	and	
dryness	(oxford	grading	scheme)	was	mild.	Trichiasis	was	however	a	significant	
problem	affecting	eight	of	ten	eyes	examined.	In	terms	of	lid	deformities,	only	one	eye	
had	a	lower	lid	deformity.	No	upper	lid	deformities	were	recorded	and	this	was	in	
keeping	with	the	pattern	of	cicatrisation	in	ocular	mucous	membrane	pemphigoid.	
These	data	show	that	the	group	of	patients	examined	had	moderate	to	severe	ocular	
mucous	membrane	involvement.		
	
4.8.3	 Pilot	exercise	to	develop	recommendations	for	a	pro	forma	
Some	of	the	problems	with	the	pro	forma	became	apparent	during	the	pilot	tests.	The	
fornix	rule	was	approximately	1mm	thick.	It	became	apparent	therefore	that	it	
underestimated	the	true	depth	of	the	fornix.	For	example,	in	the	patient	photographed	
in	Figure	97,	the	inferior	fornix	depth	was	measured	as	0mm.	The	fornix	ruler	
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measurements	would	however	prove	useful,	particularly	in	the	assessment	of	the	
superior	fornices,	which	are	otherwise	difficult	to	assess	and	rarely	documented.(157)	
Recommendations	from	this	pilot	are	therefore	to	develop	an	alternative	ruler	that	is	
sufficiently	thin,	long	and	curved	to	be	inserted	comfortably	within	fornices	or	use	that	
designed	by	Williams	and	colleagues	that	has	already	undergone	validation	tests.(157)		
	
The	inflammatory	score	was	easy	to	assess	and	was	time	efficient,	taking	on	average	
around	2	minutes	to	complete.	Some	difficult	was	noted	however	in	differentiating	
between	‘minimal’	and	‘mild’	inflammatory	grades,	however,	advanced	grades	were	
easy	to	score.	This	grading	system	has	been	used	in	clinical	trials	however	validation	
and	further	investigation	into	its	inter-rater	and	intra-rater	reliability	may	provide	
further	opportunities	for	its	improvement.(163,	164)	My	recommendation	would	be	
therefore	to	use	the	scoring	system	for	disease	activity	following	formal	validation	as	
there	are	no	other	available	validated	scoring	systems.	Furthermore,	it	is	of	paramount	
importance	to	include	a	tool	for	grading	conjunctival	inflammation,	as	it	is	the	only	
available	measurement	of	disease	activity.	In	contrast,	all	other	graded	features	
measure	disease	sequelae.	In	end	stage	or	near	end	stage	ocular	disease,	however,	it	
may	be	difficult	to	assess	disease	activity.	This	was	demonstrated	in	the	present	study	
(patient	4,	Figure	101).	Although	activity	at	alternative	sites	such	as	the	oropharynx	
could	be	used,	it	is	unclear	whether	this	would	mirror	ocular	activity.		In	the	study	by	
Reeves	and	colleagues,	no	correlation	was	found	between	the	graded	scores	for	the	
eyes	and	oropharynx.	The	score	for	the	oropharynx,	however,	graded	activity	whereas	
the	score	for	the	ocular	involvement	measured	cicatricial	and	therefore	structural	
change.	Future	work	to	compare	activity	scores	at	multiple	sites	would	therefore	be	
warranted	in	patients	who	have	extra-ocular	manifestations	of	mucous	membrane	
pemphigoid.		
	
The	presence	or	absence	of	trichiasis	and	lagophthalmos	were	included	in	the	pro	
forma	and	could	be	assessed	within	minutes.	Similarly,	the	Oxford	grading	scheme	for	
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dryness,	grading	of	lid	deformity	and	corneal	involvement	were	relatively	quick	to	
score.	The	ease	of	administration	of	the	pro	forma	was	determined	by	comparing	the	
scoring	tool	with	a	tool	designed	to	document	a	much	greater	level	of	detail	designed	
by	Rauz	and	colleagues,	Birmingham	and	Midlands	Eye	Centre,	Birmingham.	The	latter	
tool	took	approximately	and	hour	to	complete	whereas	the	developed	pro	forma	took	
approximately	20	minutes	in	total.	Components	of	the	information	gathering	process	
including	eyelids,	adnexa	in	addition	to	ocular	dryness	are	important	to	note	in	the	
assessment	of	MMP	patients	as	they	may	alert	the	clinician	to	initiate	supportive	
interventions	in	a	timely	manner	to	prevent	or	delay	the	desiccation	of	ocular	surface	
epithelia.	The	documentation	of	corneal	signs	provides	an	indication	of	the	visual	
impairment	and	need	for	medical	or	surgical	management.	The	treatment	of	a	central	
corneal	defect,	for	example,	may	be	required,	whereas	peripheral	corneal	signs	
pathology	such	as	limbitis	or	corneal	vascularisation	indicates	a	potential	need	for	
future	limbal	stem	cell	transplantation.	This	information	is	important	when	planning	
the	sequence	of	ocular	surface	reconstruction.		
	
There	were	insufficient	numbers	of	patients	examined	as	part	of	this	pilot	to	comment	
on	the	correlation	and	agreement	between	the	various	methods	of	grading	
cicatrisation.	It	has	been	determined	however	that	good	levels	of	agreement	exist	
between	the	Rowsey	score	and	the	Tauber-Liverpool.(156)	Rowsey	and	colleagues	have	
also	demonstrated	that	their	grading	scheme	is	concordant	with	that	of	Tauber	and	
Mondino	and	Brown.	(46,	154,	155)	During	this	pilot	experiment,	when	using	all	the	
described	grading	schemes	it	became	apparent	that	there	was	some	overlap.	Some	
grading	systems	prompt	more	detailed	assessment	of	cicatricial	features	e.g.	the	
Tauber	scheme	provides	further	subdivisions	to	that	by	Mondino	and	Brown,	and	the	
Liverpool	scheme	provides	more	accurate	quantification	that	builds	upon	the	existing	
Tauber	scheme.(46,	154,	156)	The	Liverpool-Tauber	scheme	may	detect	more	subtle	
structural	progression	than	the	Tauber	grading	scheme	alone	although	the	Tauber	
grading	scheme	is	sensitive	to	tarsal	conjunctival	change.	My	recommendation	based	
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on	the	pilot	work	therefore	would	be	to	grade	cicatrisation	as	described	on	page	2	of	
the	pro	forma	which	includes	the	Tauber-Liverpool	measurements	together	with	the	
Rowsey	scheme	on	the	following	page	(Appendix	1).	By	doing	so,	there	would	be	no	
need	to	also	include	the	Foster	and	Mondino	and	Brown	grading	scheme	as	there	is	
already	overlap	between	these	measurements.		
	
	
4.9	 Treatment	of	cicatrising	eye	disease	and	the	potential	use	of	the	
substrates	developed	in	this	study		
There	is	no	consensus	on	the	degree	of	cicatrisation	that	would	specifically	warrant	
surgical	ocular	surface	reconstruction.	Some	studies	have	suggested	that	‘pathogenic’	
symblephara	may	be	defined	by	dry	eye	from	interruption	of	spread	of	tears,	blink	
related	microtrauma	from	an	irregular	tarsal	surface,	cicatricial	entropion,	exposure	
due	to	lagophthalmos	and	restriction	of	ocular	motility.(240)	Furthermore,	it	is	
imperative	that	the	disease	process	is	controlled	prior	to	any	surgical	intervention	
otherwise	a	marked	inflammatory	response	in	the	post-operative	period	would	
compromise	the	success	of	reconstruction.		
	
Of	the	patients	studied,	the	right	eye	of	patient	4	would	warrant	ocular	surface	
reconstruction	given	the	degree	of	symblepharon	and	almost	complete	obliteration	of	
the	inferior	fornix	in	the	right	eye.	The	surgeon	would	need	to	be	wary	of	the	fact	that	
signs	of	active	disease	were	present	in	the	fellow	eye	and	delay	treatment	even	though	
the	activity	score	suggests	disease	quiescence	in	the	right	eye.	Presuming	that	disease	
quiescence	could	be	achieved	through	immunosuppression,	surgical	intervention	could	
be	undertaken.	In	the	first	instance	the	patient	should	undergo	lash	electrolysis	to	
ensure	permanent	removal	of	misdirected	lashes.	As	no	other	lid	deformities	were	
present,	the	next	stage	would	involve	lysis	of	symblephara	and	forniceal	
reconstruction.	As	described	in	earlier	sections,	amniotic	membrane	would	be	the	
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current	available	standard	for	forniceal	construction	but	is	prone	to	recurrent	scarring	
and	forniceal	shortening.(54)	
	
Such	patients	may	be	treated	in	the	future	with	novel	conjunctival	grafts	developed	
through	the	ex-vivo	expansion	of	conjunctival	epithelium	on	decellularised	conjunctiva	
or	ePTFE.	A	major	problem	to	approach	in	this	scenario	is	the	autologous	biopsy	
required	to	develop	the	construct.	With	this	regard,	the	risk	of	scarring	and	
inflammation	is	significant	and	therefore	disease	quiescence	at	the	outset	of	treatment	
in	addition	to	immunosuppression	in	the	perioperative	period	would	be	of	paramount	
importance.	Culture	methods	and	the	substrates	themselves	need	to	be	developed	
such	that	adequate	conjunctival	expansion	could	be	achieved	from	small	biopsies	taken	
from	the	patient.	Other	research	groups	also	advocate	the	use	of	intraoperative	
mitomycin	C	(MMC)	or	β-irradiation	to	prevent	re-adhesion.(240,	241)	It	is	unlikely	that	a	
construct	developed	from	decellularised	conjunctiva	would	afford	any	advantage	over	
amniotic	membrane	for	forniceal	reconstruction	as	it	may	be	equally	prone	to	
recurrent	scarring	given	it	will	also	degrade.	I	hypothesise	that	surface	optimised	ePTFE	
may	be	more	suitable	for	forniceal	reconstruction	given	that	it	is	not	biodegradable	and	
may	i)	provide	long-term	forniceal	support	and	ii)	act	as	a	substrate	for	the	ex	vivo	
expanded	conjunctival	epithelium.	Ideally	the	developed	epithelial	culture	would	
comprise	a	suitable	proportion	of	mucin	producing	goblet	cells	that	could	improve	the	
tear	film	of	the	eye	and	a	subset	of	progenitor	cells	that	would	enable	the	epithelium	
to	self	renew.			
	
Surgery	has	been	described	to	involve	cicatrix	lysis	via	a	circumlunar	incision	of	the	
conjunctiva	along	the	corneal	limbus	followed	by	relaxing	incisions	towards	the	fornix	
along	the	borders	of	the	symblepharon	with	dissection	of	subconjunctival	fibrovascular	
tissue.	Following	dissection,	MMC	exposure	could	be	initiated	via	soaked	sponges	and	
the	fornix	extensively	rinsed	following	their	removal.	This	additional	step	may	prevent	
the	subsequent	overgrowth	of	fibroblasts.	The	ex-vivo	developed	ePTFE	conjunctival	
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construct	could	then	be	attached	to	bare	sclera	with	fibrin	glue	and	secured	with	
sutures	to	the	recessed	conjunctiva	on	the	bulbar	and	tarsal	aspects	as	previously	
described.(240)		
	
The	decellularised	conjunctival	substrate	is	likely	to	be	available	in	much	smaller	
sections	and	therefore	this	will	limit	its	use.	It	could	be	ideal,	for	example,	in	fornix	
reconstruction	following	an	ocular	burn	once	inflammation	has	settled,	but	this	would	
depend	on	the	size	of	decellularised	tissue	available	for	use.	A	decellularised	
conjunctival	substrate	may	also	suit	indications	such	as	that	following	the	removal	of	
pterygia,	conjunctival	tumours	or	even	glaucoma	surgery	including	following	the	
placement	of	drainage	valve	implants.			 	
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5.	 Conclusions	
This	study	determined	the	potential	of	both	ammonia	gas	plasma	modified	ePTFE	and	
decellularised	conjunctiva	as	substrates	for	the	ex-vivo	expansion	of	conjunctival	
epithelium.	These	substrates	may	be	used	for	a	different	range	of	indications	and	
warrant	consideration	for	use	in	tissue	engineering	applications	to	address	the	clinical	
need	for	conjunctival	replacement.	These	therapies	could	lead	to	successful	treatments	
for	a	range	of	sight	threatening	and	painful	ocular	surface	disorders.		
	
	
Ammonia	gas	plasma	treated	ePTFE	is	an	effective	substrate	for	the	expansion	of	
conjunctival	epithelium	
	
• Ammonia	gas	plasma	treatment	of	ePTFE	increases	its	hydrophilicity	and	
enables	the	culture	of	conjunctival	epithelium	on	the	treated	surface.	The	cell	
density	was	further	improved	by	treatment	of	the	ePTFE	membrane	on	both	
sides,	an	effect	marked	after	14	days	in	culture.		
	
• A	similar	phenotype	of	conjunctival	epithelial	cultures	was	demonstrated	on	
double	side	plasma	treated	ePTFE	as	PET	membrane.		
	
• The	culture	of	primary	cells	on	double	side	ammonia	plasma	treated	ePTFE	
resulted	in	a	decline	in	cell	number	after	14	days	in	culture	in	contrast	to	HCjE-
Gi	cells,	which	increased	up	to	28	days.	Overall,	the	primary	cell	cultures	were	of	
a	more	differentiated	phenotype	with	less	proliferative	potential	demonstrated	
by	greater	CK4,	CK7	and	MUC5AC	expression	and	lower	PCNA,	ΔNp63	and	
ABCG2	expression.		
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Decellularised	human	conjunctiva	is	an	effective	substrate	for	the	ex	vivo	expansion	
of	conjunctival	epithelium		
	
• Human	conjunctival	was	successfully	decellularised	by	optimising	a	previously	
developed	protocol	for	the	decellularisation	of	amniotic	membrane.		
	
• The	decellularisation	protocol	was	effective	in	the	removal	of	DNA.	The	tissue	
did	not	exhibit	cytotoxicity,	there	was	no	evidence	of	collagen	denaturation	and	
the	histology	demonstrated	no	significant	change	in	the	general	tissue	
architecture,	elastin	or	glycosaminoglycan	distribution	(basement	membrane)	
demonstrated	by	H&E,	Van	Gieson’s	and	PAS	stains	respectively.		
	
• Decellularisation	did	not	affect	the	distribution	of	extracellular	matrix	proteins	
laminin,	collagen	IV	or	fibronectin.		
	
• There	was	greater	variability	in	the	architecture	of	the	conjunctival	tissue	in	
comparison	to	amniotic	membrane	between	donors.		
	
• The	development	of	stratified	primary	conjunctival	epithelial	culture	on	
decellularised	conjunctiva	was	demonstrated	for	the	first	time.	
Immunohistochemical	staining	also	confirmed	that	the	developed	epithelium	
was	of	a	conjunctival	phenotype	with	a	subpopulation	of	progenitor	cells,	
proliferating	cells	and	CK7	positive	cells.		
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6.	 Future	directions		
There	are	opportunities	in	future	research	to	influence	the	stem	and	goblet	cell	
populations	in	cultures	of	conjunctival	epithelium	through	the	further	investigation	and	
optimisation	of	culture	conditions.	Important	improvements	in	culture	techniques	have	
taken	place	such	that	serum-free	media	has	been	developed	and	the	use	of	animal	
feeder	layers	has	not	been	required	in	recent	work.	Further	optimisation	and	
investigation	should	lead	to	an	improved	understanding	of	media	and	culture	
requirements	aiming	to	further	reduce	or	eliminate	animal	products	to	reduce	the	risk	
of	zoonotic	infection.	Indeed,	a	serum	free	system	has	been	developed	in	an	attempt	to	
simulate	the	conjunctival	stem	cell	niche	by	co-culture	of	conjunctival	epithelium	with	
subconjunctival	fibroblasts.(238)	It	was	found	that	that	this	allowed	conjunctival	cells	
with	progenitor	characteristics	to	develop	and	has	been	proposed	as	an	ideal	method	
to	allow	expansion	of	epithelial	progenitor	cells	in	vitro.(238)	In	addition,	it	has	been	
demonstrated	that	a	collagen	gel	containing	human	fibroblasts	resulted	in	greater	
numbers	of	goblet	cells,	which	were	not	observed	on	collagen	gels	seeded	with	Swiss	
3T3	cells.(239)		
	
Seeding	explants	from	conjunctival	sites	known	to	be	rich	in	stem	cells	and	goblet	cells	
and	the	development	of	methods	to	develop	enriched	cultures	of	progenitor/stem	cells	
could	result	in	optimised,	self-renewing	epithelial	constructs.(19)	Decellularised	trachea,	
one	of	the	most	successful	models	of	tissue	engineering	in	which	great	success	has	
been	achieved	in	patients,	crucially	required	an	ex	vivo	epithelial	culture	rich	in	stem	
cells	with	the	appropriate	angiogenesis	and	differentiation	promoting	growth	
factors.(74)	To	this	end,	techniques	to	expand	and	support	cultures	rich	in	conjunctival	
stem	cells	are	acutely	warranted	and	currently	lacking.		
	
Examination	of	the	proliferative	capacity	of	conjunctival	explants	taken	from	several	
locations	revealed	that	forniceal	explants	exhibit	the	greatest	proliferative	potential	in	
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both	rat	and	rabbit.(16,	133)	In	keeping	with	this,	it	has	been	suggested	that	the	human	
fornices	house	conjunctival	stem	cells.(18)	In	particular,	the	inferior	fornices	and	the	
medial	canthus	have	been	found	to	have	the	greatest	density	of	cells	expressing	
markers	in	keeping	with	conjunctival	progenitor	cells.(19)	It	has	been	also	been	
proposed	by	Pellegrini	and	colleagues	that	goblet	cells	arise	from	a	common	bipotent	
cell	from	which	conjunctival	epithelial	cells	arise	and	that	commitment	to	goblet	cell	
differentiation	can	occur	late	in	the	differentiation	pathway.(18)	Pellegrini	and	
colleagues	found	transiently	amplifying	cells	at	specific	times	in	their	life	cycle	prior	to	
senescence	and	suggested	that	differentiation	into	a	goblet	cell	lineage	was	influenced	
by	a	‘cell	doubling	clock’.	(18)	It	follows	therefore,	that	methods	of	explant	culture	using	
human	conjunctiva	should	be	optimised	with	respect	to	the	biopsy	location	site	and	
with	an	understanding	of	the	factors	that	influence	goblet	cell	differentiation.		
	
Given	that	explants	arising	from	the	fornices	and	medial	canthus	have	been	shown	to	
have	the	greatest	growth	potential,	it	may	be	possible	in	future	work	to	develop	a	two-
stage	culture	system	if	there	is	insufficient	tissue	for	the	direct	seeding	of	explants	from	
biopsies.	Indeed,	a	two-stage	procedure	has	been	reported	for	other	tissue	engineering	
models	e.g.	endothelial	cell	seeding	in	vascular	grafts	to	maximise	the	cell	density	of	
cells.	Potential	disadvantages	are	the	potential	for	infection	during	this	extended	
period	of	culture	and	also	of	potential	alterations	in	the	cell	phenotype.(185)	Alternative	
methods	for	greater	efficiency	of	cell	propagation	include	the	use	of	fibroblast	
conditioned	media	and	supplementation	of	media	with	human	serum.(132)		
	
Tsai	and	colleagues	also	demonstrated	that	conjunctival	epithelial	cell	culture	on	
collagen	gels	containing	human	fibroblasts	resulted	in	epithelium	stratified	up	to	8	cells	
thick	in	comparison	to	an	acellular	collagen	matrix	on	which	only	a	monolayer	of	
epithelium	was	demonstrated.(239)	Indeed,	the	epithelial	cultures	in	the	present	study	
could	be	improved	by	a	greater	number	of	cell	layers	and	stratification.	This	in	turn	may	
promote	the	differentiation	of	goblet	cells.	Alternatively,	the	differentiation	of	goblet	
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cells	and	stratification	may	be	stimulated	by	a	common	factor	such	as	the	presence	of	
fibroblasts.	The	role	of	subconjunctival	fibroblasts	warrants	further	study	including	the	
potential	for	initial	culture	within	the	substantia	propria	prior	to	seeding	conjunctival	
epithelia	on	the	basement	membrane	side.	It	would	also	be	of	interest	to	determine	
whether	explant	cultures	develop	successfully	due	to	the	presence	of	a	stem	cell	‘niche’	
that	potentially	includes	a	small	population	of	conjunctival	fibroblasts.		
	
Further	optimisation	of	media	constituents	are	warranted	to	promote	conditions	that	
support	the	maturation	of	goblet	cells	and	mucin	production.	This	could	be	achieved	
through	a	better	understanding	and	use	of	the	most	appropriate	growth	factors	and	
possibly	a	lengthened	time	in	culture	to	upregulate	MUC5AC	expression.(17)	Alternative	
methods	to	potentiate	the	culture	of	goblet	cells	could	include	the	use	of	bronchial	
epithelial	growth	medium,	epidermal	growth	factor	mediated	signalling	or	γ-secretase	
as	studied	by	other	research	groups.(112,	131,	242)	
	
The	ePTFE	is	a	promising	substrate	for	cellular	expansion	that	warrants	further	
optimisation	of	surface	chemistry	to	ensure	that	a	favourable	conjunctival	phenotype	
can	be	developed	on	its	surface.	It	may	prove	to	be	an	ideal	substrate	for	forniceal	
reconstruction	and	act	as	a	long-term	scaffold	for	conjunctiva	whilst	maintaining	
forniceal	depth.	Given	the	example	of	other	tissue	engineering	applications	of	ePTFE	
use,	it	is	unlikely	that	a	vascular	system	would	be	required	for	the	maintenance	of	
conjunctival	tissue	given	that	is	only	a	few	cell	layers	deep.(185)	Ultimately	the	number	
of	cell	layers	may	be	limited	by	factors	relating	to	the	rate	at	which	supply	of	nutrients	
and	ability	to	remove	waste	occurs.(185)	Following	further	optimisation	of	the	surface	
chemistry	on	ePTFE,	early	animal	studies	are	warranted	to	investigate	it’s	potential	for	
conjunctival	growth	and	fornix	reconstruction	in	vivo.		
	
A	soft,	pliable	graft	derived	from	decellularised	conjunctiva,	with	or	without	ex	vivo	
expanded	conjunctival	epithelium,	may	suit	a	range	of	indications	including	glaucoma	
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surgery,	conjunctival	replacement	following	resection	of	conjunctival	tumours	and	
conjunctival	chemical	burns.	The	role	of	decellularised	human	conjunctiva	may	even	be	
extended	for	other	ocular	cellular	replacement	therapies	such	as	limbal	stem	cell	
transplantation.	Indeed,	xenogeneic	conjunctival	matrix	has	even	been	demonstrated	
as	an	effective	scaffold	for	corneal	epithelium	in	a	rabbit	model	of	limbal	stem	cell	
disease.(92)	This	therefore	demonstrates	the	range	of	cellular	replacement	therapies	in	
which	decellularised	matrices	provide	major	advancements	in	the	field	of	tissue	
engineering.	Decellularised	human	conjunctiva	warrants	further	investigation	into	its	
potential	clinical	applications	in	ocular	surface	disease.		
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7.	 Appendix	
	
1.	The	Liverpool	corneal	and	external	eye	disease	clinic	pro	forma		
	
(pages	224-228)	
	
	
2.	Ethical	approval		
(pages	229-231)				 	
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BCVA		RE………..									LE……….			
Co-existing	ophthalmic	pathology	(accounting	for	reduced	VA)		………………………………			
Photograph	taken				Y		 N					
Inflammation	activity	score		(Grade	1-5)		RE	 	 	 	 	 	 LE	
	
	
	
	Total	score	 …………			 	 	 Total	score	 …………	
	
	
Limbitis	 RE	 Y	………quadrants/score	 N														LE	 Y	………quadrants/score	 N		
	
Anterior	segment	drawings		
	
RE	
	
	
	
	
	
	
	
	
LE	
Affix	patient	label	
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Cicatrisation	grading	(Tauber-Liverpool)		
	
RE	 	 	 	 	 	 	 	 LE												
Horizontal	width		 ……….mm			
	
Symblephara	 	 ……….mm	
	
	
Horizontal	width		 ……….mm	
	
Symblephara	 	 ……….mm	
	
	
	
I							Subconjunctival	scarring	and	fibrosis	
II					Fornix	foreshortening		
a	 0-25%	
b	 25-50%	
c	 50-75%	
d	 75-100%	
	
I							Subconjunctival	scarring	and	fibrosis	
II					Fornix	foreshortening		
a	 0-25%	
b	 25-50%	
c	 50-75%	
d	 75-100%	
III	 Presence	of	symblepharon		
a	 0-25%	
b	 25-50%	
c	 50-75%	
d	 75-100%	
	
III	 Presence	of	symblepharon		
a	 0-25%	
b	 25-50%	
c	 50-75%	
d	 75-100%	
	
IV	 Ankyloblepharon/	frozen	globe		 IV	 Ankyloblepharon/	frozen	globe		
	
	
	
Vertical	grading			=	………%	
Vertical	grading			=	………%	
Horizontal	grading			=	………%	
Horizontal	grading			=	………%	
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Cicatrisation	by	Foster	grading	scheme	
	
RE	 LE	
I						subconjunctival	scarring	and	fibrosis	
II					fornix	foreshortening	(any	degree)	
III				symblepharon	(any	degree)	
IV				ankyloblepharon/frozen	globe	
I						subconjunctival	scarring	and	fibrosis	
II					fornix	foreshortening	(any	degree)	
III				symblepharon	(any	degree)	
IV				ankyloblepharon/frozen	globe	
	
	
	
Cicatrisation	by	Rowsey	grading	scheme	
	
RE	 LE	
	 	
Score	……./45	 Score……/45	
	
	
Fornix	measure		
	
RE	 Upper	 														mm	 LE	 Upper	 													mm	
	 Lower	 														mm	 	 Lower	 													mm	
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Corneal	involvement		
	
	 	 Grade	0	 Grade	1	 Grade	2	 Grade	3	
RE	 Conjunctivalisation	 	 	 	 	
	 Neovascularisation	 	 	 	 	
	 Opacification-	
peripheral		
	 	 	 	
	 Opacification-	
central	
	 	 	 	
	 	 	 	 	 	
LE	 Conjunctivalisation	 	 	 	 	
	 Neovascularisation	 	 	 	 	
	 Opacification-	
peripheral		
	 	 	 	
	 Opacification-	
central	
	 	 	 	
	
	
	
	
Ocular	dryness	score	(oxford)		
	
	
RE	 	 0	 1	 2	 3	 4	 5	
	
	
	
LE	 	 0	 1	 2	 3	 4	 5	
				
	
Eyelids		
		
Lagophthalmos	 	 Y				……mm	 N				……mm	
	
	
Lashes		 	 no	trichiasis	 	 trichiasis	 acquired	distichiasis	 	
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	 RE	 	 LE	 	
	 Entropion/	
Ectropion	
	 Entropion/	
Ectropion	
	
	 Upper	lid			 Lower	lid	 Upper	lid	 Lower	lid	
Grade	0	 	 	 	 	
Grade	1	 	 	 	 	
Grade	2	 	 	 	 	
Grade	3	 	 	 	 	
	 	 	 	 	
Medial	 	 	 	 	
Lateral	 	 	 	 	
Lateral	+	
Medial	
	 	 	 			
	 229	
	 230		
	 231	
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